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CHAPTER 1 
INTRODUCTION 
1.1 DNA 
1.1.1 Generalities 
All living organisms have a genome containing their complete genetic code. In 
eukaryotic cells, this genetic code is distributed among chromosomes consisting of 
double strand helical DNA molecules. DNA encloses coding and non-coding 
sequences. The coding sequences correspond to genes, which specify the type of 
proteins that are made by the cells. The first step consists of the transcription of the 
DNA to build the messenger RNA (mRNA, Figure 1). Proteins are then synthesized 
from mRNA in a second step called translation [1].  
DNA mRNA Protein
transcription translation  
Figure 1:  Flow of genetic information in normal cells [1] 
As mentioned above, DNA is the center of the complete genetic information for all life 
forms. It consists of a long polymer composed of two twisted polynucleotide chains 
forming a double helix. Each chain is made of repeating units called 
deoxynucleotides or bases. The backbone of each strand is composed of alternated 
phosphate on the 3’ position and sugar moieties on the 5’ position of the 2-
deoxyribose. The bases are located on the 1’ position of 2-deoxyribose. Two different 
classes of bases containing respectively two purine and two pyrimidine derivatives 
build up these chains. The purines are adenine (A) and guanine (G), and the 
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pyrimidines are cytosine (C) and thymine (T, Figure 2). The sequence of bases 
corresponds therefore to the primary structure of DNA. 
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Figure 2:  Purine and pyrimidine bases (abbreviations are shown in brackets)  
In the early 50s Watson and Crick have proposed a model for the structure of DNA 
still in use to date showing four major features: 
- DNA is constituted of two polynucleotide strands forming a double helix and 
held together by hydrogen bonds. Each base has its complementary base 
(Figure 3). Adenine always pairs with thymine (A:T) and guanine with cytosine 
(G:C). This corresponds to the secondary structure of DNA.  
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Figure 3:  On the left, A:T base pairing with two hydrogen bonds and on the right, G:C base 
pairing with three hydrogen bonds. The non-covalent interactions are shown as 
dashed lines.  
- Double helix DNA has different conformations called tertiary structures. They 
show a specific right-handed direction as the most common B-type and as A-
type. Only Z-type DNA is left-handed (Figure 4). DNA is also found in other 
conformations as hairpins, triplexes or guanine quadruplexes [2]. 
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Figure 4:  Tertiary structures of A-DNA (right), B-DNA (middle) and Z-DNA (left) [3]. 
- The ends of each strand are called 5’ and 3’, which correspond to the position 
of the OH groups on the deoxyribose units forming the DNA backbone (Figure 
5). DNA double helixes are anti-parallel and the 5’ end of one strand is paired 
with the 3’ end of its complementary strand. DNA helix is constituted of one 
minor and one major groove. One helical turn is about 34 Å and corresponds to 
about 10.5 base pairs [4]. The main forces stabilizing the double helix are  
π-π interactions between aromatic rings of the bases [5]. 
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Figure 5:  Representation of a DNA helix and a deoxyguanosine moiety (phosphate +  
2-deoxyribose + guanosine) (reproduced after [4]) 
- N-atoms from the bases are still partially accessible to form potential hydrogen 
bonding. These hydrogen bonds provide access to other molecules, like drugs 
or proteins that play essential roles in the replication and transcription of DNA 
[6]. 
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In humans, the complete extended DNA contained in one cell is about 2 m long. To 
fit in the nucleus DNA has to be compressed having a diameter of 5 to 10 µm [7]. 
This packaging is obtained by an interaction of DNA with small basic proteins, the 
histones. DNA wrapped around 8 histones forms the basic unit of chromatin called 
nucleosome (Figure 6). These aggregates have the primary function to reduce the 
volume of DNA and to fortify DNA during the different cell division processes, 
preventing damage, as well as controlling gene expression and DNA replication [1].  
 
Figure 6:  Multiple levels of chromatin compaction (left) with one nucleosome (right). 
(reproduced after [8]).  
Modifications of histones by acetylation, methylation or phosphorylation modulate the 
chromatin structure and mediate the epigenetic regulation of gene expression. This 
mediation is essential for cellular differentiation and morphogenesis, and will induce 
the creation of different cell types possessing different gene expressions but keeping 
exactly the same genome sequence [1]. 
1.1.2 Epigenetics 
From a historical point of view, the word “epigenetics” described all phenomena that 
were impossible to explain by genetic principles. Conrad Waddington defined 1942 
epigenetics as “the branch of biology which studies the causal interactions between 
genes and their products, which bring the phenotype into being” [9].  
A modern definition of epigenetics is “the study of mitotically and/or meiotically 
heritable changes in gene function that cannot be explained by changes in DNA 
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sequence” [10]. In concrete terms, the term “epigenetic” is used to explain the study 
of stable chemical modifications in gene expression that happen during the different 
cell division processes [11], resulting for example in physical changes between 
parents and offspring, as eye or hair color, but maintaining the exact genome 
sequence. The two major molecular mechanisms influencing gene expression are 
histone modification and DNA methylation.  
Epigenetics became recently one of the most expanding fields in biology because of 
important discoveries as the CpG islands, or the finding of new histone variants and 
modifications. Specially recent technological breakthroughs made large-scale studies 
on complete sets of epigenetic modifications on the genetic material of the cell 
possible, and allow nowadays the mapping of epigenetic marks that are critical for 
regulating gene or RNA expression as e.g. histone modification, DNA methylation, or 
nucleosome positioning [12]. Misregulation of these epigenetic marks and mutations 
in the epigenetic development are associated to e.g. cancer, neurological disorders, 
and autoimmune diseases [12]. Exhaustive comprehension of epigenetic 
mechanisms, their interaction and alteration in health and diseases, has become a 
priority in biomedical research [12]. 
1.1.3 DNA mutations 
Mutations are basically changes in the genomic sequence and the most important 
cause of diversity between organisms. All organisms undergo mutations that are 
divided in advantageous, neutral and lethal classes [13]. Advantageous mutations 
can contribute to evolutionary changes due to environmental influences. Lethal 
mutations in cellular processes have been associated with damages in the genomic 
sequence that often result in cancers.  These damages can arise from endogenous 
changes like DNA methylation, replication errors, DNA base instability, or free radical 
attack generated during metabolism. They can also result from exogenous factors 
like ionizing and UV radiations, or chemical carcinogens [14]. 
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a) DNA methylation 
DNA methylation is a very important epigenetic process. It is essential for human 
development, maintaining the organism working normally. DNA methylation is used 
as a powerful mechanism in gene expression and silencing, maintaining genome 
stability. An increasing number of human diseases with many different syndromes as 
e.g. lupus and muscular dystrophy have been associated with aberrant methylation 
[15]. 
The mechanism of DNA methylation is based on the covalent addition of a methyl 
group on the 5 position of a cytosine that is preceded by a guanosine in the DNA 
sequence (CpG nucleotide). This methylation, also called CpG methylation, depends 
on the methyl donor cofactor S-adenosyl methionine (SAM) and the enzyme DNA 
methyl-transferase, whereby SAM is transformed in S-adenosyl homocysteine (SAH) 
as shown in Figure 7. The SAM/SAH ratio has often been used as an indicator of 
cellular methylation potential with cases of hypomethylation (decrease of 
methylation) or hypermethylation (increase of methylation). This ratio is determined 
using stable isotope dilution tandem mass spectrometry [16]. 
 
Figure 7:  DNA methylation mechanism (reproduced after [17])  
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b) UV induced mutations 
UV solar radiation is known to induce DNA mutations and to be directly involved in 
human skin cancer. UV light is classified in three categories, UVA (400-315 nm), 
UVB (315-280 nm), and UVC (<280 nm). Only radiations in the range of UVA and 
about 10% of UVB reach the earth surface, the rest of UVB and UVC is absorbed by 
the ozone protecting layer in the atmosphere [18]. Decrease of the ozone layer due 
to human activities became recently a problem on earth. The resulting increase of 
UVB radiations, the most energetic, mutagenic and carcinogenic part of solar 
radiation, is directly absorbed by cellular DNA and associated to skin cancer [19].  
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Figure 8:  Wavelength domains of UV radiations and absorption spectra of single and 
double strand DNA 
DNA absorbs UV light between 220 and 300 nm (Figure 8), leading to the formation 
of mainly cyclobutane pyrimidine dimers (CPD) and pyrimidine pyrimidone 
photoproducts (6-4 PP). CPDs are formed in a [2+2] photocycloaddition reaction, 
whereby the C5-C6 double bonds of adjacent bases are fused in a cyclobutane ring. 
6-4 PPs also undergo [2+2] photocycloadditions, involving the C5-C6 double bond 
and the C4 carbonyl group of two adjacent pyrimidines [20].  
Formation of other photoproducts has been observed to a lesser extent, e.g., 
reaction between two adjacent adenine bases or between adenine and vicinal 
thymine, oxidation of adenosine in 8-oxo-7,8-dihydro-2’-deoxyguanosine (Figure 9), 
and photohydration of cytosine [21]. Cross-linked reactions have also been reported 
in G-quadruplex between two non-adjacent thymidines [19].  
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Figure 9:  Photooxidation of adenosine generated by either UVB or UVA light 
The most intensively investigated UV induced DNA modifications are cyclobutane 
pyrimidine dimers and pyrimidone photoproducts [21]. These mutations occur 
between adjacent purine bases TpT, TpC, CpT and CpC under UVB and A radiations. 
The dimerization yields are variable and correspond to about 1-18 lesions per  
109 bases [21]. TpT is described as most reactive pair. Figure 10 represents all 
cyclobutane pyrimidine dimers (c-s T<>T and t-s T<>T) and pyrimidone 
photoproducts (6-4 TT and Dewar TT) formed under UVC and B radiations. The 
yields of photoisomerisation of 6-4 TT in Dewar TT are significantly increased at  
312 nm.  
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Figure 10:  Structure of thymine dimeric photoproducts induced by UV-light 
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Many DNA mutations are triggered by UVB radiation because of the low energy 
absorbance of DNA at wavelengths above 315 nm. Nevertheless, UVB and UVA 
radiations can lead to photooxidative reactions. The reaction mechanism is still 
unclear but deoxyguanosine is probably transformed to 8-oxo-7,8-dihydro-2’-
deoxyguanosine, induced either by !OH radical or by a reaction between a singlet 
oxygen and a triplet excited purine base [18, 22].  
Non-covalent interactions of small molecules with DNA may have an influence on 
DNA mutations. They will therefore be discussed more in detail in the next chapter. 
1.1.4 Non-covalent interactions with DNA 
a) Generalities  
Non-covalent interactions with DNA play an essential role in biological processes 
because they are the molecular basis of many anti-tumor, anti-bacterial and anti-viral 
drugs [23]. DNA is a long polymer chain made of two strands held together through 
non-covalent H-bonding between complementary bases and stabilized by π -π 
interactions. The wrapping of both strands forms a right-handed helix with a major 
groove and a minor groove. These grooves and the anionic  
5’-phosphate 2-deoxyribose backbone lead DNA to form non-covalent complexes 
with various substrates, as e.g. small molecules, metal ions, and proteins.  
Different interactions have been observed including major- and minor-groove, 
intercalation between bases, ion pairing with the sugar-phosphate backbone, 
covalent binding or metal–coordination with the bases [24].  
Compounds with a high affinity to DNA can influence gene expression and at the 
same time affect cell proliferation and cell differentiation [25]. The structure of drugs 
with a broad domain of activity as e.g. antiviral, antibiotic, and anticancer that interact 
non-covalently with DNA are shown in Figure 11 [23, 25, 26]. 
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Figure 11:  Drugs forming non-covalent interactions with DNA.  
Chemical bonds are classified in covalent, ionic, metallic, and intra-molecular or non-
covalent bonds. They have a different energy, varying roughly from 100 kcal/mol for 
carbon-hydrogen bonds down to 2-20 kcal/mol for non-covalent interactions. Weak 
reversible bindings due to e.g. electrostatic forces (Van der Waals, Coulomb, Debye, 
Keesom, or London, several kcal/mol), π -π interactions (2-10 kcal/mol), and 
hydrogen bonding (5-18 kcal/mol) are playing a key role in the majority of relevant 
biological processes [27]. 
b) Non-covalent interactions between oligonucleotides and ligands 
Five types of non-covalent binding between ligands and oligonucleotides have been 
described: 1) electrostatic attraction with the negatively charged DNA backbone,  
2) major groove interactions, 3) minor groove interactions, 4) intercalation between 
base pairs in the major groove, and 5) intercalation between base pairs in the minor 
groove [28].  
Considering the two most important binding modes, intercalation and minor groove 
interactions, intercalation was recognized first because tertiary structure and 
chemical properties of DNA are affected. Rapidly, this change of DNA shape showed 
a high mutagenic potential and inspired DNA-targeted chemotherapy [29].  
The driving forces of intercalation interactions are coming essentially from π-stacking 
and stabilizing electrostatic interactions, where the ligand, mostly small organic 
molecules with an aromatic system, needs maximum overlap with the DNA base pair 
(Figure 12). Interactions occur with a slight preference in regions of alternating 
pyrimidine-purine bases, with a weak selectivity for 5’-CG compared to 5’-TA [29]. 
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Figure 12:  Intercalation complex between two doxorubicin drugs (pink) and DNA [24] 
The concept of groove binding by small molecules is more recent. Despite the fact 
that minor groove binding drugs are under-represented in clinical use, they are 
presented as the most promising targets for de novo design [29]. The minor groove 
of DNA is reported as an AT-rich region, and a majority of minor-groove ligands bind 
certainly to the minor-groove in B-DNA [25]. Stability is obtained via strong van der 
Waals interactions between negative electrostatic potential of the DNA backbone and 
mainly positively charged ligands at physiological pH (Figure 13).  
N
H
NH2
NH2
NH2
H2N
 
Figure 13:  Minor-groove interactions between DAPI (pink) and DNA [24] 
Groove width, groove depth, and electrostatic potential are critical DNA features for 
the recognition of small molecules. Width of the minor groove varies with the 
sequence [29]. GC-rich grooves (8 Å) are twice as large as AT-rich ones (3-4 Å). The 
depth of GC-rich grooves is less pronounced than that of AT due to the exocyclic 
amine. On the other hand, this amine has a nucleophilic character, increasing the 
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recognition through formation of H-bond bridges. Compared to intercalation, minor 
groove binding induces little or no conformation changes in DNA [29]. Interactions 
along minor grooves occur simultaneously with individual base pairs and the sugar 
wall and provide cooperative binding contacts, leading to an increase of recognition 
specificity and also to a high degree of target selectivity [29]. 
c) Examination of non-covalent interactions using mass spectrometry 
It is normally impractical to study interactions between the huge genomic DNA and 
small ligands. Therefore, short sequences of single or double DNA strands with 
around 4-20 oligomers have been chosen. They can on one hand mimic important 
DNA active sites and on the other hand allow collection as well as interpretation of 
analytical data. Various methods are known for investigating non-covalent 
interactions between substrates and DNA. Analytical procedures based on NMR or 
IR spectroscopy, circular dichroism, gel footprinting or X-ray crystallography have 
been described to determine binding stoichiometry, specificity and affinity of such 
complexes.  
The possibility to measure and analyze large and fragile biomolecules raised with the 
development of electrospray ionization mass spectrometry (ESI-MS) by Fen et al. in 
the 80’s [30]. ESI is a soft ionization technique, which allows the direct transfer of 
numerous samples from solution to gas phase at room temperature and atmospheric 
pressure. This method is so soft that non-covalent interactions can be investigated 
with mass spectrometry. Furthermore, Mc Lafferty mentioned 1981 that MS merges 
the three “S” benefits, sensitivity, specificity and speed, leading to one of the most 
powerful analytical technique available [31].  
ESI-MS has the major advantage of requiring only very small amounts of sample in 
the low-picomole range [25]. The selectivity of the method leads to a decrease of 
chemical noise arising from complicated matrices by tuning the MS parameters in 
order to favor transmission of large ions. Depending on their molecular mass and 
polarity, (bio)molecules are detected as single or multiple charged particles.  
Figure 14 shows for example the ESI-MS of a 14mer double strand (ds) DNA 
acquired in the negative ionization mode under formation of 4– and 5– charged ions. 
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Figure 14:   ESI-MS spectrum of ds DNA, d(GGCGGAATTCGCGG/CCGCCTTAAGCGCC) 
(ssa/ssb; MR 8525.5 Da),  
1 pmol/µL in propan-2-ol/(2.5mM piperidine+imidazole v/v) 1:1 
Many different types of non-covalent interactions as e.g. protein-protein [32], protein-
ligands [32], DNA-protein [32, 33], DNA-RNA [34], DNA-DNA [34], and DNA/RNA-
small molecules [23, 25, 34] have been investigated by MS. Two important aspects 
have to be considered in such analyses: 1) how do the complexes behave during the 
transfer from solution to gas phase and 2) do the observed ion signals really 
correspond to ionized species present in sample solution? Joseph Loo summarized 
in 2000 the experimental principles of the MS method used for studying non-covalent 
complexes. At the same time, he tried to correlate the problematic of transfer 
between solution and gas phase. He pointed out important experimental variables as 
solution conditions for efficient and effective desolvation, insisting on buffer pH and 
ionic strength, which are critical for the targeted non-covalent complex stability.  
By now it is broadly accepted that stoichiometry of complexes in solution and their 
relative signal intensities show good correlations in ESI-MS. It has been 
demonstrated that the types of interactions in the complexes influence MS results 
and can be differentiated by ESI-MS considering the gas phase ions [35]. Of course, 
results obtained by ESI-MS should be confirmed by other analytical methods, in 
particular by those based on dissolved samples such as NMR, IR spectroscopy, or 
circular dichroism. To smaller extent also other methods such as X-ray 
crystallography can be used to support MS results. 
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Stoichiometry 
MS can be used for qualitative and quantitative studies of non-covalent interactions. 
Figure 15 shows two ESI-MS spectra of a 14-mer ds DNA sequence mixed with 
vitexin, a common flavonoid, at two different ratios of 1:10 and 1:80. 
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Figure 15:  Complex of 14-mer ds DNA, d(AACTCCCGGCACAC/GTGTGCCGGGAGTT,  
1 pmol/µL in propan-2-ol/(2.5mM piperidine + imidazole v/v) 1:1, with vitexin at a 
DNA/vitexin ratio of (A) 1:10 and (B) 1:80, respectively 
In a first step the charge state of the ions detected has to be assigned and the most 
abundant ionic species characterized. Considering the 5– ions, the base peak signal 
at 10-fold excess of vitexin was corresponding to free ds DNA. However, at 80-fold 
excess, the base peak was shifted to the 1:2 ds DNA // vitexin complex. 
Selectivity 
The affinity of a ligand to specific DNA sequences, e.g. with GC rich or AT rich 
regions, can also be investigated using ESI-MS. After measuring different sequences 
with one ligand, it is possible to determine if this ligand has more affinity with AT or 
with GC rich regions. In a further step, such results can be extrapolated to interaction 
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properties of this substrate with DNA [25]. This type of studies, where different 
ligands have been mixed to different DNA sequences, will be presented in Chapter 2. 
Estimation of interaction forces 
ESI-MS can also be used to estimate relative forces of interactions. Competitive 
experiments can be performed using for example one sequence of single or double 
stranded DNA mixed with different ligands. The sequence is chosen in order to mimic 
the DNA active site or to show some specific properties as e.g basicity or shape. 
Comparing the signal intensities of the complexes detected by ESI-MS allowed the 
determination of the ligand showing the highest affinity to a given sequence [25]. 
In Figure 16 self-complementary single strand ATAT has been used to screen the 
four ligands Hoechst 33342, 4',6-Diamidino-2-phenylindole (DAPI), Netropsin, and 
Berenil. Comparing signal intensities in all ESI-MS spectra, one can conclude that 
Hoechst 33342 shows the strongest interactions with ATAT, with almost 
disappearance of ATAT signals [36]. 
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Figure 16:  Comparison of four different drugs interacting with the single strand sequence 
ATAT (10 pmol/µL in NH4OAc aq. with 20 % MeOH) (reproduced after [36]).  
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Another way to estimate le relative force of interaction is to use ESI-MS/MS, as for 
example between ds DNA and flavonoid aglycones or glycosides [37]. Aglycone 
flavonoids were shown to interact less strong with DNA than glycosylated flavonoids, 
because the neutral loss of the ligand was found to be more prominent in the MS/MS. 
On the other hand, the higher affinity of glycoside flavonoids to DNA was confirmed 
with the loss of base fragments. Figure 17 shows the MS/MS spectra of a given DNA 
sequence with four different flavonoids obtained by fragmenting the 5– precursor ions 
of the ds DNA // flavonoid complexes [38]. The four spectra show rather different 
fragmentation patterns. At most complete loss of ligand is observed in spectrum A), 
indicating a rather low force of interaction between the aglycone flavonoid quercetin 
and ds DNA. In the case of the isoflavone glycoside genistin (spectrum C), the loss of 
a few bases losses is observed in the ESI-MS/MS. However, in the case of the ds 
DNA complexes of glycosylated flavonol and flavanone vitexin and rutin, almost 
exclusively loss of nucleobases and no loss of the ligands was observed (spectra B 
and D), indicating strong interactions between ligands and ds DNA. 
A C
B D
[m/z][m/z]
 
Figure 17:  (–)-ESI-MS/MS spectra showing the 5– charged complexes of dsDNA with A) 
quercetin; B) vitexin; C) genistin; and D) rutin. Precursor ions are labeled with an 
asterisk [39].  
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1.2 Quantification!
1.2.1 Introduction 
Quantitative determinations are demanded in various domains as, e.g. discovery, 
development and manufacturing of new pharmaceutical drugs, food contaminants, 
environmental pollutants, forensics, and proteomics. Many analytical methods have 
been developed for this purpose, principally based on high-performance liquid and 
capillary gas chromatography combined with detection systems as e.g. mass 
spectrometry, UV, fluorescence, or flame ionization.  
Two approaches of quantitative determination can principally be followed:  
- Qualitative: consists in calculating the relative quantity of one or more 
substances in comparison to each other. This is presented in Chapter 2, where, 
the relative intensities of complexes between secondary metabolites and short 
DNA sequences are used to quantify the fraction of bound DNA. 
- Quantitative: leads to determine absolute amount or concentrations of one or 
more substances, as showed in Chapter 4, where the absolute amount of 
methylation grade is quantified in patients DNA. 
These procedures do not depend on the analytical method used. Qualitative 
quantifications are usually easier to perform whereby quantitative are more accurate. 
Considering the application domains mentioned above, quantitative methods are 
prevalent.  
Since all quantitative experiments are subject to various errors and uncertainties, it is 
essential to consider and to estimate these errors in order to be able to interpret 
correctly the results obtained and to draw the right conclusions. For this purpose, a 
model based on a theoretical error distribution has been designed with a 
mathematical equation in order to evaluate the “precision” of the measurement. 
Typically, repeated analyses follow a Gaussian or normal distribution that can be 
represented by equation (1) and the curve shown in Figure 18 [40]. 
(1) f (x) = 1
σ 2π exp
−(x −µ)2
2σ 2
"
#
$
%
&
' −∞ < x < +∞  
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Figure 18:  Gaussian curve with µ mean and σ2 variance 
In a normal distribution, µ represents the mean corresponding to the real value of the 
quantity that is measured (Figure 18). The spread of the curve σ, also known as 
standard deviation, indicates the random error of the measurement.  
The mean x , average value of a few replicate measurements (see equation 2), and 
its standard deviation s (3) can be used to evaluate µ and σ, which are the 
characteristics of hypothetical and infinite populations of data. 
(2) x =
xii∑
n  
and 
 
(3) s =
(xi − x )i∑
n−1  
with n measurements, x1,x2 , etc. 
The mean x  and the standard deviation s allow calculating the relative standard 
deviation (RSD) that is more commonly expressed as a percentage and is called 
coefficient of variation (CV): 
(4) CV (%) =100 sx  
CV represents the dispersion of the probability distribution of x1,x2 , etc.  
Qualitative quantification approaches can be used, e.g., to follow the completion of 
chemical reactions by comparing the signal intensity of the reaction product(s) with 
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that of the starting material(s). Within this thesis, absolute amounts of sample 
components have been determined and therefore quantitative aspects will be 
presented in more details.  
1.2.2 Quantitative aspects 
a) Calibration 
Every quantitative measurement needs a specific calibration for each analyte. In this 
most important step, the detector response of the instrument has to be correlated to 
the concentration of the analyte. 
Different modes of calibration are available and their choice depends on sample 
complexity, matrix, and accuracy of the results required. “External calibration” and 
“internal calibration” are the two most familiar methods used. The “area 
normalization” approach is often used to determine the purity of a sample in the case 
where no internal standard exists or where the relative concentration of a substance 
is more significant than the absolute concentration. The technique of “standard 
addition” is applied if no blank sample is available and the matrix of the sample may 
influence the retention time and/or the detector response of the analytes.  
For complex matrices as e.g. plasma or plant material, it is suggested to prepare the 
calibration curve in blank matrix, where all elements of the sample are found except 
the compounds that have to be quantified. Such a matrix-based calibration is not 
required if the matrix does practically not influence chemical or physical properties of 
the molecules and therefore their signal response [41]. 
External calibration 
First, a precise amount of reference standard – analyte itself in a pure form or 
substance with closely related structure – is weighted and diluted in an adequate 
solvent (aqueous or organic, with or without buffer) to prepare a stock solution. From 
the stock solution, different dilution steps are performed to obtain several solutions of 
different concentrations in the range of interest and to have enough data to make a 
calibration curve. At least five to six points are needed for a suitable calibration curve.  
A calibration curve can be built up following a linear or an exponential dilution 
scheme [41]. Linear calibration points are distributed regularly over the chosen 
concentration range. However, by an exponential dilution scheme, there is a higher 
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density of calibration points in the lower concentration range. Then the same volume 
is injected for each concentration. In both cases a linear plot is usually obtained. 
Analyses of highly concentrated standards in the upper range of the calibration curve 
can lead to sample carry over. It is therefore preferable to perform the measurement 
for the calibration curve from the lowest to the highest concentration to avoid this 
problem and measuring a blank sample after the most concentrated standard 
solution. 
When all standard concentrations used for the calibration curve have been measured, 
the calibration curve can be plotted and the concentration of an unknown analyte 
calculated using the slope S’ of this curve: 
(5) ng /mL analyte = area analyteS '  
An external calibration can only be used in cases of simple sample preparation 
(weighing, dilution, dissolution, pipetting, filtration) and minor matrix effects, which 
exclude loss of analyte and standard. 
An example of the use of external calibration to determine the concentration of 
cytosine is shown in Figure 19. These data of quantification of the DNA methylation 
grade were obtained with a method base on UHPLC-MS/MS for the quantification of 
the methylation in DNA (see Chap. 4 for more details). 
A better accuracy can be obtained with the addition of an internal standard (IS) and 
performing an internal calibration. 
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"Linear" regression: y = 2.2e+003 x 
R = 0.9821
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Figure 19:  Quantification determination of cytosine with external calibration and linear 
dilution scheme using UHPLC-ESI-MS/MS 
Internal calibration 
Internal calibration is often used in cases of critical sample preparation, e.g. low 
extraction yields and problems of adsorption or evaporation. 
Set up of the standard solution and of the calibration curve is similar for internal and 
for external calibration. In the case of internal calibration, a known amount of IS is 
added to all samples and to all calibration standards preferentially prepared in blank 
matrix, prior to any sample preparation step. All samples are then treated with the 
same sample preparation procedure.  
After analyzing all samples in a sequence, analyte concentrations are calculated on 
the same basis as for external calibration with one modification. Instead of measuring 
absolute analyte areas, the ratio between areas of analyte and IS as shown in 
equation (6) are used [41]: 
(6) ng /mL analyte = area analyte / area ISS '  
In case of external calibration, the quantity is correlated to an absolute value of the 
signal area. However, the quantity is related to the ratio of IS and analyte signal area 
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if internal calibration is performed. The use of relative amounts usually significantly 
improves accuracy of the calibration curve and leads to increased correlation 
coefficient. 
Data quality strongly depends on the choice of the IS. Prerequisites for successful 
quantification with internal calibration are [41]: 
i) Has to be as similar as possible to have the most comparable chemical 
properties compared to the analyte in order to avoid any discrimination 
during sample preparation and analysis;  
ii) The IS must be chemically stable under work-up conditions; 
iii) Whether IS nor any sample compound with the same retention time as the IS 
have ever been detected in the same sample; 
iv) Pure IS or at least IS with known purity is required. Eventual contaminations 
have to be characterized and may not interfere with the sample;  
v) The IS has to be well resolved from all unknown peaks in the chromatogram 
but still have a preferably similar retention time as the analyte; 
vi) Chromatographic resolution higher than 1.5 1  is recommended between 
analyte and IS, except in LC-MS methods using stable-isotope-labeled 
(SIL) internal standards (see Chap. hereafter); 
Figure 20 shows a calibration curve with IS calculated from the same data used for 
external calibration (Figure 19). After internal calibration correction, the coefficient of 
correlation of the linear regression increased from R = 0.9821 to 0.9997. Such an 
improvement illustrates the importance of IS for correcting handling and instrumental 
inaccuracies. 
                                            
1 The resolution Rs is defined as the distance between the centers of two eluting peaks as measured 
by retention time or column volume divided by the average width of the respective peaks. Baseline 
resolution between two well formed peaks indicates 100% purity and requires an Rs value above 1.5 
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"Linear" regression: y = 0.0302 x + 0.0108
R = 0.9997
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Figure 20:  Calibration curve obtained for cytosine quantification after correction with the 
signal area of labeled cytosine as IS according to equation (6) 
Standard addition 
The method of standard addition consists of spiking the sample that contains the 
substance to quantify with this substance in a pure form. This procedure is 
appropriate if no blank sample is available and if the sample matrix may influence the 
recovery and the detector response of the analyte.  
The method can be used with a single or a multiple-point calibration. In the case of a 
single point calibration, the sample is split in two similar fractions. The first one is 
used as it is and to the second a known amount of reference standard is added. Both 
samples are then prepared and analyzed exactly the same way. The signal areas of 
the two measurements are then compared, and known this, the concentration of the 
original sample, without added standard, can be estimated. 
More accurate than the single point calibration is the multiple-point calibration. For 
this, the sample is split into fractions that contain different amounts of standard 
material in order to obtain a calibration curve. The concentration of the unknown 
sample corresponds then to the intersection of the regression line with the x-axis [41] 
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(Figure 21). The accuracy can be improved by using an internal standard (different 
compound with similar properties (see above)). 
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Figure 21:  Benzene quantification in urine samples using standard addition. The 
concentration can be calculated using the equation of the linear regression  
(y = 10.863x + 2.5748, R2 = 0.9981). A and B are urine samples spiked with 2.30 
and 0.29 µg/L of benzene, respectively. Intersection y = 0: x = –0.237 and 
[benzene] = 0.237 µg/L (Reproduced after [42]). 
Area normalization 
This procedure is often used to follow the completion of a chemical reaction and the 
purity of the product(s) formed. The results of this qualitative method can be reported 
as “percentage peak area” or as “area normalization”. In the first case, all signal 
areas are added and then every peak is described as a percentage of the total. 
In the case of results expressed as “area normalization”, all peaks are reported to 
one chosen reference signal and described as a percentage of this reference.  
For both techniques it is presumed that the detector response is the same for 
unknown and standardized signals. This is often not the case and represents a 
strong limitation factor that is difficult to avoid [41]. 
Quality control (QC) samples 
QCs analyses during method development and validation are used for several 
reasons, e.g. to check precision, accuracy, limit of quantification, recovery and 
robustness and ruggedness of a method. They are required for the validation of new 
analytical processes (inter- and intra-day, inter- and intra-assay) and for stability 
studies. 
Chapter 1 ! Introduction 
 25 
QC samples are preferably prepared from weighed aliquots of blank matrix spiked 
with known amounts of analytical standard. Stock solutions of analytical standard 
used for QC samples should be set up independently from those used to obtain the 
calibration curve in order to check potential weighing errors. 
Measurements of QC samples are distributed into the analysis sequence between 
blanks, calibrators and analytical samples. They are not used in the calculation of the 
calibration curve but they permit to evaluate the acceptability of the results within the 
sequence and in a longer-term study, e.g. over weeks or months [43]. 
b) Systematic and random errors 
Analytical instruments produce error-prone data. In order to estimate the individual 
error of a final result it is necessary to know the type and origin of the contribution 
errors due to the experimental set-up or the analytics (every single instrument has its 
own error). Two types, random and systematic errors, have been described.  
Random errors, which are unpredictable, describe errors that affect the measurement 
such as temperature changes or mostly human errors. The term of “random errors” is 
also associated with the term of “precision” (see Figure 22). The random errors are 
analyzed with statistical methods, using means, standard deviation and coefficient of 
variation. Random errors can be reduced by repeating the measurement many times, 
and obtaining a more precise mean value. Higher precision measurements will lead 
to smaller standard deviations (fluctuation) of the final result. 
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Figure 22.  Illustration of “mean value”, “accuracy” and “precision”  (Reproduced after [43]) 
Systematic errors are predictable and are usually due to the analytical 
instrumentation. They could arise from problems such as poor calibration or 
imperfection in data processing. Systematic errors represent the deviation of the 
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mean values obtained from the “true” values. This deviation is also called “accuracy” 
(Figure 22).  
It is important to know the quality of the quantification in terms of precision and 
accuracy (see Figure 23) and to find out the origin of observed or even suspected 
systematic errors in order to minimize them. In contrast to random errors, multiplying 
the number of analyses will not attenuate systematic errors. Only identifying and 
quantifying systematic errors can improve the accuracy of the results. 
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Figure 23:  Dartboard visualizing term of precision and accuracy (Reproduced after [43]) 
c) Limit of detection (LOD) and limit of quantification (LOQ) 
The LOD is defined as lowest amount or concentration of an analyte where still a 
signal-to-noise ratio (S/N) of 2-3 is observed (see Figure 24). At this ratio, the analyte 
is still detected but the signal intensity is not sufficient to allow quantifications. In 
chromatographic methods, the signal of the analyte would have two or three times 
the intensity of the base line (noise). 
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Figure 24:  Minimal S/N ratio allowing (A) detection and (B) quantification 
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The LOQ corresponds, on the other hand, to the minimum amount injected producing 
a signal that would be within the standard deviation of the calibration curve. Ten to 
twenty times the intensity of the base line noise obtained for the matrix (blank 
sample) is usually enough to be used for precise quantifications [44]. 
d) Dynamic range and linearity 
The dynamic range of a detector is defined as upper and lower limit of analyte 
concentration allowing quantifications with sufficient precision and accuracy.  
Analytical methods with a linear dynamic range yield data proportional to the analyte 
concentration. Usually, this domain corresponds to a linear sensitivity of the detector 
within a determined value (normally ±5%) [44]. Dynamic ranges are mostly 
expressed in linear curves, although quadratic or enhanced quadratic curves can 
also be obtained.  
Determination of cytosine using a QTOF mass analyzer in full scan mode, lead to a 
quadratic regression over the quantification range. The same determination 
measured with a Qtrap mass analyzer, scanning in triple quadrupole MS/MS mode, 
leads to a linear regression (Figure 25). 
0 500 1000 1500 2000 2500 3000
0.0
0.5
1.0
1.5
2.0
2.5
3.0
Analyte concentration / IS concentration
A
na
ly
te
 a
re
a 
/ I
S
 a
re
a
0.0
0.5
1.0
1.5
2.0
2.5
3.0
A
na
ly
te
 A
ae
a 
/ I
S
 a
re
a
200 600 1000 1400 1800 2200 2600 3000
QTOF cytosine calibration curve QTrap cytosine calibration curve
A B
 
Figure 25:  Calibration curve of cytosine obtained from (A) QTOF and (B) QTrap mass 
analyzer data 
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1.2.3 Selection of the analytical method 
a) Generalities 
The choice of the analytical method used for quantification depends extremely on the 
complexity of the sample. Urine, plasma, blood, plant extracts, spider venom, 
wastewater, or solid matters are analyzed with different procedures due to different 
properties of the matrices. It is also important to know how many components have 
to be quantified in order to choose the adequate method. For instance samples 
containing only one component do not require the use of hyphenated 
chromatographic methods. For mixtures, However, a chromatographic separation 
method is required, e.g. gas chromatography (GC), ultra high performance liquid 
chromatography (UHPLC) or, to lesser extent, capillary electrophoresis (CE).  
Numerous spectroscopic methods can be used for quantification as e.g. nuclear 
magnetic resonance spectroscopy, Fourier transform infrared spectroscopy, UV/Vis 
spectroscopy, fluorescence spectroscopy, flame ionization (in combination with GC), 
diode array (HPLC, CE), or mass spectrometry (GC, HPLC, CE). Hyphenation of 
chromatography prior to detection leads to the most powerful quantification methods.  
b) Chromatography 
Chromatography is required in many areas of analytics, like e.g. discovery, 
development and manufacturing of new pharmaceutical drugs, food contaminants, 
environmental pollutants, or forensics, because the target compounds are dissolved 
in complex matrices. The two separation methods most widely used in analytical 
quantification are GC and HPLC/UHPLC. Both techniques are complementary and 
will be described in more detail below. 
Gas chromatography (GC) 
The basic process of GC involves sample evaporation in a heated injector, followed 
by separation of the mixture components in an appropriate GC column. Only (small) 
volatile molecules, which do not decompose during injection, are appropriate for GC 
analysis as e.g. pesticides, flavors, essential oils, hydrocarbon fuels, and many drugs. 
Analytes as e.g. acids, amino acids, amines, amides, saccharides, and steroids are 
too polar and require derivatization in order to increase their volatility and/or stability 
[45]. GC can be used for qualitative analyses like controlling purity of a substance, 
and for quantitative determinations. The parameters that influence separation on GC 
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columns are the type of carrier gas, the properties of the stationary phase, the length 
and diameter of the column, and temperature. 
An inert carrier gas, usually helium or nitrogen, allows the analytes to elute. The gas 
has to be highly pure to avoid constant detection of chemical noise and column 
degradation. The velocity of the carrier gas plays a role in the separation of the 
analytes. 
A GC column consists of an open fused silica capillary of 10 to 60 m length with an 
inner diameter between 0.10 – 0.53 mm [45]. The inner capillary walls are uniformly 
coated with a liquid film of stationary phase as e.g. methylated polysiloxane. The 
choice of the column and its stationary phase is mainly depending on, the polarity of 
the compounds and the presence of specific functional groups. The column is heated 
because the boiling point (or vapor pressure) also influences the separation. 
Analyses can be performed at constant temperature (isothermic run) or temperature-
programmed. In this case, the temperature is increased at a constant rate in order to 
elute also compounds with stronger retention [45]. A compromise in the temperature 
gradient has to be found in order to optimize separation efficiency and analysis time.  
The critical point in GC injection is the required fast transfer of the mixture into the 
gas phase and onto the column. The goal is to minimize peak broadening and to 
maximise the signal-to-noise ratio for each analyte [45]. Many injection systems have 
been developed, whereby split/splitless is most common. The split mode is used for 
highly concentrated samples and splitless mode for trace analyses. Programmable-
temperature vaporizing (PTV) and cold on-column injectors are used for the analysis 
of heat-sensitive compounds. These injectors also show optimal recovery for most 
analytes because the discrimination during the injection process is reduced [45]. 
Quantitative determinations by GC are usually performed with a mass spectrometer 
or with flame ionization detector, whereby MS is the most sensitive and selective 
analyzer (see hereafter). 
High performance liquid chromatography (HPLC) and ultra high performance liquid 
chromatography (UHPLC) 
HPLC and UHPLC are used for the separation of various analytes, in particular non-
volatile organic compounds. Both techniques need a stationary (column) and a 
mobile (solvent) phase. In analytical chemistry, columns of 30 to 250 mm length and 
1 to 4.5 mm diameter are filled with stationary phase, usually silica based, of 1.7 to 
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10 µm particle size [41]. Columns are characterized according to retention strength 
and selectivity, whereby several practical requirements such as sufficient stability, 
reproducibility, peak shape and column efficiency N2 play an important role.  
Various solid supports exist for separation by reversed-phase (most widespread), 
normal phase, hydrophilic interaction liquid chromatography (HILIC), ion exchange, 
and size exclusion. 
Reversed-phase chromatography involves alkyl chains like C18, C8 or C4 covalently 
bound via silicon to a solid support and a polar mobile phase containing water. Polar 
molecules will interact stronger with the polar mobile phase and are retained less on 
the column, whereas apolar molecules will interact stronger with the hydrophobic 
column and be retained more. Selection and percentage of the organic solvent 
(mostly acetonitrile or MeOH) influences the strength of retention. Analyses can be 
performed with isocratic or gradient elution. The advantage of the gradient elution is 
to obtain best analyte separation efficiencies at different polarities. 
Solvent pumps of HPLC instruments support pressures up to 400 bar. Recently, 
UHPLC systems have been developed for very fast separations in a few minutes [41].  
They can operate with up to 1000 bar pressure and allow the use of special columns 
with smaller particle sizes, between 1.7 to 2.2 µm. The high backpressure resulting 
from the small particle size can be partially compensated by increasing the column 
temperature.  
Higher N values and better separation efficiency allow decreasing run time without 
loss of resolution, as shown in Figure 26 [41]. 
                                            
2 Column efficiency is influenced by the particle size and characterized as number of theoretical plates 
N 
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Figure 26:  Separation of a standard mixture using (A) HPLC and (B) UHPLC (Reproduced 
after [46]) 
c) Mass spectrometry as method of choice 
Mass spectrometry (MS) is nowadays one of the most powerful detection methods 
used in quantitative analytics. Because of unreached specificity and sensitivity, 
quantitative applications have been developed in a wide range of areas such as 
environmental and food chemistry [47-50], doping analysis [51-53], pharmacokinetics 
[54-56] and all “omics” technologies [57-59].  
Selection of ionization methods 
For mass spectrometry, neutral molecules have to be ionized, in order to be 
separated according to their mass-to-charge ratio. The most common methods used 
for ionization are electron ionization (EI), chemical ionization (CI), electrospray 
ionization (ESI), atmospheric pressure chemical ionization (APCI) and matrix-
assisted laser desorption ionization (MALDI). The choice of the ionization mode will 
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depend on the polarity and molecular weight of the compounds of interest (see 
Figure 27).  
Molecular 
Weight
1’000
15’000
200’000
EI/CI
APCI
ESI
Non
Polar
Highly
Polar
 
Figure 27:  Domains of efficient ionization in relation to polarity and molecular weight of the 
analytes 
i) Electron ionization is the method of choice for thermally stable and volatile 
compounds with a molecular mass below 1’000 g/mol. Substances are transferred in 
the ion source of the MS into the gas phase by evaporation. The vaporized 
molecules collide with a 70 eV energy rich electron beam, are ionized by loss of an 
electron, and form cationic radicals (M+!, molecular ion). These ions possess a 
residual energy of 10 ± 3 eV that leads to fragmentation reactions [60], whereby the 
most abundant charged particles are stable fragment ions or products of favored 
fragmentation reactions. Knowledge about these reactions can be used for structure 
elucidation. Furthermore each compound shows under EI conditions (70 eV) a 
specific EI fragmentation pattern that can be used as fingerprint. These analytical 
data can be collected in databases of EI mass spectra, as e.g. the well-known NIST 
or Wiley libraries. 
ii) Chemical ionization is also used for the thermally stable and volatile molecules. It 
is softer than EI, and quasi-molecular ions [M + H]+ or [M - H]- with almost no 
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fragmentation are produced. Negative chemical ionization is mostly used with 
compounds containing acidic or highly electronegative (halogen or nitro) groups. The 
process of chemical ionization starts with the ionization of a reactant gas as  
e.g. CH4, i-C4H10 or NH3 by EI. These ionized reactant gases can then act as acids, 
and the molecules of the analyte are ionized in a second step by proton transfer 
reactions. CI is principally used for the quantification of pesticides containing nitro-
aromatic derivatives. 
iii) Electrospray ionization allows the soft transfer of a broad diversity of compounds 
into the gas phase; compounds with a molecular mass up to several 100 kDa as e.g. 
inorganic ions, peptides, proteins, nucleic acids, and polymers [61]. Ionization is 
effected by spraying a sample dissolved in a polar solvent, such as H2O, CH3CN, or 
CH3OH, and that contains a volatile buffer from a capillary tip into the ion source. The 
use of N2 sheath gas and a high electric field (2-5 kV) is required to form charged 
droplets and to evaporate them, leading to charged molecules [60]. Protonated  
[M + H]+, deprotonated [M – H]– quasi-molecular-ions or adducts like [M + Na]+,  
[M + K]+, [M + NH4]+, or [M + CF3COO]– are formed in ESI-MS. Multiple charged 
adducts as [M + nH]n+ and [M - nH]n- are also very common. An extremely low limit of 
detection, picomole per analysis, can be obtained but this limit strongly depends on 
the conditions used (solvent, flow rate, buffer, sample purity).  
iv) Atmospheric pressure chemical ionization allows the analysis of polar to relatively 
non-polar molecules such as esters, steroids, nitro-compounds or alcohols with a 
mass range of up to 2’000 Da. The sample solution is directly nebulized through a 
heated capillary at atmospheric pressure. A high-voltage corona needle ionizes the 
N2 sheath gas by discharge. N2+• reacts then with the eluent to form species like 
H3O+, OH-, or OH! if H2O is used as the solvent. Finally, the ionized solvent reacts 
with analyte molecules to form protonated [M + H]+ or deprotonated [M - H]- quasi-
molecular-ions [60].  
In comparison to ESI, APCI does not form metal adducts like e.g. [M + Na]+,  
[M + K]+, which improves the accuracy of quantitative determinations. Furthermore, 
APCI sources tolerate higher flow rates and allow the use of analytical HPLC column 
with 4 mm ID. 
Properties and specifications of the most common ion sources used in quantitative 
determinations are summarized in Table 1. 
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 EI CI ESI APCI 
Sample introduction Evaporation Evaporation 
Dissolved in polar solvent 
(e.g. H2O, CH3CN, and 
CH3OH) and buffered with 
volatile ions (conc ≤ 0.1%) 
Dissolved in polar to 
mid-polar solvents 
(e.g. CH3CN, CH3OH, 
CHCl3, or CH2Cl2; and 
buffered with volatile 
ions (conc ≤0.1%) 
Substance class 
Alkane, 
aromatic, 
halogen, ester, 
ketone, nitrile, 
nitro and amine 
derivative 
Alcohol, ketone, ester, 
amine, lipid (M=1000) 
DNA, RNA, protein, peptide, 
polymer, polar lipid, 
nucleotide, nucleoside, 
saccharide, organo metallic 
compound, non-covalent 
complex 
Nitro, alcohol, ester, 
amine, and steroid 
derivatives!
Decomposition Thermic Thermic None Little thermic 
Mass range m/z 1-1000! 18-1000 18-200’000 (Formation of Mn+ ions) 18-2000 
Common molecular 
or quasi-molecular-
ion 
M+! [M + H]
+, [M + C4H9]+, 
[M + NH4]+, [M – H]– 
[M + H]+, [M + Na]+,  
[M + K]+, [M + nH]n+, [M - H]-
, [M - nH]n- 
[M + H]+, [M – H]–, M–! 
[M + solvent + H]+ 
Coupling to 
Chromatographic 
methods 
GC GC HPLC/UHPLC/CE HPLC/UHPLC & GC 
     
Table 1:  Overview of ionization methods and their characteristics [60] according to 
literature 
There is an increasing need for analyzing complex biological matrix like urine, blood 
or plasma. MS is often the detector of choice for quantitative determinations because 
the ionization methods that have been implemented allow hyphenation with GC for 
the analysis of volatile and non-polar compounds and with HPLC for the analysis of 
non-volatile and more polar analytes. On-line coupling to chromatographic 
techniques also allows automation and higher throughput of samples. Separation of 
analytes from matrix molecules also increases selectivity and sensitivity. 
Discrimination of detection due to variable ionization efficiencies can be reduced for 
compounds with different functionalities. This phenomenon, called ion suppression, is 
principally observed in ESI-MS and can be partially compensated by using internal 
standards (see below) 
Selection of mass analyzer 
Ionized molecules are separated in mass analyzers according to their mass to 
charge ratio (m/z). Mass analyzers have been categorized according to physical 
principles used for ion separation [62]: 
- Ion beam (e.g. sector field, quadrupole or triple quadrupole instruments) 
- Ion trap (quadrupole ion trap, Orbitrap, Fourier-transform ion cyclotron 
resonance) 
- Time-of-flight (TOF) 
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Principally, all mass analyzers can be used for quantitative determinations, but 
technical characteristics will often limit their application. The most important 
properties are scan rate, sensitivity, resolution power, mass accuracy and mass 
range. For example, the number of MS scans in one chromatographic signal is 
related to the peak width and to the scan rate of the mass analyzer. Increase of scan 
rate can lead to better chromatographic resolution but decreases sensitivity.  
Mass analyzers characteristics will be presented shortly in order to facilitate the 
development of the most appropriate method in quantitative determination. 
i) Ion beam  
- Double focusing sector field instruments are the oldest mass spectrometers still in 
use. They are made of electric and/or magnetic field sectors. After acceleration, ions 
are deflected in function of their kinetic energy and velocity [60]. These instruments 
are usually equipped with electron or chemical ionization sources and are easily 
coupled with GC. They have a mass range of up to m/z 6’000. Sector field 
instruments provide high resolving power (RP) up to 100’000, but at the cost of 
transmission efficiency and therefore sensitivity [43]. In quantitative analysis, high RP 
is used to increase the selectivity by decreasing the chemical background noise. In 
combination with GC, sector field instruments are often used in quantification of e.g. 
dioxins (LOD below 20 fg) . 
- Quadrupole mass analyzers are widely used because of their ease of operation and 
maintenance, robustness, low price and compactness. They consist of four parallel 
rods whereby beams of ions with a unique m/z value have a stable trajectory at a 
given potential. At the same time, all other ions entering the quadrupole will be lost. 
These analyzers provide a mass range until ca. 4’000 m/z at low resolution 
(ca. 0.6 Da) [62]. Two operating modes are usually used. The full scan (FS) mode is 
used to transmit one m/z value after another over a mass range. The selected ion 
monitoring (SIM) mode is chosen to filter a specific m/z value. Almost all ionization 
sources can be interfaced to quadrupole mass analyzers, and their high scan rate 
allows coupling to chromatographic systems [60]. The FS mode is used for structure 
elucidation and the most sensitive SIM mode for quantitative measurements [63]. 
However, the SIM mode does not differentiate compounds with the same nominal 
mass and can lead to wrong results, especially if samples with complex matrices are 
analyzed. 
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- Triple quadrupole instruments (Q1q2Q3) are tandem in space mass spectrometers 
whereby three quadrupole mass analyzers are linked together in series [64]. 
Precursor ions can be selected in Q1, fragment ions formed in q2 via collision-induced 
dissociation (CID), and separated in Q3. Q1 and Q3 can work in both, FS or SIM mode. 
Filled with an inert gas (Ar or N2) q2 is used as collision cell. In combination with 
HPLC, Q1q2Q3 have been described as workhorses of trace level quantitative 
analysis because of their reliability, high data acquisition rate, and short duty cycle 
(fraction of total operating time spent to measure target ions in the SIM mode) [43], 
allowing them to detect several fragmentation reactions in a single run, in the  
so-called multiple reaction-monitoring (MRM) mode. 
ii) Ion trap 
- There are two types of quadrupole ion trap (QIT) mass analyzers on the market, the 
cylindrical (3D) and the linear (2D). In both cases, the trap is filled with an inert gas, 
usually He, to cool the collected ions on one side – effecting an increase of the 
resolution – and to allow the execution of collision induced dissociation experiments 
after excitation of ion packets on the other side. QIT instruments work with as high 
scan rates as 52’000 m/z/s or 10 spectra/s [60], which makes them ideal detectors for 
chromatographic systems. Additionally, powerful structure elucidation can be 
performed by MSn experiments. This technique consists of isolating precursor ions at 
a given m/z value, fragment them, isolate some of the formed fragment ions, and 
fragment them again. This can be done up to the 10th generation of fragmentation. 
For quantitative measurements, ion traps are usually operated in full scan MS/MS 
mode. In contrary to triple quadrupole analyzers, ion traps have high sensitivity in full 
scan mode due to variable accumulation times related to ion abundance. Low ion 
intensities lead to much longer scan times heading to a decrease of performances 
[43]. Another drawback of ion traps is the so-called “low-mass cut-off”. This partial or 
complete suppression of ion detection in the low mass range is particularly 
problematic in MS/MS mode, when small fragment ions containing relevant structural 
information are not detected. 
- Orbitrap and Fourier-transform ion cyclotron resonance (FT-ICR) mass spectro-
meters are ion traps allowing wide mass range detection with a high or extremely 
high resolving power and mass accuracy. Although these analyzers can be easily 
coupled with LC, their low scan rate of only around 1 scan per second do not allow 
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effective and precise quantitative determinations [65]. For this reason, Fourier-
transform ion traps have only rarely been mentioned in scientific literature in 
combination with quantification [43]. 
iii) Time-of-flight (TOF) 
- TOF analyzers identify ions according to the time they need to pass a given 
distance to a detector. This time is related to the acceleration voltage, the length of 
the field-free region, and the mass-to-charge ratio of the ions. The TOF analyzers 
provide high sensitivity at high scan rate of several hundred spectra per second in full 
scan mode and high mass range above 300’000 m/z. The newest TOF analyzers 
achieve good resolving power (resolution up to 60’000 full-width half-maximum) and 
good mass accuracy below 2 ppm with internal calibration [60]. The high scan rate in 
particularly make TOF analyzers perfect to be coupled with fast chromatographic 
methods, as fast-GC or UHPLC.  
- Quadrupole TOF (QTOF) is a hybrid mass analyzer, combining the benefits of two 
analyzers: the possibility to perform CID with quadrupoles and the high performance 
with regards to speed, resolution, and sensitivity of TOF. The advantage of QTOF 
used for quantification, is the acquisition of full scan product ion spectra at high mass 
accuracy. The noise can be decreased and, at the same time, the amount of 
information collected increased [66]. 
An example of improved signal-to-noise ratio obtained by calculating accurate 
extracted ion chromatograms (HR-EIC) from data recorded at high-resolution is 
shown in Figure 28. In comparison to a mass window of ± 0.5 m/z (A), the sensitivity 
can be improved by a factor of 16 by using a mass window of ± 0.01 m/z (B).  
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Figure 28:  HR-EIC of m/z 130.09144 calculated with (A) 0.5 and (B) 0.01 mass width 
iv) Tandem mass spectrometry  
MS/MS is practicable with double focusing sector field, triple quadrupole, ion trap, 
and QTOF instruments. They can be categorized in tandem-in-time (ion traps) and 
tandem-in-space (double focusing sector field instruments, QqQ, QTOF) types. Both 
principles have their pro and contra. Ion traps permit multiple stage MS/MS 
experiments (MSn) and have higher sensitivity in FS mode. However, quantification 
of analytes present at very different concentrations is difficult due to the limited 
dynamic range (two to three orders of magnitude). The low-mass cut-off is also a 
severe drawback because ions with low m/z ratios are discriminated or even not 
detected below 1/3rd of the mass of the precursor ions without special 
parametrization [22, 67] 
Triple quadrupoles are the most widely used tandem in space instruments. They 
allow operation in four different MS/MS acquisition modes, product ion, precursor ion, 
constant neutral loss, and selected or multiple reaction monitoring (SRM/MRM) 
scans (see figure 29). 
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- Product ion scan is certainly the most common MS/MS mode. Precursor ions at a 
specific m/z value are selected in the first quadrupole (Q1). They are then transferred 
to the collision cell (q2) where they collide with inert gas (N2 or Ar) and where 
fragmentation occurs to form product ions and neutral species. The ions are 
transferred into the third quadrupole (Q3), which scans over the mass range and 
delivers the product ion mass spectra. 
- In the precursor ion scan mode, Q3 is set to a specific m/z value (fragment ions of 
interest). Q1 is scanning over the mass range transferring the ions of different m/z 
ratios separately into the collision cell (q2) and finally to Q3. This allows the detection 
of all precursor ions sharing the same fragment. In peptide chemistry for example, 
compounds containing glycine or tryptophan can be recognized if Q3 is set to m/z 30 
or 159 corresponding to the respective immonium ions [68].  
Product ion scan
Precursor ion scan
Constant neutral loss
Multiple reaction monitoring
SRM/MRM
Q1 (MS1)
Static 
selected precursor mass
Scanning
Scanning
Static 
selected precursor mass
Q3 (MS2)
Scanning
Static product
Static 
selected product ion
Scanning
q2 (CID)
Collision cell
Collision cell
Collision cell
Collision cell
 
Figure 29:  MS/MS scanning modes 
- During constant neutral loss experiments, Q1 and Q3 are both scanning with a 
constant mass difference corresponding to a specific neutral loss that can usually be 
observed in a compound class. Typically neutral losses are water Δ=18 u, CO Δ=44u, 
NO2 Δ=46 u [62]. 
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- Selected or multiple reaction monitoring (SRM/MRM) is the method of choice for 
quantitative determinations using LC-MS/MS. Both mass analyzers Q1 and Q3 are set 
to fixed m/z values corresponding to a fragmentation reaction that is specific for a 
compound. Then, Q1 and Q3 switch simultaneously to a different value corresponding 
to another fragmentation reaction. Modern mass analyzers can switch very quickly, 
allowing the detection of more than 100 components within one second. MRM is the 
most selective and sensitive method, because only one mass is fixed in MS1 and 
MS2 at the same time removing all chemical noise [62].  
Figure 30 illustrates the LC-MS/MS chromatogram recorded under MRM conditions. 
In this example the sample was a TpT solution that was irradiated with UV light. The 
instrument was set to two MS transitions (m/z 545 " 447 and m/z 545 " 432), which 
allowed the detection of four photoproducts. Both parameters, mass of fragment ions 
and RT, are essential for the description of each photoproduct. 
To conclude, MS/MS is the method of choice for quantitative determinations, in 
particular when components of complex matrices are analyzed. The sensitivity of GC 
and HPLC-MS experiments is improved because MS/MS increases selectivity of 
detection and reduces chemical noise. SRM and MRM experiments can be 
performed with Q1q2Q3, QTOF and ion trap instruments whereby triple quadrupole 
mass analyzers provide the highest duty cycles and are therefore more sensitive if 
several compounds have to be quantified. 
Compared to MS, MS/MS provides a higher degree of confidence in the target 
structure detected and can also be extremely useful for structure elucidations, in 
particular when mild ionization sources are used [69]. 
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Figure 30:  Photoproducts of TpT determined in MRM mode with Q1 set at m/z 545 and Q3 at 
(A) m/z 447 and (B) m/z 432, respectively 
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Criteria for method selection 
For choosing the most appropriate quantitative analytical method, it is essential to 
consider the properties of analyte, matrix, and available instrumentation in relation to 
sample complexity and limit of detection. Sample preparation and chemical 
derivatization procedure, chromatographic method, ionization mode and mass 
analyzer will be chosen depending on these properties. Most of the modern 
quantification procedures are based on GC and HPLC and only such methods will be 
discussed below. 
i) Analyte properties 
Molecular weight, polarity, stability, and concentration are properties of an analyte 
that have to be considered for sample preparation procedure, need of chemical 
derivatization, chromatographic method, and especially choice of the ionization mode. 
Volatile compounds with low molecular weight below around 600 g/mol are ionized 
under EI/CI conditions. Polar molecules are well ionized with ESI, less polar with EI, 
CI, or APCI. Further, stability of the analyte is often related to the polarity and a 
chemical derivatization maybe requested when a GC-EI/CI procedure has to be used. 
The analyte concentration is also a concern as it influences (a) the choice of the 
domain of the calibration curve, and (b) the presents of the analyte in the linearity of 
detector response. This is particularly important for the concentration-dependent ESI 
method. When analyte concentration is high, the limit of quantification is also strongly 
depending on the mass analyzer (e.g. Q1q2Q3, QIT, or QTOF) and acquisition mode 
(e.g. SIM or MRM) that have been chosen. 
ii) Sample complexity 
Number and concentration range of the target analytes also influence selection of the 
analytical method. For example, if several volatile compounds with similar physical 
properties have to be quantified, GC-MS will be often the method of choice because 
of the high chromatographic separation efficiency. Complex mixtures can be 
separated and, if some of the components are still co-eluting, on-line coupling to a 
MS often still allows the quantification thanks to detection of some specific fragment 
ions of these co-eluting compounds [70]. 
A high variety of analytes, mid-polar to polar and small to large, can be analyzed with 
HPLC-MS. Samples can be straightforwardly measured after extraction in contrary to 
GC where labile and/or polar molecules have to be derivatized prior to injection. The 
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recent development of ultra-high performance liquid chromatography (UHPLC) with 
stationary phases below 2 µm particle size dramatically increased separation 
efficiency, sample throughput (less than 5 min per run are possible), and sensitivity.  
iii) Matrix complexity 
Quantification of analytes from complex matrices like e.g. urine, plasma, and 
environmental or plant extracts requires reproducible sample preparation procedures 
to obtain best accuracies. These procedures usually involve solid-phase (SPE) or 
liquid-liquid (LLE) extraction. Extraction conditions (solvent, buffer, stationary phase) 
have to be chosen according to the complexity of the matrix and to the 
chromatographic method that will be used. Biological matrices contain hundreds of 
potential interfering components with the analyte that should be removed prior 
analysis. Otherwise, matrix effects could lead to poor reproducibility of 
chromatographic separations and ion suppression effects.  
Choosing an MS/MS mass analyzer can partially solve the problems of analyzing 
complex matrices. The detection is selective, filtering the interfering signals improving 
signal-to-noise ratio.  
In any case, addition of internal standards (IS) is essential for quantitative 
determinations. Matrix effects can be compensated and accuracy increased. The 
choice of the IS is very important and its structure should be closely related to the 
structure of the target analyte. Otherwise, ion-suppression effects occur and the ratio 
of the detector response between both compounds will vary and lead to poor 
quantitative results [71].  
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Figure 31.  Analog and SIL structure of D-24851 that have been used for quantitative 
determinations [71] 
Stable isotopically labeled (SIL) compounds are the most appropriate internal 
standards used for quantitative measurements with MS detection since they show 
the same chromatographic and mass spectrometric (ionization efficiency and 
fragmentation) properties (example shown in Figure 31). SIL standards are usually 
labeled with 13C, 15N, 17O or D (deuterium) atoms [72].  
It is noteworthy that deuterium-labeled compounds have to be stable. Exchange 
between deuterium and hydrogen would result in a lower recovery of the SIL [73, 74]. 
SIL internal standards have to be as pure as possible to avoid interferences with the 
analyte response that could lead to inaccurate results. These requirements make 
standards either very expensive or not available. Internal standards with analog 
structure can thus be preferred [73-75]. 
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CHAPTER 2 
METHOD DEVELOPMENT TO STUDY NON-COVALENT 
DNA COMPLEXES 
2.1 Introduction 
Non-covalent interactions with DNA or RNA are essential in a variety of biological 
processes [1-3]. These interactions with specific regions of DNA are described by 
different binding modes such as intercalations, minor and major groove binding [4] 
based on Van der Waals forces, hydrogen bonds and electrostatic interactions. The 
presence of either adjacent AT- or GC-rich regions in the oligomer sequence can 
lead to selective binding between ligands and DNA [5, 6]. Non-covalent interactions 
have been investigated in more detail because they are of pharmacological interest. 
Some compounds such as polyamide drugs bind to the minor groove (AT-rich 
regions) of B-DNA. Other molecules, such as flavonoids, were suggested to bind 
DNA by intercalation with a minimal sequence selectivity (slight preference to GC-
rich regions) [7]. 
At physiological pH, non-covalent complexes are formed between protonated 
polyamine derivatives and charged phosphate groups of oligonucleotides through 
electrostatic interactions. These complexes are known to stabilize the tertiary 
structure of DNA [8-10] and RNA [11, 12], to protect them from thermal and alkaline 
denaturation, enzymatic degradation, shear breakage, or radiation damage [8]. 
Members of this class of compounds have already been used to inhibit prostate 
cancer [13] and HIV-1 protease [14]. 
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Biological activity related to non-covalent interactions of DNA/RNA duplexes with 
small organic molecules have been investigated using many analytical techniques, 
e.g. NMR [10, 12, 15], X-ray crystallography [5, 16], footprinting [6], and differential 
scanning calorimetry [8]. These methods are often laborious and/or require large 
quantities of material.  
Mass spectrometry (MS) is known as one of the most sensitive analytical tools that 
requires very small amounts of substance (pmol or less). Thermo-labile molecules 
are usually measured with atmospheric pressure ionization (API) techniques by 
which they are charged and transferred from solution into the gas phase. In particular, 
electrospray ionization (ESI) is a soft and sensitive ionization technique and usually 
yields quasi-molecular ions with low fragmentation. This technique is particularly 
suitable for the investigation of polar molecules such as polyamines, flavonoids or 
larger biomolecules such as oligonucleotides, proteins, or DNA. Due to the mildness 
of this ionization method, non-covalent complexes built on very weak interactions are 
preserved during the transfer from the liquid to the gas phase. Thus, ESI-MS has 
proven to be a powerful tool for analyzing organic molecules/DNA complexes [17] 
and was successfully employed to determine the binding affinity of drugs with DNA [4, 
18-20]. 
One example illustrated in Figure 1 shows the investigation of the binding affinity of 
the ligand trans-D1 in presence of three different ds DNA sequences, which vary in 
their AT- and GC-content [20]. GC-content decreases from DNA1 to DNA3. In this 
study, three signals corresponding to free DNA, 1:1 complexes (DNA/ligand) and 1:2 
complexes (DNA/ligand) are compared (highlighted with the red frame). A significant 
trend is observed. With the decrease of GC-content in the DNA sequences signal of 
1:1 and 1:2 complexes drop compared to the increase of the signal of free DNA. This 
shows that the trans-D1 bis-intercalator favored GC-rich sequences selectivity [20]. 
This indicates that selective binding interactions between ligands and DNA can be 
investigated using ESI-MS. 
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Figure 1: ESI-MS investigation of the binding affinity of the drug trans-D1 with three 
different double stranded DNA sequences (reproduced after [20]).  
A) DNA1, d(GCGGGGATGGGGCG/CGCCCCATCCCCGC)  
B) DNA2, d(GCGGGAATTGGGCG/CGCCCAATTCCCGC, and  
C) DNA3, d(GCGGAAATTTGGCG/CGCCAAATTTCCGC). 
As discussed previously in chapter 1.1.4, the proportionality between analyte 
concentrations in solution and their response obtained with ESI-MS is generally 
accepted. However, the correlation is restricted to molecules with similar ionization 
efficiencies under given conditions. When this criterion is fulfilled, structure-activity 
relationship (SAR) studies between small organic molecules and DNA oligomers can 
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be performed with ESI-MS. All the non-covalent studies between DNA and ligands 
cited above were performed with short DNA sequences (< 20 bases). There are two 
main advantages of using short oligomers over genomic DNA: First, short DNA 
sequences have much lower molecular masses (MR), which simplify the resulting 
spectra; second, only specific regions and selective complexations with drugs can be 
investigated (Chapt. 1.1.4). As discussed above, the selectivity can be tested using 
various AT- or GC-rich sequences. The strength of the binding mode between 
ligands and double stranded (ds) DNA has been estimated by Wang et al. performing 
collision induced dissociation (CID) experiments [7] or by Wan et al. with competitive 
experiments between two different ligands and one ds DNA sequence [3]. 
Within this project, an analytical method based on ESI-MS with a high-resolution 
Bruker maXis QTOF mass spectrometer (ESI-HR-QTOF-MS) was developed for 
investigating non-covalent complexes between short ds DNA sequences and small 
organic molecules such as flavonoids, polyamines or polyamine derivatives. The 
objectives were the following: (1) to implement an ESI-HR-QTOF-MS method using 
continuous flow electrospray ionization, to characterize and to estimate the binding 
affinities of these interactions. The choice of the instrument was set because it was 
the most sensitive MS available in our laboratory, and non-covalent studies have not 
been performed on this specific instrument so far. If reliable results regarding 
sensitivity and reproducibility, were obtained for non-covalent interactions with this 
setup, additional studies could be performed in this field; (2) to compare our own data 
obtained for the non-covalent complexes between various flavonoids and three ds 
DNA sequences with the results reported by Wang and coworkers using a less 
sensitive LCQ ion trap mass spectrometer [7]; (3) to examine if the chosen ds DNA 
shows any selectivity towards ethidium bromide (EthBr, described as intercalator 
ligand [18]), and 4',6-diamidino-2-phenylindole (DAPI, described as a minor groove 
binder [21]); and (4) to apply the method and verify if interactions between polyamine 
and their derivatives with ds DNA can be investigated. 
2.2 Formation of double stranded DNA 
For our investigations, the three different synthetic DNA oligomer sequences where 
chosen with similar molecular mass (MR) but with different AT and GC contents (ds1, 
ds2, and ds3, see Table 1). They were selected according to the previous study done 
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by Wang et al. in order to have comparative data [7] and allowing to validate our 
newly developed ESI-HR-QTOF-MS method. One of the sequences, ds1, contains 
two adjacent TT bases located at the beginning of the sequence ss1b. For ds3, four 
adjacent TTAA bases are present in the middle of both single strands. The ds2 
sequence contains six adjacent T and A bases in the center of the sequence. All 
three sequences show various positions and numbers of AT bases in order to 
compare them according to their selectivity with different ligands. 
Name Sequence Tm (°C) MR (Da) 
ds1 d(AACTCCCGGCACAC/GTGTGCCGGGAGTT) (ss1a/ss1b) 46/46 8524.5 
ds2 d(GGCGAAATTTGCGG/CCGCTTTAAACGCC) (ss2a/ss2b) 44/44 8523.5 
ds3 d(GGCGGAATTCGCGG/CCGCCTTAAGCGCC) (ss3a/ss3b) 48/48 8525.5 
    
Table 1: Complementary oligonucleotide sequences used for non-covalent interaction 
studies 
In order to form the expected ds DNA, it is essential to know the melting temperature 
(Tm) of the ds DNA. Tm corresponds to the temperature at which half of DNA strands 
are in a double helical and half in a single strand state [22]. This temperature strongly 
depends on the length of the oligonucleotides. The 14-mer DNA strands used in this 
study have a calculated Tm of ca. 46°C (according to the manufacturer). 
The ss DNA oligomers employed in this study were obtained as 100 µM aqueous 
solutions and used as they were. To form the ds DNA helices, equal amounts of two 
complementary ss DNA solutions were mixed in NH4OAc buffer (500 mM), and 
heated at 95°C for 15 min, which is clearly above the ds DNA Tm (ca. 46°C). At such 
temperatures, only free ss and no ds DNA were expected in solution. Finally, the 
solutions were slowly cooled to room temperature to form the thermodynamically 
more stable ds DNA. With this procedure ds DNA stock solutions of 10 µM 
concentration were prepared and further used for complexation experiments and 
ESI-MS analyses. 
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2.3 Optimization of the ESI-MS method 
DNA complexes investigations by ESI-MS require maximal sensitivity to be 
successful. To obtain optimal conditions, solvent additives and instrument 
parameters had to be optimized. The synthetic ds DNA shown in Table 1 were 
evaluated first using the most appropriate solvent for direct infusion ESI-MS analyses. 
In a second step, the most important MS parameters were tuned to minimize adduct 
formation and fragmentation while keeping S/N maximum. 
2.3.1 Solvent and buffer optimization 
Direct infusion ESI-MS of ds DNA using H2O/MeOH/NH4CH3CO2 as a solvent 
mixture in the negative ionization mode is known to yield the best response fords 
DNA [3, 7]. Samples were thus prepared by mixing 10 µL of ds DNA stock solution 
(containing 500 mM NH4CH3CO2) with 90 µL of a 3:1 (v/v) 
MeOH/50 mM NH4CH3CO2 solution. The parameters used to acquire the preliminary 
data were defined by tuning the instrument with a commercial tune mix, composed of 
phosphazen derivatives (Bruker). 
Typical data obtained for ESI-MS of ds DNA sequences with a MR of ca. 8’500 Da is 
illustrated using ds1 (Figure 2). Under such conditions, the spectrum shows an 
intensive signal of five times negatively charged ds DNA (ds1 5-). A signal (with less 
than 10 % relative intensity) is observed for ds1 4- ions. Single stranded molecules 
were also detected as ss1a 3– and ss1b 3- ions, originating from material that did not 
anneal properly or from decomposition occurring during the ionization process. 
 
Figure 2:  ESI-MS of ds1 measured at 1 µM concentration in MeOH/aqueous NH4CH3CO2 
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The MS analysis of oligonucleotides is difficult because the polyanionic backbone 
has a high affinity to ubiquitous cationic contaminants e.g. potassium and sodium 
ions, resulting from HPLC purification procedures or DNA synthesis (sample handling 
in glassware). These adducts, lead to signal multiplication at one charge state 
reducing the sensitivity of ESI-MS analyses and complicating data interpretation 
(Figure 3 A). 
In order to reduce the formation of adducts of alkali metal ions, a solution consisting 
of a propan-2-ol/(aqueous 2.5 mM piperidine + 2.5 mM imidazole v/v) 1:1 (called 
spray solution) was added to the sample solution in a 9:1 ratio. The combination of a 
strong base such as piperidine with a weaker base such as imidazole has been 
described to reduce cation adduction and therefore improve the signal intensity [23, 
24]. Muddiman et al. have proposed two different mechanisms for the reduction of Na 
adducts to the ds DNA backbone. Suppression of alkali adducts possibly results [23]: 
(1) both bases form hydrogen bonds with the DNA backbone, thereby 
displacing Na cations. Upon transfer of ds DNA from solution to the gas phase, 
neutral loss of piperidine and imidazole occurs leading to protonated DNA 
molecule. 
(2) both bases interact with the Na cations, which leads to have ds DNA free of 
Na adducts in solution, and can be detected without Na adducts. 
The comparative ESI-MS data of ds1 measured without and with addition of spray 
solution are illustrated in Figure 3. A decrease of adducts formation and an increase 
of sensitivity can be observed. 
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Figure 3: ESI-MS of ds1 prior and after optimization of the sample solvent. The region of 
the 5– ions is zoomed. 10 µL DNA stock solution + 90 µL spray solution 
consisting of (A) MeOH/aqueous NH4OAc 50 mM 3:1 and  
(B) propan-2-ol/(aqueous 2.5 mM piperidine + 2.5 mM imidazole v/v) 1:1 
2.3.2 MS parameters optimization 
Optimal MS instrument parameters often depend on the analyte investigated. This is 
particularly the case when labile molecules or non-covalent interactions have to be 
measured. Several variables of the maXis QTOF mass spectrometer were therefore 
optimized such as source conditions (temperature and N2 flow), transfer time from 
the ion source to the TOF, collision energy, and ion cooler in front of the TOF. 
Regarding the collision cell, a minimum energy is already necessary to cool the ions 
and have optimal ion transmission. In contrast, high collision energies can lead to 
dissociation of the double strands and even fragmentation of single strands. In our 
case, ions have passed through the cell with an optimal collision energy of 8-10 eV 
giving us the best ion transmission with maximal sensitivity and with minimal 
fragmentation reactions. The task of this device is to focuse the internal energy of 
ions and to define the size of the ion packets before they enter the TOF, in order to 
increase the sensititviy. However, if too many ions are collected, they start to collide, 
resulting in fragmentation and loss of resolution. 
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Figure 4 illustrates the increase of sensitivity of ds1 DNA by a factor of 1.7 obtained 
after instrument parameter optimization compared to the method based on the 
Bruker calibration tune mix. 
 
Figure 4: ESI-MS of ds1 (10 µL stock solution + 90 µL of a propan-2-ol/(aqueous 2.5 mM 
piperidine + 2.5 mM imidazole v/v) 1:1 acquired before (A) and after (B) tuning of 
the mass analyzer. The region of the 5– ions is zoomed. 
2.3.3 Summary 
The sample solutions and the instrument parameter methods were optimized in order 
to obtain the highest sensititvity for the signal of ds DNA five times negatively 
charged (ds DNA5-), with a minimum fragmentation and adduct formation. With this 
set of optimized parameters, the efforts will now be put on the investigation of the 
non-covalent interactions between ds1-3 and our ligand library. 
2.4 Investigation of non-covalent interactions 
The primary goal was to check the suitability of maXis QTOF mass spectrometer to 
investigate non-covalent interactions between ds DNA and various classes of ligands. 
Two classes of natural compounds, polyamines [8-12] and glycosylated flavonoids 
and their aglycone derivatives [7], were investigated because they are known to bind 
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DNA and RNA. Hydroxycinnamic acid derivatives of polyamines, which should 
behave like polyamines were also studied. 
Finally, two DNA stains, ethidium bromide (EthBr) and 4',6-diamidino-2-phenylindole 
(DAPI), widely used for fluorescence detection, were tested. They should give us an 
indication of the selectivity of the sequences, since EthBr principally interacts with 
DNA by intercalation [18] and DAPI by minor groove binding [21]. 
The study of the aforementioned non-covalent interactions was performed with the 
same ESI-MS conditions as the ones optimized for free ds DNA (see Chap. 2.2.2). 
Solutions of ds1-3 DNA (10 µL, 10 µM) and ligand (10 µL, 40 µM) were mixed and 
diluted in a 1 to 4 ligand excess with 80 µL of optimized solution containing 2.5 mM of 
piperidine and imidazole additives in order to improve the S/N and suppress the 
formation of adducts. All samples were prepared and measured consecutively with 
continuous flow ESI-MS in the negative, full scan mode.  
The relative DNA binding affinities were estimated by means of MS signal intensities 
reflecting the relative concentrations of the several complexes present in solution. Ion 
species in solution were determined relative to the most abundant 5– ions and the 
fraction of bound DNA (fbDNA) was calculated in mol %1 using the following equation:  
 
I represents the relative intensity of free DNA or DNA-ligand complexes at a specific 
charge state. 
  
                                            
 
1 MS is a concentration sensitive detector and the ratio of signal intensities can therefore be 
correlated to the mol ratio 
(1) Fraction of bound DNA (mol%)=
I(1:1) + I(1:2) + I(1:3)...
I(DNA) + I(1:1) + I(1:2) + I(1:3)...
X100
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2.4.1 Interactions of DNA with flavonoids 
Non-covalent interactions between flavonoids and duplex or triplex DNA have been 
investigated in detail using ESI-MS [3, 7, 25]. Flavonoids formed preferentially 
intercalation complexes due to their interactions with GC-rich regions of DNA and 
occurring via strong π-π stacking. Comparative complexation studies of different 
classes of flavonoids with ds DNA further revealed that the position of the OH- 
groups on their different ring systems are influencing the binding properties and that 
glycoside substitution enhanced complex formation [7]. 
The goal of this study was principally to confirm that complex formation between ds 
DNA and a broad range of flavonoid classes (flavone, isoflavone, flavanone, and 
flavanol) can be investigated with the maXis QTOF mass spectrometer. The resulting 
data should then be compared to reported ones obtained with a thermo LCQ ion trap 
[7]. Direct data comparison of the fraction of bound DNA obtained from different MS 
platforms is essential, as it can lead to different ESI spectra due to differences in 
ionization energy, pressure, temperature and acceleration voltage. Nevertheless, the 
relative complexation affinity of the flavonoid ligands with the three ds DNA should 
remain the same. 
Six ligands were measured in presence of ds1, ds2 and ds3 in order to evaluate the 
ESI-MS method developed on the maXis QTOF instrument (see Chapt 2.3). The ds 
DNA sequences were chosen in analogy to those used by Wang et al. [7]. The 
ligands were selected to be able to compare mono-glycosilated flavone (vitexin) with 
the corresponding aglycone (apigenin) as well as with glucose, to obtain reference 
values for fbDNA and to compare them with literature. In addition, flavonol, isoflavone, 
flavanone C- and O-glycosides, glycoside and rhamnosyl derivatives were also 
tested. The complete ESI-MS complexation data together with the one found in the 
literature is summarized in Table 2. Only ds1 from Wang et al. is mentioned in 
Table 2 because the values for ds 2 and ds 3 are reported to follow the same trend 
[7]. 
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 Fraction of bound DNA (mol%) 
 ds1 
5- ds2 5- ds3 5- ds1 
5- 
Literature [7] 
apigenin  
(flavone aglycone)  
(ap) 
 
17 13 20 25 
glucose  
(glu) 
 
0 0 0 – 
vitexin  
(flavone-8-C-glu)  
(vi) 
 
28 26 29 74 
genistin  
(isoflavone-7-O-glu) 
 
18 13 15 60 
liquiritin  
(flavanone-4’-O-glu) 
  
9 6 7 57 
quercitrin  
(flavonol-3-O-rha) 
 
8 6 6 – 
      
Table 2: Comparison between the fbDNA (mol%) measured with maXis ESI-QTOF-MS and 
published data (LCQ ion trap) obtained for solutions of ds1, ds2, and ds3 in 
presence of a four-fold ligand excess 
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Figure 5:  ESI-MS spectra of ds1 d(AACTCCCGGCACAC/GTGTGCCGGGAGTT) mixed 
with (A) apigenin, (B) glucose and (C) vitexin in a 1:4 ratio. Calculated fbDNA (in 
mol%) is framed. 
At a first glance it appears that all values of fbDNA obtained are significantly lower than 
those published [7]. Since the samples had an identical ligand to ds DNA ratio of 1 to 
4, the lower signal intensities corresponding to the complexes might be due to the 
different instrumentation used or to the different concentrations of sample solutions 
(samples measured with the maXis QTOF were diluted 20x in order to avoid 
saturation of the detector). 
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Comparison of the values of fbDNA calculated from the maXis QTOF data lead to a 
more differentiated interpretation. In line with published results, no differences of 
binding affinities were observed within the different DNA strands ds1, ds2 or ds3. The 
higher values observed for a glycosylated flavone (vitexin) compared to the 
corresponding aglycone (apigenin) has been reproduced and glucose was not 
interacting at all (see Figure 5). This supports the fact that flavonoids and not glucose 
moieties are essential for the interactions with ds DNA. However, a differentiation of 
flavonoids of various classes using the developed method seemed to be risky, 
although in both cases, maXis and published data, vitexin presented the highest 
binding affinity with ds DNAs. In particular the mono-glycosylated liquiritin and 
genistin lead to values of fbDNA that were similar or much lower than the ones 
obtained for apigenin (9, 18 and 17 mol%, respectively). This is in disagreement with 
the results of Wang et al. where aglycone flavonoid showed a tendency to lower 
binding affinities than the glycosylated one. 
In conclusion, the method developed in Chapter 2.2 allowed investigations of the 
binding affinities between ds DNA and flavonoid derivatives. The fact is that the 
absolute values of fbDNA obtained were lower than in reference data. Although the 
glycosylated flavone vitexin displayed the highest affinities to ds1, no significant 
selectivities of ligands to any ds DNA sequences or of ds DNA to ligands were 
observed. 
2.4.2 Interaction of ds DNA with fluorescent tags 
According to the literature, EthBr is known to interact with ds DNA as an intercalating 
tag, whereby this type of molecules are non-specific binders, with a slight affinity for  
GC-rich regions [18]. On the other hand, DAPI is a very strong minor groove binder, 
with a preference for sequences containing three or more consecutive AT base pairs 
[21]. 
The synthetic ds DNA sequences chosen (see chapter 2.2.1, Table 1) contain 
various amounts of AT-rich domains found in the middle (ds2 four AT base pairs, ds3 
six AT base pairs) or at the end of the oligonucleotide chain (ds1 two AT base pairs). 
With this choice of sequences, it should be possible to verify: (1) if signals 
corresponding to the complexes can be detected with ESI-MS; (2) if the number of 
AT base pairs has an influence on the constant of complex formation; and (3) if the 
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position of the AT base pairs has an influence on the ligand selectivity. The ESI mass 
spectra of the complexes were measured with the method optimized for free DNA. 
 
Figure 6.  ESI-MS spectra of ethidium (Eth) complexation with ds1, ds2, and ds3 DNA in a 
1 to 4 ratio. Calculated fbDNA (in mol%) is framed 
Analogous to free ds DNA, the ds DNA // Eth complexes formed preferably ions with 
a charge state of 5– under these ESI-MS conditions. The spectra show relatively high 
signal intensities corresponding to free ds DNA (see Figure 6). Furthermore, Eth 
seemed to interact a bit stronger with ds1 (46 %), the DNA with the highest number 
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of GC base pairs in a row (six compared to four and five for ds2 and ds3 
respectively). These observations provide some evidence about the slight preference 
of intercalators for GC-rich sequences. 
The ESI-MS analysis of the solution containing DAPI mixed with the ds DNA, 
compared to Eth, led to big differences of fraction of bound DNA (see Figure 7). 
 
Figure 7. ESI-MS spectra of DAPI complexation with ds1, ds2, and ds3 DNA in a 1 to 4 
ratio. Calculated fbDNA (in mol%) is framed. 
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Again, the complexes with a 5– charged state are preferably formed and their 
response will be used for the determinations of the fraction of bound DNA. 
The affinity of DAPI to ds1 DNA was obtained in the range already observed for Eth 
complexes (fbDNA = 40%). However, this value rose up to 96 and 95 % for ds2 and 
ds3 sequences, respectively. Stronger interactions of the minor groove binder DAPI 
with the AATT-containing site are completely in agreement with the published DNA 
association binding constant (K) obtained by fluorescence spectroscopy [26]. In this 
work, the binding of DAPI with different (A/T)4 sequences in a stable 28-mer hairpin 
was studied, showing much stronger affinities for the AATT site (association constant 
Ka = 5.5 x 108 M-1) compared to e.g. TAAT or TTAA (ca. 2 x 10 7 M-1). In our case, 
both ds2 and ds3 but not ds1 DNA contain AATT sequences. 
In conclusion, the data obtained for Eth and DAPI confirm that ESI-MS with a maXis 
QTOF can be used as an investigation method for the analysis of non-covalent 
interactions between ds DNA and intercalators and minor groove binders. 
In this case, ESI-MS signals of DAPI complexes with ds 2 and 3 were very abundant 
(> 95 mol % of fbDNA), in contrast to residual signals observed in spectra of Eth 
complexes, corresponding to free oligonucleotides. This demonstrates that the 
developed method is able to detect the presence of a specific binding site as AATT in 
an oligomer sequence. 
ESI-MS measurement of weaker intercalating interactions lead to a low part of bound 
DNA (< 50 mol %) and further experiments are required to validate the method 
regarding the recognition of GC-rich sequences and the mechanism of interaction. 
2.4.3 Interactions of ds DNA with polyamines and derivatives 
Polyamines have been described as major and minor groove binders with a 
preference for AT-rich regions of DNA [8, 21]. Furthermore, cinnamic acid derivatives 
of polyamines have been isolated in high amounts from plant material, e.g. pollen of 
Aphelandra sp. [27] or Alnus glutinosa, Betula verruscosa and Pterocarya fraxinifolia 
[28]. Non-covalent interactions of such derivatives have, to our knowledge, never 
been investigated previously. The objective was therefore to see if the ESI-MS 
method developed (see Chapt. 2.3) is appropriate to study interactions with other 
secondary metabolites, the polyamines, and to see if a substitution with cinnamic 
acid has an influence on their binding affinities towards ds DNA. In order to assess 
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the complexation properties, a library of available linear polyamines (spermine and 
spermidine), cinnamate derivatives ((E)-ferulic and p-coumaric acid), and cinnamate 
polyamine conjugates were selected and analyzed in presence of the synthetic ds1, 
ds2 and ds3 used previously. 
 Fraction of bound DNA (mol%) 
 ds1 
5- ds2 5- ds3 5- 
spermidine (spd) 
 
2.3 2.1 2.2 
spermine (spm) 
 
1.7 1.7 1.2 
(E)-ferulic acid 
 
0 0 0 
p-coumaric acid (cou) 
 
0 0 0 
N-(E-coumaroyl) 
putrescine 
 
2.6 2.5 2.8 
1,14-bis(E-cinnamoyl) 
spermine  
(1,14-cin spm) 
 
4.2 3.3 3.6 
5,10-bis(E-cinnamoyl) 
spermine  
(5,10-cin spm) 
 
4.1 4.4 4.4 
    
Table 3:  fbDNA (mol%) obtained from the ESI-MS analyses of ds1, ds2, and ds3 performed 
in presence of a four-fold excess of polyamines, cinnamic acids and polyamine 
derivatives 
Compared to flavonoids, very low binding affinities were measured between 
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eventhough strong interactions were expected considering those observed by X-ray 
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diffraction across the binding groove of the B-DNA duplex [d(CGCGAATTCGCG)]2 
[26] (see Table 3 and Figure 8). 
 
Figure 8:  ESI-MS spectra of ds1 d(AACTCCCGGCACAC/GTGTGCCGGGAGTT) mixed 
with (A) spermine, (B) p-coumaric acid and (C) 5,10-bis(E-cinnamoyl) spermine 
in a 1:4 ratio. Calculated fbDNA (in mol%) is framed. 
(E)-ferulic and p-coumaric acid did not show any affinity to DNA. The polyamine 
derivatives showed a two times higher fbDNA, compared to the free polyamines. As 
introduced earlier in the chapter, it may be possible that the observed ESI-MS signals, 
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representing complexation of ds DNA with polyamine and polyamine derivatives, 
arise from electrostatic interactions between the polyamine backbone and the 
negatively charged phosphate groups of DNA. SAR studies showed that the most 
stable complexes did not only result in simple electrostatic spanning of the anionic 
DNA backbone by protonated spermine [21]. 
Poor information concerning the relative interactions of polyamines, hydroxycinnamic 
acid derivatives of polyamines and hydroxycinnamic acids with ds DNA were gained 
in this study due to low binding affinities observed with the ESI-MS method 
developed. Nevertheless, no interaction of hydroxycinnamic acids with ds DNA were 
observed, and higher affinities of acyl-polyamines compared to free polyamines 
spermidine and spermine were detected (1,2 - 2,3 compared to 2.4 - 4.4 mol %). 
2.5 Conclusion and outlook 
The aim of this project was to develop a sensitive method based on direct-infusion 
ESI high-resolution QTOF-MS in order to investigate non-covalent interactions 
between synthetic DNA sequences containing 14 base pairs and small organic 
molecules. The synthetic ds DNA ds1, ds2, and ds3 were used for optimizing sample 
solution and instrument parameters, and for the complexation studies. 
The ESI-MS analyses were performed in the negative ionization mode to get a 
minimal formation of adducts. The sample solvent appeared to be an essential 
parameter and best results were obtained with addition of imidazole and piperidine to 
the DNA dissolved in a mixture of propan-2-ol/aqueous NH4OAc. Some specific MS 
parameters were also critical to obtain optimal S/N, in particular collision energy and 
ion cooler. 
Non-covalent interactions between ds1, ds2, and ds3 and a library of glycosylated 
and aglycone flavonoid derivatives (apigenin, genistin, liquiritin and vitexin) were 
investigated using the optimized ESI-MS conditions and the results were compared 
to published data. It appeared that the same compound, vitexin, showed the highest 
binding affinities to DNA (30 mol %). But compared to literature data, the values of 
fractions of bounded DNA obtained were all lower and their relative order was 
sometimes different. This could be due to harder electrospray ionization conditions 
(compared to literature, a different instrument and ion source have been used) or 
lower solution concentrations of ligand and ds DNA. 
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In a second part, DAPI and EthBr were chosen to assess the method with regard to 
the selectivity of the interactions between ligands and ds DNA containing different 
number of AT base pairs. These ligands are known as minor grove binders and 
intercalators, respectively. Eth exhibited almost equal affinities of ca. 50 mol% of 
fraction of bound DNA to all sequences. However, DAPI was much more selective 
and displayed high binding affinities of approximately 100 mol% to ds2 and ds3. The 
ds DNA ds2 and ds3 contain AAATTT and AATT sites, respectively. These sites are 
known to form preferentially minor grove bindings. It appears therefore that the 
method developed here could be used to study interaction mechanisms as long as 
the binding affinities are high enough. This was not the case with the interactions 
between flavonoids and ds DNA. In this case, the method was not sensitive enough 
to reproduce literature data.  
Finally, the non-covalent interactions of polyamine and their derivatives with ds DNA 
were investigated with the same optimized ESI-MS method. Although successful 
NMR and XRay investigations have been published, it appeared that binding affinities 
of polyamine derivatives were clearly weaker (< 5 mol%) than those of flavonoid 
derivatives and the DNA fluorescent tags DAPI and Eth (data summarized on 
Figure 9). Nevertheless, it seemed that the substitution of polyamines with cinnamic 
acid derivatives increased the binding affinities toward ds DNA.  
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Figure 9: Overview of DNA-binding affinites of the investigated ligands with ds1, ds2 and 
ds3 
In the future, some competitive experiments with two ligands and one ds DNA 
sequence should be performed in order to correlate the relative ion abundance with 
the binding affinities [3]. This would be also essential for correlating the relative 
values of fractions of bounded DNA by the different ligands under investigation. 
Furthermore, a larger variety of flavonoid and polyamine derivatives should be 
compared in order to confirm the first observations and to assess the method as a 
tool for investigating the binding modes of DNA with small organic molecules.  
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2.4. Experimental part 
2.4.1 Chemicals and ligands 
Propan-2-ol, ammonium acetate (NH4CH3CO2), triethylamine (Et3N) (all in LC-MS 
Ultra Chromasolv® quality), piperidine (puriss), imidazole (puriss), and glacial acetic 
acid (puriss) were obtained from Sigma-Aldrich (Buchs, Switzerland). The 14mer 
complementary single strand DNA sequences used to form ds1 (ss1a and ss1b), ds2 
(ss2a and ss2b), and ds3 (ss3a and ss3b) were purchased from Microsynth (100 µM, 
HPLC purified, Balgach, Switzerland). LC-MS grade H2O (< 2 ppb) was obtained by 
purification of deionized H2O with a MilliQ gradient apparatus equipped with a 
BioPack® ultrafiltration module (Millipore, Milford, MA, USA). 
Spermine tetrahydrochloride, spermidine trihydrochloride, (E)-ferulic acid,  
p-coumaric acid, glucose, 4',6-diamidino-2-phenylindole (DAPI), ethidium bromide 
(EthBr) and vitexin were purchased from Sigma-Aldrich, quercitrin and apigenin from 
Extrasynthese (Lyon Nord, France), and liquiritin and genistin from Chengdu 
Biopurify Phytochemicals Ltd. (Chengdu, China) in the best qualities available.  
N-(E-Coumaroyl) putrescine, 1,14- and 5,10-bis(E-cinnamoyl) spermine were 
synthesized in our laboratories [29]. 
2.4.2 Instrumentation 
On-flow ESI-MS 
ESI-MS data were obtained from a maXis UHR-QTOF mass spectrometer (Bruker 
Daltonik GmbH, Bremen, Germany) equipped with an ESI source. Acquisitions were 
performed under continuous-flow injection conditions at a flow rate of 6.7 µL/min. ESI 
parameters: end plate offset (–500 V), capillary (4500 V), nebulizer gas (N2, 0.4 bar), 
dry gas (N2, 4 L/min), dry temperature (160 °C). MS parameters: funnel RF (3200 
Vpp), ISCID energy (0 eV), multipole RF (350 Vpp), ion energy (4 eV), low mass (350 
m/z), collision energy (22 eV), collision RF (1000 Vpp), ion cooler RF (600 Vpp), 
transfer time (125 µs), and pre-puls storage (25 µs). Mass spectra were acquired as 
soon as the MS signal intensities were stable during 1 min in the negative mode at a 
resolution of 20’000 (FWHM), in the full scan mode, in the mass range m/z 50 – 3500 
and with a scan rate of 2 Hz. 
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2.5.3 Experimental description 
Formation of ds DNA and complex solutions 
For the study of non-covalent interactions between ligands and ds DNA, three 
different solutions are necessary: the ds DNA, ligand and the spray. 
The ds DNA stock solution: stock solutions of double strand oligonucleotides were 
purchased at a concentration of 100 µM in MilliQ water. Annealing solution was 
obtained by mixing 10 µL of each complementary single strand solution (ssa and ssb) 
with 80 µL of 500 mM ammonium acetate solution. The annealing solution was 
heated to 95°C for 15 minutes in a Techne® Dri-Block® heater (Model DB-3D, 
Staffordshire, UK). The block heater was then switched off and slowly cooled to room 
temperature overnight. The final concentration of the ds DNA stock solution was  
10 µM. After one weak, the stock solutions were freshly prepared. 
The ligand solution: All ligands were prepared at a concentration of 40 µM. 
Flavonoids and hydroxycinnamic acids were diluted in MeOH and the polyamines 
and their derivatives in H2O. 
The spray solution: One solution of 2.5 mM piperidine and one solution of 2.5 mM 
imidazole were prepared. They were mixed together in a 1:1 ratio with a final  
1.25 mM concentration of piperidine and imidazole. This 1:1 solution is then mixed 
volume to volume (v/v) with propan-2-ol to have the final spray solution with a  
0.625 mM concentration of piperidine and imidazole. 
For ds DNA signal optimization 10 µL of the resulting double strand DNA stock 
solution (10 µM) was diluted to 100 µL with the spray solution prior mass 
spectrometric analyses.  
For complexation studies, 10 µL of ds1, ds2 or ds3 (10 µM) with 10 µL ligand (40 µM) 
and diluted with 80 µL of spray solution were prepared prior to mass spectrometric 
analysis. 
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CHAPTER 3 
THE QUANTIFICATION OF PHOTOPROTECTION 
3.1 Introduction 
The protection of DNA from damage induced by UV-radiation is of critical importance 
to all organisms that are exposed to sunlight. Evolution due to effects of UVB 
radiation on aquatic and terrestrial plant ecosystems concerns different aspects like 
comparison of growth and physiological responses to various levels of solar UVB or 
induction (initiation) of UV-absorbing compounds, their chemical characterization, 
and their localization. A comparative assessment of the physiological function of UV-
absorbing compounds as protective UV-screens for plants has been described [1]. 
In DNA, UV-induced damage occurs mainly by photodimerization of two adjacent 
pyrimidines, mostly thymine bases, in the same polynucleotide chain. These lesions 
are named cyclobutane pyrimidines (c-s T<>T and t-s T<>T) and pyrimidine (6-4) 
pyrimidone (6-4 TT) dimers, whereby the c-s T<>T is the major photoproduct formed. 
The 6-4 TT photoproduct can further photoisomerize into Dewar TT valence isomer 
under UVB irradiation (Figure 1). 
DNA mutations induced by UV-light have been associated with skin cancer [2, 3]. 
Different endogen or exogen protection mechanisms exist for human beings to 
protect from damage by UV-irradiation, such as gene p53 with a function of repairing 
damaged DNA, or sunscreen application. 
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Figure 1:  Structures of thymine dimeric photoproducts induced by UV-light 
In plants, secondary metabolites, such as mycosporine-like amino acids (MAA) [4], 
cuticular waxes [5], flavonoids [1, 6] and substituted (mono, di and tri) cinnamic acid 
derivatives of spermidine [7] have been described to play important roles in the 
protection from damage caused by UV-radiation. The mechanism of protection 
probably stems from the property of the secondary metabolite to absorb UV-light in 
the same range (230-300 nm) as DNA (Figure 2). For example DNA damage caused 
by UV-irradiations was shown to be higher in mutants of Zea mays that are 
specifically defective in flavonoid accumulation [6], than in the wild type.  
Some cinnamic acid derivatives of spermidine were found in high concentrations in 
the pollen of different plants of the family of Betulaceae, Fagaceae and 
Juglandaceae [7-9]. These secondary metabolites absorb light in a way that could be 
beneficial for protection of plant genetic material [10]. Furthermore, they undergo a 
reversible daylight-induced E/Z isomerization, which may be a way of dissipating the 
energy of UV-irradiation.  
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Figure 2: UV-absorbance of DNA, genistein, flavonoid, and (E/Z)-(4-hydroxycinnamoyl)-
spermidine derivatives.  
Several analytical methods have been developed to follow the mutagenicity of UV-
irradiation on DNA, in particular IR- [11] and UV- [12] spectroscopy, chromatography 
[13, 14] and enzyme-linked immunosorbent assays (ELISA) [15]. Since the quantum 
yield of the photoproducts formation is very low (maximum of 2 % for c-s T<>T [2]), 
sensitive analytical methods are required for the investigation of these DNA 
mutations. The most specific and sensitive assay for the detection of DNA 
photoproducts is based on monoclonal antibodies [6]. 
Mass spectrometry (MS) is known to be one of the most sensitive analytical 
techniques, as it needs only very small amounts (pmol or less) of analyte. The extent 
of DNA mutation by formation of photoproducts has also been determined by 
methods based on MS. Quantitative liquid chromatography tandem mass 
spectrometry (HPLC-ESI-MS/MS in the MRM mode) approaches, compared to full 
scan MS (HPLC-ESI-MS), have the advantage of increased selectivity and sensitivity 
[2, 16]. Such instrumentation allows additionally qualitative investigations and the 
characterization of unknown DNA lesions. 
In this project, analytical methods based on ultra high performance liquid 
chromatography (UHPLC) and mass spectrometry (MS) have been developed for 
investigating the effects of UV-light irradiation between thymidylyl(3’-5’)thymidine 
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(TpT) and synthetic ds DNA, in presence of organic molecules. The selected 
molecules, mostly secondary metabolites, are potentially acting as UV-filters. 
In the first part of the chapter, complete optimization of the experimental setup 
including irradiation box, chromatographic separation, and MS using a Waters UPLC 
coupled to a maXis QTOF mass spectrometer (HR-QTOF-MS), is presented in detail. 
The objectives were to form photoproducts with the highest yield, to separate them in 
a short time with the best sensitivity and determine their relative quantities. 
Various classes of UV-filter compounds have been described [6, 8]. The goal of this 
project is to evaluate UV-filter properties of our target molecules either at 254 or 
312 nm. TpT or synthetic ds DNA solutions were therefore irradiated in presence of 
UV-absorbing metabolites and the formation of photoproducts monitored using the 
previous optimized analytical method. 
3.2 Development of the quantification and irradiation 
methods 
Optimization of the experimental setup was performed with a 10 µM solution of TpT 
dissolved in H2O/MeCN, which was irradiated in a quartz micro-cuvette according to 
the procedure described by Douki et al. [2] to obtain the photoproducts. This solution 
was then used to optimize the chromatographic and mass spectrometric conditions. 
3.2.1 Optimization of fast chromatography  
Photoproduct dimers are highly polar compounds with similar structures. They are 
poorly retained and therefore difficult to separate on reversed-phase (RP) material 
(C18 columns). However, a good separation is necessary to avoid ion suppression in 
the MS and in order to obtain reproducible quantitative data. 
Various RP columns with particle sizes between 1.7 and 3 µm were tested (see 
Table 1). The conditions were optimized to have an optimal retention and separation 
of the photoproducts c-s T<>T and Dewar TT (1.4 < Rs < 2.0), and the latter in the 
shortest analysis time [17]. 
  
Chapter 3 ! The quantification of photoprotection 
 79 
Additive 
Mobile phase 
(minimal portion of 
organic solvent) 
Column Rs
1 
Flow 
[mL/min] 
Analysis 
time [min] 
0.1% HCOOH H2O/MeCN (> 3 %) 
Waters Acquity BEH, 
50 x 1 mm, 1.7 µm 0.0 0.25 5 
10 mM NH4HCO2 H2O/MeOH (> 3 %) 
Waters Acquity BEH, 
100 x 2.1 mm, 1.7 µm 0.0 0.35 6.3 
5 mM NH4HCO2 H2O/MeOH (> 3 %) 
Waters Acquity BEH, 
50 x 2.1 mm, 1.7 µm 0.0 0.20 8 
5 mM NH4HCO2 H2O/MeOH (> 10 %) 
Interchim Uptisphere 
UP3NEC#20QS, 
200 x 2.1 mm, 3 µm 
0.5 0.2 11 
5 mM NH4HCO2 H2O/MeOH 
Interchim Uptisphere 
 UP3HDO#20QS, 
200 x 2.1 mm, 3 µm 
1.2 0.2 11 
5 mM NH4HCO2 H2O/MeOH 
Interchim Uptisphere PLP, 
100 x 2.1 mm, 2.2 µm 1.5 0.25 7 
5 mM NH4HCO2 H2O/MeOH 
YMC-PACK ODS-AR, 
150 x 4.6 mm, 3µm 1.7 0.80 9 
5 mM NH4HCO2 H2O/MeOH 
YMC-Hydrosphere C18, 
150 x 4.6 mm, 3µm 1.7 0.90 8 
5 mM NH4HCO2 H2O/MeOH 
Waters Acquity HSS T3 C18, 
100 x 2.1 mm, 1.8 µm 2.0 0.30 7.5 
5 mM NH4HCO2 H2O/MeOH 
Waters Acquity HSS C18, 
100 x 2.1 mm, 1.8 µm 1.7 0.32 7.8 
      Table 1:  Overview of the chromatographic conditions tested (gradient elution). HPLC 
columns highlighted in blue do, and green do not tolerate the use of 100 % 
aqueous mobile phase, respectively. Rs was calculated using the peaks 
corresponding to c-s T<>T and Dewar TT. 
First, an Acquity® BEH (Bridged Ethylene Hybrid) column with 1.7 µm particle size 
was tested using different additives (HCOOH and NH4HCO2) and organic solvents 
(MeCN and MeOH). The next column tested was an Uptisphere® NEC (non-end-
capped2) column. Although both columns were operated at their tolerance aqueous 
phase content limit of 97 and 90 %, respectively, the results were insufficient with a 
maximal Rs of 0.5 (green part in Table 1). 
The following columns were chosen with respect to their tolerance for 100 % 
aqueous mobile phase (blue part in Table 1). They were obtained from different 
manufacturers and have various carbon content, silanol activity, pore sizes and C18 
functionalization.  
                                            
 
1 The resolution factor defining the chromatographic separation between compounds A and B is 
defined as !! = !! !!– !! !(!!/!)!! (!!/!)! (W1/2 = peak width at 50 % relative intensity). 
2 Non-encapped columns have silica based reversed phase sorbents with extra silanol residues for 
strong retentions of polar compounds 
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The best results were obtained with the Waters Acquity HSS C18 column. This 
trifunctional C18 stationary phase, with 1.8 µm particle size is endcapped, and shows 
low silanol activity. The mobile phase consisting of H2O and MeOH was buffered with 
5 mM NH4HCO2. Using this combination, the photoproducts were separated in a 4 
minutes gradient and a total run time of 7.8 minutes (Figure 3), which is almost 40 % 
faster than published data (total time 20 minutes) [2]. 
 
Figure 3:  UV-chromatogram (left scale) showing the optimized separation of the 
photoproducts with an HSS C18 column. A gradient of H2O/MeOH +  
5 mM NH4HCO2 buffer was used (dotted line, right scale). 
3.2.2 MS method optimization 
After chromatographic separation, the photoproducts were detected by ESI-MS with 
a high-resolution maXis QTOF mass spectrometer in the full scan (FS-MS) or in the 
multiple-reaction monitoring (MRM) mode. To date, published data were obtained 
using triple quadrupole mass analyzers acquired in the MRM mode [2, 18]. 
Optimization of the MS/MS fragmentation parameters (precursor ions m/z 545) with 
direct injection of the irradiated TpT solution (3 µL/min flow rate) appeared to be 
challenging. Yields of fragment-ion formation varied a lot and were strongly 
depended on the structure of the different photoproducts. Baseline chromatographic 
separation was required with FS-MS mode since high-resolution extracted ion 
chromatograms (HR-EIC) for each photoproduct have identical monoisotopic masses 
(m/z 545.128). Finally, the data was processed with HR-EIC (± 0.01 m/z) in order to 
improve signal-to-noise ratio (S/N) and sensitivity at the same time. The developed 
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LC method (see Chapt. 3.2.1) did fulfill the peak resolution criteria, and could thus be 
used in combination with FS-MS. A direct comparison of both acquisitions, full scan 
MS and MRM modes, is shown in Figure 4. 
 
Figure 4:  UHPLC-ESI-QTOF-MS analyses of a 10 µM TpT solution after irradiations at 254 
(formation of c-s and t-s T<>T and 6-4 TT) and 312 nm (photoisomerization of 6-
4 TT in Dewar TT). Acquisitions were performed in (A) FS-MS and (B-D) in MRM 
mode (precursor ions m/z 545.1). The S/N is given for each peak. 
According to S/N, the use of FS-MS (Figure 4A) led to a much higher sensitivity 
(factor of ten) compared to MRM detection (Figure 4B-D). This is an important 
criterion in quantitative determinations. The higher S/N in the FS-MS method, and 
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therefore better sensitivity, was crucial because of the low quantum yield of 
mutations observed during irradiation of TpT and synthetic ds DNA. 
Additional aspects relevant for quantification in general are, the correlation between 
relative amounts and ion responses, as well as the precision of the method. The 
relative areas of the five main photoproducts were therefore compared using both 
MS acquisition modes (Figure 5). 
 
Figure 5:  Relative response of all four photoproducts acquired in the FS-MS and in the 
MRM mode (n=5) 
The two acquisition methods used, led to different relative signal responses. First, 
MS/MS fragmentations were strongly related to the structure of the precursor ions 
and each reaction generated different fragmentation yields and thus signal responses. 
Second, similar ionization efficiencies were prerequisited to obtain comparable FS-
MS responses. As all photoproducts belong to the same class of compounds, the 
relative areas obtained from FS-MS data should probably better reflect the relative 
amounts in the samples. 
A further advantage of the FS-MS over the MRM method is the lower systematic 
error due to its higher sensitivity. This is illustrated with the smaller error bars 
obtained after 5 injections of the same irradiated TpT solution (see Figure 5). 
In conclusion, FS-MS was shown to be the method of choice. The higher selectivity 
of MRM methods would only be beneficial in the presence of more complex matrices. 
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In our case, this was not the problem because of good chromatographic separation 
(see Chapt. 3.2.1). 
3.2.3 Optimization of the irradiation setup 
The quantum yield of the photoreaction is very low (Φ = 0.02)3 and only traces of the 
major product c-s T<>T can be isolated from e.g. irradiated calf thymus DNA [2]. It 
was therefore essential to find an efficient and reproducible irradiation method in 
order to form photoproducts with the highest yield. Three main points were thereby 
crucial: the UV-lamp, the sample container and the irradiation setup. 
The lamp was chosen according to the system used by Douki et al. [2]. Two 
wavelengths can be selected, one at 254 nm to form c-s T<>T, t-s T<>T and 6-4 TT, 
and the other at 312 nm to transform 6-4 TT into Dewar TT.  
 
Figure 6:  Irradiation setup with Eppendorf® tube (in the black frame) and microplate 
Containers used for irradiation with different shape and materials have been tested. 
First irradiation experiments were performed using Eppendorf® tubes and micro-
plates. These inexpensive consumables, allow irradiation of many samples at the 
same time and the analyte can be refrigerated in an ice bath (see Figure 6). They are 
                                            
 
3 The quantum yield is defined as: [15] 
 
Φ =
Nprod
Nph,abs
=NAhc
cprodV
PabsΔtλLamp
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made of polypropylene, a material that absorbs UV-light at wavelengths below 300 
nm (Figure 7, curve D). For this reason, irradiations had to be performed from the top 
with open containers. However, the surfaces of irradiation were small compared to 
the sample volumes and sample solvent was evaporating. This led to low yield of 
photoproducts and poor reproducibility.  
 
Figure 7:  Background absorbance of (A) quartz and (B-E) various microplates4 
The UV-light transparent quartz micro-cuvettes were finally chosen (see Figure 7, 
curve A). These cuvettes offer the largest surface of irradiation (5 cm2) for a volume 
of only 500 µL. They can also be sealed with caps, avoiding evaporation during the 
long irradiation periods. 
  
                                            
 
4 P. Held, The Importance of Using the Appropriate Microplate for Absorbance Measurments in the 
Ultraviolet Region of the Spectrum, Technical Note, BioTeck Instruments, Inc, 2001. Link: 
http://www.biotek.com/resources/articles/absorbance-measurement-ultraviolet-spectrum.html. 
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An irradiation box was finally constructed in order to achieve best reproducibility. This 
setup allowed uniform irradiations as the samples are shielded from daylight and 
defined irradiation distances of 20 to 95 cm between the lamp and the micro-cuvettes 
can be chosen. With this system it was also easy to place a second row of micro-
cuvettes in front of the one containing TpT or DNA solutions.  
 
Figure 20:  Irradiation setup consisting of a black box, quartz micro-cuvettes with caps, and 
three marked positions for experiments at e.g. 20, 50, or 95 cm distance from the 
UV-lamp 
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3.3 Estimation of the UV-protection factor 
The primary objective of the project was the verification of the reliability regarding 
reproducibility, sensitivity and accuracy of the UV-irradiation instrumental set up 
developed in Chapter 3.2. Additionally, insight in the effectiveness of some plant 
secondary metabolites to act as UV-filters should be gained on the basis of some 
preliminary tests. These secondary metabolites were chosen with regard to their 
classification: flavones (apigenin and its C-glycoside derivative vitexin), anthocyanin 
(kuromanine), cinnamic acid (p-coumaric acid), polyamines (spermine and its 5,10-
bis(E-cinnamoyl) derivative).  
UV-filter Log10 ε254 Log10 ε312 
Apigenin 
(ap) 
 
4.11 4.22 
Vitexin 
(vi) 
 
4.09 4.20 
Kuromanin 
(ku) 
 
3.94 3.53 
p-coumaric acid 
(cou) 
 
3.57 4.21 
Spermine 
(spm)  
0 0 
5,10-bis(E-cinnamoyl) 
spermine 
(5,10-cin spm) 
 
4.02 3.56 
    Table 2:  UV-filters and their extinction coefficients ε at 254 and 312 nm, respectively 
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With this experimental setup, we tried to correlate absorption properties of the 
selected UV-absorbing molecules with their capacity to protect TpT or ds DNA 
against photoproduct formation. For this reason, the extinction coefficients5 (log10 ε) 
of compounds shown in Table 2 were measured at 254 and 312 nm, which 
correspond to our irradiation wavelengths. It appeared that these molecules present 
similar log10 ε values except for spermine and p-coumaric acid at 254 nm, and 
kuromanin and 5,10-bis(E-cinnamoyl) spermine at 312 nm. 
Three irradiation setups were therefore developed for the screening of the UV-filters. 
The first consisting of two cuvettes (one containing the TpT and the other the UV-
filter solution), the second with a unique cuvette (containing both, the TpT and the 
UV-filter), and a third including a synthetic ds DNA instead of the TpT dimer. 
3.3.1 Irradiation of TpT and UV-filter solutions in separated cuvettes 
First experiments were performed in separate cuvettes and at the shortest distance 
from the UV-light source (20 cm). This arrangement should avoid problems of 
solubility and lead to maximal yields of photoproducts. Their formation was followed 
by UHPLC-ESI-HR-QTOF in the FS-MS mode by collecting aliquots of 40 µL of the 
TpT solutions and by integrating all photoproduct signals. 
In a control assay accomplished with a pure TpT solution, steady state of c-s T<>T 
formation was already reached after ca. one hour irradiation at 254 nm (see Figure 9, 
TpT without UV-filter). These results are in agreement with the data published by 
Douki et al. [2]. 
The rate of photoproducts formed after irradiation of TpT, was used as reference 
data. The UV-filter solutions (50 µM) were then positioned in front of the dimer 
solutions  
(10 µM). The kinetic of the photoproduct formation (c-s T<>T) was then followed in 
absence and in presence of three UV-filters (apigenin, vitexin and kuromanin) as 
presented in Figure 9. 
                                            
 
5 Molar extinction coefficient , A corresponding to the absorbance measured at a defined 
wavelength divided by C the mole concentration of the absorbing material and l the path-length. SI 
unit: m2/mol [19] 
ε =
A
C ⋅ l
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Figure 9:  Formation of c-s T<>T as a function of irradiation duration λ = 254 nm, (solution 
of 10 µM TpT without and with a 1:5 molar ratio of apigenin, vitexin, and 
kuromanin, respectively) in a separate cuvette. Data were obtained from the HR-
EIC of UHPLC-ESI-HR-QTOF-MS analyses. 
The data were then processed allowing a more precise comparison of the formation 
of each photoproduct separately in presence of the various UV-filters (see Figure 10). 
It appears that the formation of photoproducts was mainly due to increased 
concentration of 6-4 TT and the major reaction product c-s T<>T dimer. Further, 
summation of the absolute peak areas of all photoproducts led to a better visibility of 
protection effects and to an improved reproducibility of the quantification. Although 
only two series of experiments were performed, it seems that good coefficients of 
variation (around 3 %) can be obtained for the quantification of the sum of all TpT 
photoproducts (see error bars in Fig 10). 
Surprisingly, from all plant metabolites tested, only p-coumaric acid did not show any 
UV-protection effects at 254 nm. This can be explained with the relatively low 
extinction coefficient of 3.57 at this wavelength (Table 2). However, the results 
observed with spermine, a molecule lacking any UV-absorbing group, seem to 
contradict this assumption. In this case an overall protection effect of 2 % was 
observed. This is close to those observed with the other UV-filters (between 6 and 
0.5 %). The most significant effects of UV protection (10 %) were observed with 
apigenin. Although this value is obtained for the molecule with the highest log10 ε 
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value at 254 nm, it is too risky at this stage of the research, to correlate the extinction 
coefficient values with the formation of TpT photoproducts. 
   
Figure 10:  Formation of photoproducts after 56 min irradiation at 254 nm of an aqueous 
solutions of 10 µM TpT without and with a 50 µM UV-filter solution of apigenin, 
vitexin, kuromanin, p-coumaric acid, spermine or 5,10-bis(E-cinnamoyl) spermine 
prepared in a separate cuvette. Data were obtained from the HR-EIC of UHPLC-
ESI-HR-QTOF-MS analyses. 
With the hope of observing more significant effects, a second irradiation series was 
performed under the same conditions (concentration, distance and duration) at 312 
nm. This wavelength is closer to the one of the UV-light reaching earth and probably 
closer to reality. The sum of the absolute peak areas were lower by a factor of 1/3 if 
TpT was irradiated at 312 nm (Figure 11) compared to the experiments achieved at 
254 nm (Figure 10). The major compound formed is still c-s T<>T (see Figure 11) 
Considering the UV-protection effects, spermine was, as expected from the log10 ε 
values, the only compound that did not show any photoprotection effects (Figure 11). 
The other plant metabolites exhibited similar mutation inhibitions of ca. 20 ± 3 %, 
although kuromanin and 5,10-bis(E-cinnamoyl) spermine have at 312 nm clearly a 
low log10ε of only 3.53 and 3.56 compared to e.g. apigenin with a log10ε = 4.22. It 
seems therefore possible, this time, to correlate the quantified UV-protection effect of 
the tested UV-filters tested with their extinction coefficients. 
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Figure 11:  Formation of photoproducts after irradiating at 312 nm an aqueous solutions of 
10 µM TpT during 56 min without and with 50 µM UV-filter solution of apigenin, 
vitexin, kuromanin, p-coumaric acid, spermine or 5,10-bis(E-cinnamoyl) spermine 
prepared in a separate cuvette. Data were obtained from the HR-EIC of UHPLC-
ESI-HR-QTOF-MS analyses. 
In conclusion, UV-protection effects can be monitored using our developed UHPLC-
ESI-HR-QTOF method in the FS-MS mode, irradiating two micro-cuvettes in series, 
containing in one the TpT and in the other the UV-filter solution. The sensitivity and 
the accuracy (± 3 % at 312 nm) of the instrumental setup developed is satisfactory. 
The robustness of the assay needs to be probed by performing additional 
experiments. Irradiations at 254 nm lead to higher concentrations of mutation 
products than at 312 nm. However, the inhibition of the formation of photoproducts 
with our target filters is more evident if irradiations are performed at 312 nm with a 
maximum of 23 % for vitexin compared to only 10 % for apigenin at 254 nm. 
At this stage of the project, it is may be too early to correlate the log10ε values of the 
UV-filters with the quantification of the photoproducts formed in their presence. 
Nevertheless, the previous tests done at 312 nm appear to be more appropriate to 
perform further experiments with supplementary UV-filters with a broader range of 
extinction coefficients. 
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3.3.2 TpT irradiation in presence of a UV-filter using one cuvette 
Preliminary irradiation tests of TpT (5 µM) and UV-filters mixed together were done 
using a 4-fold excess of one spermine derivative (1,14-bis(E-cinnamoyl) spermine, 
20 µM) and one flavone glycoside (vitexin, 20 µM) in an aqueous solution. The 
cuvettes were irradiated at 254 nm for ca. one hour and photoproduct concentrations 
determined with the UHPLC-ESI-QTOF method in the MRM mode (see Chapter 
3.2.2). 
Figure 12 shows the extracted ion chromatogram of the major photoproducts at  
m/z 447 after 64 min irradiation of TpT at 254 nm in presence of 1,14-bis(E-
cinnamoyl) spermine. 
 
Figure 12:  UHPLC-ESI-QTOF-MS/MS (m/z 545.1 ! 447.1) of an aqueous solution of TpT 
and 4-fold excess of 1,14-bis(E-cinnamoyl) spermine after 64 min of irradiation at 
254 nm 
Similar to the two cuvettes experiment, sensitivity, chromatographic separation and 
peak width were reasonable and would allow quantification of the TpT photoproducts, 
but the S/N are about a factor of 3 lower (S/N = 2300 and 6200 for  
c-s T<>T and S/N = 2200 and 600 for t-s T<>T with one and two cuvettes, 
respectively). This can be attributed to the MRM method (as discussed in Chapter 
3.2.2), which is less sensitive than the full scan one. 
The quantification of the photoproducts with vitexin present in solution appeared to 
be more complicated as this flavonoid is not soluble in H2O. The vitexin stock 
solution was therefore prepared in MeOH and then added to the aqueous TpT 
solution to obtain a final solvent mixture of H2O/MeOH 3:2. The rest of the handling 
was exactly the same as in the experiment with 1,14-bis(E-cinnamoyl) spermine. 
Unfortunately, the chromatographic separation caused major problems 
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(see Figure 13) due to the injection of 5 µL sample solution containing a relatively 
high fraction of organic solvent in an almost exclusively aqueous mobile phase (only 
1 % of MeOH)6  
 
Figure 13:  UHPLC-ESI-QTOF-MS/MS (m/z 545.1 ! 447.1) of a solution of TpT and 4-fold 
excess of vitexin in H2O/MeOH 3:2 after 64 min of irradiation at 254 nm 
3.3.3 Irradiation of ds DNA in presence of a plant metabolite 
absorbing UV-light  
This experiment was designed to test the influence of binding affinities between UV-
filters and ds DNA strands, and derive their UV-protection capacity. Due to the 
problems encountered with the solubility of vitexin in pure H2O (see Chapter 3.3.2), 
only a single experiment has been performed with an aqueous solution containing 
ds2 DNA (0.3 µM) and 1,14-bis(E-cinnamoyl) spermine (1.2 µM) in a 4-fold excess. 
This assay should prove the ability of the method to quantify the UV-protection using 
longer oligonucleotide chains (in this case, ds2 with 14 base pairs). After 2.5 hours 
irradiation at 254 nm (this wavelength has been chosen in order to get higher 
amounts of photoproducts than at 312 nm) ds DNA was enzymatically digested and 
photoproducts quantified with the UHPLC-ESI-QTOF method in the MRM mode 
(Figure 14). However, the overall yields (photoproduct formation, digestion and 
extraction) were very low and the signals just above the limit of detection (see Chapt. 
1.2.2). 
The very low photolysis yields are probably due to the presence of only 6 AT base 
pairs in ds2 DNA and the very small quantum yield of the reaction. The signals 
                                            
 
6 This known phenomenon has already been described [20] 
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obtained are at the moment too low to make any quantitative determination, but the 
sensitivity may be improved by e.g. applying the full scan ESI-MS conditions 
developed in Chapter 3.2.2, or irradiating for a longer time. 
 
Figure 14:  UHPLC-ESI-QTOF-MS/MS (m/z 545.1! 447.1) of an aqueous solution of ds2 
DNA (A) without and (B) with addition of a 4-fold excess of 1,14-bis(E-cinnamoyl) 
spermine after 2.5 h of irradiation at 254 nm and followed by enzymatic digestion 
3.4 Conclusion and outlook 
The aim of this part of the project was to develop a method allowing the quantification 
of the reactivity of DNA with regard to the formation of photoproducts after UV-light 
irradiations. It should also allow to verify that the presence in the solution of small 
organic molecules absorbing UV-light leads to a decrease of the amount of formed 
photoproducts.  
In a first part, an irradiation device including black box, UV-lamp, and quartz micro-
cuvettes was designed and tested in combination with a newly implemented 
analytical method based on fast UHPLC chromatography and high-resolution  
ESI-QTOF mass spectrometry (UHPLC-ESI-HR-QTOF-MS). This arrangement 
allowed the relative quantification of TpT photoproducts with good reproducibility, the 
full-scan MS detection showing better sensitivity and accuracy than the MRM mode. 
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An absolute quantitative procedure including external calibration curve using pure 
photoproducts was not developed as the preliminary experiments were only designed 
to prove that photoprotection effects could be monitored.  
In a second part, the instrumental setup was assessed with regard to the reactivity of 
TpT and a synthetic double strand DNA (14 base pairs) to UV light in presence of 
plant secondary metabolites that were proposed as natural UV-filters [6, 8]. Three 
approaches were considered: (1) irradiation in separated cuvettes, one containing 
the TpT and the other the UV-filter solution, (2) irradiation of a unique cuvette 
containing solution of UV-filter mixed with TpT, and (3) irradiation a unique cuvette 
containing small organic molecules and synthetic ds DNA. Systems utilizing one 
cuvette were developed in order to tentatively correlate non-covalent interactions 
between DNA/small molecules with the efficiency of the UV-protection, an approach 
that failed at this stage of the project. 
It appears that the quantitative determinations of photoprotection effects are possible 
with the system based on two cuvettes. Differentiations were clearer after irradiations 
at 312 (maximum of 23 % UV-protection effect) than at 254 nm (10 %). However, it 
seems risky at this stage of the project to attempt to correlate the results of the 
quantification of the photoproducts with the extinction coefficients log10 ε of the small 
organic molecules and to reach a conclusion on relative protection effects of different 
UV filters. 
Preliminary experiments performed with the irradiation of a unique cuvette containing 
oligonucleotides and UV-filters led to problems of chromatography (a 5 µL injection of 
the solution containing irradiated TpT and vitexin disrupted chromatographic 
behavior) and of sensitivity (signal of photoproducts arising from the irradiation of 
synthetic ds DNA were close to or below the limit of detection). 
If the approach of irradiating unique solutions has to be followed up, further 
optimizations of e.g. solvent mixtures containing some DMSO or UHPLC-MS 
quantification method have to be performed. A larger variety of UV-filters with a 
broad range of extinction coefficients have also to be tested in order to try to 
correlate extinction coefficients with UV-protection effects. 
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3.5 Experimental part 
3.5.1 Chemicals, solvents and enzymes 
Methanol (MeOH), acetonitrile (MeCN), ammonium formate, triethylamine (all in LC-
MS Ultra Chromasolv® quality) and glacial acetic acid (puriss) were obtained from 
Sigma-Aldrich (Buchs, Switzerland). 
 Thymidylyl(3’-5’)thymidine (TpT) was purchased from Microsynth (Balgach, 
Switzerland). TpT (dissolved in 600 µL of solvent A) was purified by HPLC 
(Prominence HPLC system from Shimadzu Scientific Instruments, Columbia, MD, 
USA) using a YMC-pack Basic 10Pµm column (10 µm, 150 x 10 mm, YMC Co.,Ltd., 
Kyoto, Japan). The chromatography was performed with a mobile phase consisting 
of 0.01 M triethylammonium acetate (eluent A, preparation of 2 L by addition of 5.6 
mL of glacial acetic acid to MilliQ water followed by addition of ca. 27.8 mL of 
triethylamine to an adjusted pH of 7.0 ± 0.1) and MeCN (eluent B, Chromasolv). 
100 µL solution of TpT was purified with a linear gradient elution from 5% to 25% of B 
within 7 min at a flow rate of 3 mL/min. The final solution of TpT used for the 
irradiation tests, is a 10 µM (NanoDrop control) solution in H2O/MeCN 96:4 + 0.012 
M HNEt3OAc. 
Protocol for ds DNA formation see Chapter 2.5.3. LC-MS grade H2O (< 2 ppb) was 
obtained by purification of deionized H2O with a MilliQ gradient apparatus equipped 
with a BioPack® ultrafiltration module (Millipore, Milford, MA, USA). Spermine 
tetrahydrochloride, p-coumaric acid, kuromanin chloride and vitexin were purchased 
from Sigma-Aldrich, apigenin from Extrasynthese (Lyon Nord, France) in the best 
qualities available. 5,10- and 1,14-bis(E-cinnamoyl) spermine derivatives were 
synthesized in our laboratories [21]. 
Nuclease P1 from Penicillium citrinum was obtained from Sigma-Aldrich (Buchs, 
Switzerland). Shrimp Alkaline Phosphatase (SAP) was obtained from Promega 
(Madison, WI, USA). Calf Spleen phosphodiesterase, Type II, was obtained from 
Calbiochem, Merck (Darmstadt, Germany) and Snake venom phosphodiesterase, 
Type I, from MP Biomedicals (Santa Aba, CA, USA). 
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3.5.2 Instrumentation 
UHPLC-ESI-MS 
The photoproducts were quantified under following optimized conditions: 
UHPLC-MS analyses were performed on an Acquity system (Waters, Milford, MA, 
USA) using an Acquity HSS C18 column (2.1 x 100 mm, 1.7 µm, Waters), Acquity 
BEH (50 x 1 mm, 1.7 µm, Waters), Acquity BEH (100 x 2.1 mm, 1.7 µm, Waters), 
Acquity BEH (50 x 2.1 mm, 1.7 µm, Waters), Acquity HSS T3 C18 (100 x 2.1 mm, 
1.8 µm, Waters), Acquity HSS C18 (100 x 2.1 mm, 1.8 µm Waters), Uptisphere 
UP3NEC#20QS (200 x 2.1 mm, 3 µm, Interchim), Uptisphere PLP (100 x 2.1 mm, 
2.2 µm, Interchim), YMC-PACK ODS-AR (150 x 4.6 mm, 3 µm, YMC), YMC-
Hydrosphere C18 (150 x 4.6 mm, 3 µm, YMC) 
Mobile phase of the optimized method consisted of H2O (eluent A) and MeOH (B) 
both buffered with 5 mM of NH4HCO2. Elution at a flow rate of 0.32 mL/min started 
with 1 % of B during 1.5 min, followed by a linear increase to 15 % of B within 2.5 min, 
and finally to 95 % of B within 1 min. The wash step consisted in a plateau of 0.9 min 
at 95 % of B, and finally the column was re-equilibrated during 1.6 min until next 
injection. Sample solutions (5 µL) were injected using the “partial loop with needle 
overfill” technique. MeOH/H2O 2:1 and H2O were used as strong and weak needle 
wash solutions, respectively. 
The UHPLC was connected to a high resolution maXis QTOF mass spectrometer 
(Bruker Daltonik GmbH, Bremen, Germany) equipped with the ESI source (ESI 
parameters: end plate offset (–500 V), capillary (4000 V), nebulizer gas (N2, 1.8 bar), 
dry gas (N2, 9 L/min), dry temperature (200 °C). MS parameters: funnel RF (200 Vpp), 
ISCID energy (10 eV), multipole RF (200 Vpp), ion energy (4 eV), low mass (100 
m/z), collision energy (10 eV, He gas), collision RF (350 Vpp), ion cooler RF (200 
Vpp), transfer time (100 µs), and pre-puls storage (10 µs). Full scan mass spectra 
were acquired in the negative full scan mode, at 20’000 resolution (FWHM), scan 
rate of 2 Hz, and between m/z 50 and 600. An external mass calibration below 2 ppm 
accuracy was performed between m/z 112 and 1064 just before starting a series of 
measurements with a 2 mM solution of sodium formate in H2O/propan-2-ol 1:1. 
MS/MS spectra were acquired with almost the same parameters as in the full scan, 
only the collision energy was changed (25 eV). 
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3.5.3 Experimental description 
a) Measurements of Log10 ε values 
Stock solution of apigenin (dissolved in MeOH), Vitexin (DMSO), Kuromanin (H2O), 
p-coumaric acid (EtOH) and 5,10-bis(E-cinnamoyl) spermine (H2O) were prepared at 
a concentration of 5 mM. The stock solutions were then diluted to concentrations of 
0.05, 0.025 and 0.0125 mM with MeOH (apigenin, vitexin and p-coumaric acid) and 
with H2O (kuromanin and 5,10-bis(E-cinnamoyl) spermine). Absorbance of 400 µL of 
each solution was measured between 200 and 450 nm in quartz micro-cuvettes with 
a UV spectrophotometer SpectraMax M5 (Molecular Device, Sunnyvale, CA, USA). 
The extinction coefficients were calculated from the linear slope obtained after 
plotting the absorbances at 254 and 312 nm over the concentrations. 
b) UV irradiations 
The solutions were irradiated with a UV-lamp (VL-215.MC, Vilber Lourmat, Marne-la-
Vallée, France) that was switched on at least one hour in advance. Two rows (in the 
experiment with two cuvettes) of quartz micro-cuvettes with caps (400 µL, 115F-QS, 
Hellma GmbH & Co. KG, Müllheim, Germany) were positioned in a 100 x 12 mm 
tube rack, the oligonucleotide at a distance of 20 cm from the lamp and the UV filter 
solution in front of them. In the experiment with one row, the micro-cuvettes were 
positioned in a 100 x 12 mm tube rack at a distance of 20 cm from the lamp. 
c) Determination of photoprotection factors 
The determination of the phototprotection factor was measured using always the 
10 µM TpT solution in H2O/MeCN 96:4 + 0.012 M HNEt3OAc, 50 µM UV-filters 
diluted either in MeOH (apigenin, vitexin) or in H2O (p-coumaric acid, spermine, 5,10-
bis(E-cinnamoyl) spermine, kuromanin) and 20 µM ds2 (see Chapter 3.5.1). 
2 micro-cuvettes (first containing TpT, the second UV-filter): 200 µL TpT is added in a 
first one and 200 µL of UV-filter is added in a second micro-cuvette. Irradiation of 
three different series consisting of three UV-filters and a control experiment with pure 
H2O were performed at 254 or 312 nm. Aliquots (40 µL) of TpT were collected after 0, 
1, 3, 6, 12, 28 and 56 minutes irradiation time and 5 µL were injected in the UHPLC-
ESI-HR-QTOF-MS system. 
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1 micro-cuvette (TpT + UV-filter): 200 µL of TpT were mixed with 160 µL UV-filter and 
diluted with 40 µL of H2O. The irradiation of the single micro-cuvette was performed 
at 254 nm. Aliquots (40 µL) of the solutions were collected after 0, 1, 2, 4, 8, 16, 32 
and 64 minutes irradiation time and 5 µL were injected in the UHPLC-ESI-QTOF-
MS/MS system. 
1 micro-cuvette (ds2 + UV-filter): 10 µL of ds2 were mixed with 16 µL of UV-filter and 
diluted with 74 µL H2O. The irradiation of the single micro-cuvette was performed at 
254 nm. One aliquot (20 µL) was collected after 150 minutes irradiation time. 
Procedure of enzymatic digestion: the aliquots were diluted with 80 µL H2O and 10 
µL of buffer (ammonium acetate 200 mM, CaCl2 100 mM, pH 6. Then 1 µL (1 U) of 
Nuclease P1 and 1 µL (0.008 U) of calf spleen phosphodiesterase are added. The 
resulting solution was incubated in a dry-block (Techne Dri-block DB-3D) for 2 h at 
37°C. Then, 10 µL of a second buffer (500 mM Tris, 1 mM EDTA, pH 8), 2 µL (0.004 
U) of snake venom phosphodiesterase and 5 µL (5 U) of shrimp alkaline 
phosphatase were added. The samples were incubated in the dry-block at 37°C for 
two additional hours, and 5 µL were then directly injected in the UHPLC-ESI-QTOF-
MS/MS sytem. 
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CHAPTER 4 
DETERMINATION OF THE METHYLATION GRADE 
OF DNA 
4.1 Introduction 
Epigenetics are related to many biological phenomena as e.g. biological 
development/differentiation, cellular differentiation, aging, environmental influences, 
or diseases (Figure 1). Epigenetic factors consist in stable chemical modifications in 
a way to affect gene transcription, silencing or activation. They influence the 
phenotype without any changes in the genotype. Two major epigenetic mechanisms, 
histone modification and DNA methylation have been described [1-3].  
 
 
 
 
 
Figure 1:  Epigenetics in various biological phenomena (reproduced after [2]) 
The growing interest in epigenetics is mainly due to a high activity in genome 
sequencing and in the mechanisms of genome regulation, and is illustrated by an 
increasing number of publications by a factor of about five the last ten years on that 
topic [2] (see Chapt. 1.1.2 for more details).  
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DNA methylation is a fundamental epigenetic modification of gene expression and 
plays an important role in the regulation of many cellular processes as embryonic 
development, transcription, chromatin structure, inactivation of X chromosomes, 
chromosome stability and genomic imprinting [4]. Aberrant DNA methylation has also 
been associated with human ailments [4]. Cancer is certainly one of the most cited 
diseases related to DNA methylation in literature [4-7]. 
As an application example, the increase of the S-adenosyl methionine/S-adenosyl 
homocysteine (SAM/SAH) ratio (see Chapt. 1.1.3) has been associated with sepsis 
in rodents [8]. This change implies a deregulation in the methylation process during 
sepsis. Although the rodent model does not exactly compare with the human one, the 
data obtained encourage further studies in order to find a correlation between sepsis 
and SAM/SAH ratio in human patients (See Chapter 5 for application).  
A further connection has been noticed between the smoking behavior and its 
influence on the global DNA methylation [9]. The findings of this study lead to the 
conclusions that possibly oncological, neuropsychiatric, or addictive diseases could 
be affiliated to DNA methylation.  
Various analytical methods have been developed to quantify the methylation grade in 
human and in calf thymus (CT) DNA. They are mainly based on GC-MS, HPLC-UV, 
and HPLC-MS (Table 1). A relatively broad range of methylation grade could be 
determined for human leukocytes (4.0 – 5.4 mol%) and CT DNA (4.75 – 8.1 mol%). 
Only a few of these methods show low standard deviations (std dev) or coefficients of 
variation (CV’s) synonymous of high precision. Low accuracy in DNA methylation 
grade suggests low precision measurement because these analytical methods are 
not necessary appropriate to determine it. 
From all the procedures based on GC, accurate determination of the methylation 
grade have been obtained for CT DNA with flame ionization detector (FID) [10] and 
for human DNA with electron capture detector (ECD) [11]. These methods are 
sensitive and low amounts of DNA, below 1 µg, are required. However, the major 
drawback of both methods is the time-consuming sample preparation, in particular 
derivatization and solid phase extraction steps [11]. Further, a long time analysis of 
around 25 min, is inappropriate for handling numerous samples.  
HPLC-UV methods lead also to good and excellent accuracy for CT and human 
leukocyte DNA, respectively [12]. However these methods have also their drawbacks 
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in long analysis times (23 to 70 min), required several µg of DNA, and a dangerous 
procedure of DNA hydrolysis with hydrofluoric acid. A higher sensitivity and best time 
analysis of 12 min are achieved with MS detection, in particular in the MS/MS mode 
(Table 1).  
Analytical method 
Methylation grade 
found in human 
leukocyte DNA  
[mol% ± std dev] 
Methylation grade 
found in CT DNA  
[mol% (CV %)] 
Analysis time 
[min] 
Amount of 
DNA 
requested 
[µg] 
Lit. 
GC-FID − 6.75 (3.0) Not indicated < 1 [10] 
GC-ECD 4.04 ± 0.26 5.7 (8.2) 25 0.35 [11] 
HPLC-UV − 6.5 (3.8) > 23 Not indicated [13] 
HPLC-UV − 8.1 > 17 1 [14] 
HPLC-UV − 8.1 - - [15] 
HPLC-UV − 6.65 (15) 70 < 10 [16] 
HPLC-UV 4.56 ± 0.05 − 70 1 - 5 [12] 
32P-base analysis − 4.76 (5.7) 1080 1 [17] 
Fluoroimmuno- 
assay − 4.75 - - - 
EI-MS − 6.43 - 1 - 20 [18] 
GC-EI-MS − 5.7 (7) > 10 0.2 [19] 
GC-EI-MS − 6.6 (6.5) > 5 1 [20] 
GC-EI-MS 5.0 - 6.0 − > 6 5 [21] 
LC-ESI-MS 5.4 ± 0.1 − 13 1 [22] 
LC-ESI-MS/MS 4.0 ± 0.44 6.5 (3.5) 12 1 [23] 
LC-ESI-MS/MS 4.7 ± 0.8 − 14 1 [24] 
      
Table 1:  Analytical methods used for the quantification of DNA methylation. Performances 
are presented as mean ± standard deviation or mean (inter-assay CV) in mol% 
(Reproduced after [23]).  
Superior sensitivity and high throughput were the reasons to combine an high 
performance liquid chromatography (HPLC) and ESI-MS/MS has been chosen for 
the development of a method to determine the methylation grade in human leukocyte 
DNA and CT DNA. The best values obtained were 4.0 ± 0.44 mol% methylation 
grade for healthy humans and of 6.5 % (CV 3.5%) for calf thymus DNA [23]. 
In biological variability studies, a large number of patient and control samples have to 
be measured in order to have enough data for statistical relevance.  
The main goal of this project was to develop a robust analytical method to quantify 
the absolute amount of 5-methylcytosine in DNA samples based on  
UPLC-ESI-HR-QTOF-MS using a maXis UHR-QTOF coupled to an UPLC system. 
This method would be then used to find a relationship between the methylation grade 
of DNA and various diseases as e.g. sepsis, alcoholics, and cancer. Kok et al. 
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developed a method for the determination of the methylation grade of CT and human 
DNA [23]. Our developed method has to be as good as the published data, and, if 
possible, in a shorter time analysis for an increased sample throughput. 
4.2 Development of the quantification method 
4.2.1 Transfer to UHPLC and high-resolution QTOF MS 
In the most accurate method developed by Kok and coworkers, approximately 1 µg 
of DNA was hydrolyzed under acidic conditions with formic acid resulting in the free 
bases. Because the 5-position of cytosine is the only reactive site that has been 
observed in DNA methylation, the global DNA methylation was only determined by 
quantifying cytosine and 5-methylcytosine. They found a methylation grade of 4.0 ± 
0.44 mol% for healthy humans and 6.5 % (CV 3.5 %) for calf thymus DNA [23]. 
Detection and quantification of the hydrolysis products were performed by LC-ESI-
MS/MS, allowing fast and sensitive analyses without derivatization.  
The first step was to transfer the method to an UHPLC system in order to increase 
the sample throughput while maintaining a good chromatographic separation, using 
same solvents (H2O and MeCN) and buffer (nonafluoro-1-pentanoic acid, NFPA). 
The major modifications were the selection of an Acquity BEH C18 stationary phase 
with smaller particle size (1.7 compared to 3.5 µm), smaller column dimensions 
(inner diameter of 2.1 instead of 4.6 mm), and an adapted flow rate (0.5 instead of 
1.0 mL/min).  
The UHPLC system was connected to Bruker maXis high-resolution mass 
spectrometer (QTOF) equipped with an electrospray ionization source. The 
instrument parameters were optimized with a solution of commercially available 
cytosine. Due to the insufficient MS/MS sensitivity of the QTOF mass analyzer for 
fragment ions below m/z 100, data were collected in the full scan mass range instead 
of the published multiple reaction-monitoring mode (MRM). Quantification was finally 
achieved with an improved selectivity using integration of high-resolution extracted 
ion chromatograms (HR-EIC) with ± 0.05 m/z width.  
Unfortunately, the NFPA buffer used in this method had to be replaced in spite of 
excellent performances in terms of peak shape, width, sensitivity, and speed. This 
ion-pairing agent used for separating the highly hydrophilic cytosine and 5-
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methylcytosine on a C18 reversed phase column lead to major contamination of the 
UHPLC-MS instrumentation in the negative ionization mode. A huge effort in flushing 
the solvent pumping system was afterward necessary to reduce the intensity of the 
long-lasting ESI-MS signals of deprotonated NFPA and restore acceptable analytical 
performances.  
 
Figure 2:  HR-EIC of cytosine and 5-methylcytosine and their respective labeled internal 
standards 2,4-[13C2,15N3]-cytosine and 5’,5’,5’,6-[2H4]-5-methylcytosine  
Several C18 endcapped or non-endcapped reversed phase columns have 
consequently been tested with various solvents and buffers, in vain. Finally, normal 
phase chromatographic conditions including an Acquity BEH Amide column, H2O and 
MeCN as solvent, and 10 mM NH4HCO2 + 0.125 % HCOOH as additives were 
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fulfilling the requirements for the separation of cytosine and 5-methylcytosine within 
less than 5 minutes (Figure 2)2. 
The robustness and sensitivity of the optimized UHPLC and ESI-HR-QTOF-MS 
method was then tested by measuring the methylation grade of 10 CT DNA samples 
prepared from the same stock solution. To obtain maximal accuracy, internal 
standards (ISTD), consisting of 2,4-[13C2,15N3]-cytosine and 5’,5’,5’,6-[2H4]-5-methyl-
cytosine,  were added to the DNA samples prior hydrolysis with concentrated formic 
acid, according Kok’s procedure [23]. Cytosine and 5-methylcytosine were quantified 
by means of the Bruker QuantAnalysis® software using calibration curves with 
6 points. The analysis of the 10 samples of 1 µg CT DNA was then repeated a 
second time and the amounts recalculated with the previously used calibration curve 
in order to test the stability of the analytical system. The mol% ratios of cytosine and 
5-methylcytosine shown in Figure 3 were finally calculated from these absolute 
amounts (see Chapt. 4.4.4) 
 
Figure 3:  Double determination of methylation grade (mol%) of 10 CT DNA samples with 
the newly developed UHPLC-ESI-HR-QTOF-MS method by applying the same 
calibration curve. 1st injection series in blue, 2nd in orange; mean value in 
brackets, CV in red, and literature value as black dashed line. 
Obviously, the accuracy and the coefficient of variation varied a lot. The dual 
determinations were therefore repeated five times including new calibration curves 
and using the same commercially available CT DNA. Again, the results were not 
                                            
2 Method developed according to Waters® Application Note WA64081, Acquity UPLC BEH Amide 
Column, Application notebook, 2009, p. 31 
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reproducible with degrees of methylation varying between 6.5 and 12.7 %, and CVs 
between 1.4 and 14.8 %.  
Comparing the data sets obtained, it seemed that the uncertainties could arise from 
the instrumental setup. The first handling of the troubleshooting was to exclude 
improper sample preparations, unreliable calibration curves, and lacking hydrolysis. 
A series of 10 hydrolyzed CT DNA samples was therefore sent to Kok’s laboratory in 
Holland in order to determine their degree of methylation and CVs. The 10 samples 
were double-checked using a unique calibration curve, leading to an average degree 
of methylation of respectively 7.12 % (CV of 1.45 %) in the first and of 7.09 % 
(1.58 %) in the second series. Therefore, there is no reason to distrust the 
preparation of the samples and the solutions used for calibration. 
The next step was to localize the origin of the discrepancies observed in the UHPLC-
ESI-HR-QTOF-MS method. Astonishingly, the poor accuracy could not be correlated 
with the variable CV’s. Looking at the analytical procedure, the DNA concentrations 
were checked prior hydrolysis with a NanoDrop instrument (± 2 % accuracy), peaks 
corresponding to cytosine and 5-methylcytosine are base-line separated (see 
Figure 2), standard ESI conditions including widely used solvents (H2O, MeCN, and 
NH4HCO2 buffer) were chosen in combination with most appropriately labeled 
internal standards and a 6 point calibration curve used.  
The accuracy and stability of the UHPLC-ESI-HR-QTOF-MS method, including 
phenomena of adsorption, carry over, and decomposition, were then checked with 
the determination of the absolute amount of cytosine and 5-methylcytosine of the 
hydrolysis of a unique CT DNA sample (1 µg). 
After complete hydrolysis of the DNA sample, the measured amounts of cytosine and 
5-methylcytosine can be compared to the theoretical value. CT DNA purchased from 
Sigma-Aldrich was certified to contain 42 % of GC base pairs [25]. A complete 
hydrolysis of 1 µg DNA would theoretically gives 72 ng of cytosine3. This cytosine is 
partially methylated (6.5 mol% according to published data [23]) leading to calculated 
absolute amounts of cytosine and 5-methylcytosine of 66.7 and 5.3 ng, respectively. 
                                            
3 
1µg DNA× 42%×111.04 g /mol M cytosineR
650.09 g /mol MGCR
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Average masses of 67.3 ± 4.4 and 7.1 ± 0.3 ng were obtained for the determination 
of cytosine and 5-methylcytosine in this unique sample. The intra-assay stability with 
CV values of around 5 % can be considered as acceptable, although better precision 
was expected for the analysis of a unique sample. As comparison, Kok’s laboratory 
reached precisions below 2 % for the determination of the methylation grade in 10 
CT DNA samples.  
 
Figure 4:  Absolute amounts of cytosine and 5-methylcytosine determined 10 times from 
the hydrolysis of one CT DNA sample (1 µg). The mean values are shown in 
brackets, the intra-assay coefficient of variation in red, and the std dev in grey 
The average amount of 67.2 ng cytosine obtained from the UHPLC-ESI-HR-QTOF-
MS is extremely close to the theoretical value. However, the measured quantity of  
5-methylcytosine is clearly above the theoretical one (7.1 ± 0.3 compared  
to 5.3 ng; + 33 %). This amount lead to a degree of methylation of 8.5 mol% that is 
definitively higher than the expected value of around 6.5 to 7 mol%.  
As for the determination of the methylation grade in 10 CT DNA samples performed 
previously, the CV values do not explain the mismatch. A inappropriate preparation 
of the 5-methylcytosine standard solutions used for the calibration curve was further 
considered and rejected for two main reasons: (1) The calibration curve with 6 points 
between 1 and 16 ng showed an excellent correlation coefficient (R = 0.999871, see 
Figure 5) and (2) exactly the same standard solutions were used in Kok’s laboratory 
and the values of methylation grade obtained there were within the expectations (7.1 
mol%, CV of 1.45 %).  
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Figure 5:  Calibration curves obtained for cytosine and 5-methylcytosine with the maXis 
QTOF expressed in relative ng amounts related to corresponding relative signal 
areas 
To conclude, the method transfer failed because of a lack of reproducibility in terms 
of accuracy and precision (CVs). Obviously, the DNA methylation grades obtained 
from the QTOF are random in spite of the use of the most appropriate labeled ISTDs 
and of good calibration curves. As miscarried sample preparations or calibration 
solutions can be excluded, a fundamental problem of mass analyzer and ion 
response has to be considered. The use of a QTOF mass analyzer in full scan mode 
is the major difference in comparison to the published method based on multiple 
reaction monitoring (MRM) data acquisition with triple quadrupole mass spectrometer, 
nowadays the gold standard in quantitative determinations. Therefore, further MS 
detection techniques will be considered. 
4.2.2 Evaluation of mass analyzers  
The Bruker maXis QTOF TM mass analyzer presented above was principally 
developed for measuring ‘large’ charged molecules. In the case of cytosine and  
5-methylcytosine, quantification of ions below m/z 130 is asked for. Special dedicated 
instrument tuning was required for measuring in such a low mass range and these 
extreme adjustments may have caused unexpected problems including e.g. non-
reproducible ion transmission and response. 
Further mass analyzers were then evaluated in order to define which one is the most 
appropriate to quantify DNA methylation in terms of precision and accuracy. At the 
same time, it should also be possible to find out whether the poor data quality is 
related to ion suppression, detector saturation, or data processing issues. 
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Next to the Bruker maXisTM QTOF, a Bruker HCTTM ion trap and an AB Sciex API 
3200 QtrapTM linear ion trap running in the triple quadrupole acquisition mode were 
chosen in order to have different kinds of mass analyzers, acquisition modes (full 
scan or MS/MS, Chapt. 1.2.3) and processing software. Electrospray ionization and 
standardized chromatographic conditions including the previously optimized UHPLC 
method (see Chapt. 4.2.1) were chosen each time in order to simplify data 
assessment. The selected MS-acquisition conditions can be summarized as follows: 
• QTOF acquisitions performed in the full-scan mode (m/z 0-200) and 
chromatograms extracted at high resolution (HR-EIC ± 0.05 m/z) to increase 
method selectivity and sensitivity (enhanced signal-to-noise ratio). 
• The ion trap used in the full-scan mode (m/z 0-200, ± 0.1 m/z). The scan rate 
was too low to acquire all four MS/MS transitions in MRM mode. In this case, 
only one data point per chromatographic peak and MRM transition was 
obtained, which is definitively not sufficient for quantitative determination. 
• Quantitative analyses on the Qtrap performed in the most selective and 
sensitive MRM mode. The published MS/MS transitions from m/z 112.10 to 
95.10, 117.10 to 99.09, 126.10 to 109.108, and 130.10 to 113.10 were chosen 
for the detection of cytosine, 2,4-[13C2,15N3]-cytosine, 5-methylcytosine, and 
5’,5’,5’,6-[2H4]-5-methylcytosine, respectively. 
a) Reproducibility of the ratio of peak areas 
In order to have a reliable appraisal of the mass analyzer ion responses, a single 
standard solution containing a defined ratio of cytosine and 5-methylcytosine was 
prepared. Concentrations of 1000 and 40 ng/mL, respectively, corresponding to a 
ratio of 3.6 mol% were chosen to be comparable to the values obtained after 
hydrolysis of 1 µg human DNA. Reproducibility of ten measurements was then 
evaluated on each instrument by comparing the peak areas of cytosine and  
5-methylcytosine under the same UHPLC conditions (column, solvents, gradient and 
flow). The chromatograms were processed and integrated according to the mass 
analyzer, and each integral ratio was plotted for each injection (Figure 6). 
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Figure 6:  Reproducibility and precision of 10 injections of a solution containing  
cytosine/5-methylcytosine standards in a 3.6 mol% ratio (black dashed line) and 
measured with the maXis QTOF, HCT ion trap and 3200 Qtrap mass analyzers. 
Mean ratios are given in brackets, intra-assay CV in red, and std dev in grey. 
Mass spectrometers are concentration sensitive detectors. Assuming uniform ion 
response for cytosine and 5-methylcytosine, an integral ratio of 3.6 mol%4 should be 
obtained, the same as the effectively weighed molar ratio. Depending on the 
instrumentation used, these ratios varied obviously a lot between 3.6 and 11.2 mol%, 
which is not a surprise as the ion response of the analytes were not expected to be 
identical. However, the huge disparity of the CVs was unforeseen because in each 
case, a unique sample was measured 10 times consecutively under exactly the same 
conditions and the ratio of the two components expressed in relative values of both.  
The measured ratios of integrals highlighted the excellent reproducibility of the Qtrap 
(CV of 1.8 %). Also the averaged integral ratio is matching perfectly (3.6 mol%), 
although MS/MS transitions were considered without ISTD corrections of the ion 
response. Furthermore, the precision of the QTOF can be rated as sufficient (6.4 %) 
and that of the ion trap as poor (12.1 %). These precisions obtained from QTOF and 
ion trap analyses are not proportional to the accuracy and worse than the precision 
achieved for the integration of cytosine and 5-methylcytosine separately (e.g. CVs of 
respectively 3.9 and 3.5 % for the QTOF, see Table 2). This is shocking because a 
better precision was expected for repeated determinations of the ratio of two 
                                            
4 The HR-EIC peak integrals for 5-methylcytosine and cytosine correspond to the nmol/mL of each 
analyte, since MS are concentration sensitive detectors. The ratio of both integrals give us the mol% 
of 5-methylcytosine in the sample. 
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components compared to absolute peak integrals, since the variability due to 
differences in injected amounts is not relevant when ratios are measured.  
 Qtrap 3200 maXis QTOF HCT ion trap 
Cytosine 1.3 3.9 5.4 
5-Methylcytosine 1.3 3.5 9.4 
    
Table 2:  Intra-assay coefficients of variation (%) obtained for integrating the signal of 
10 injections of a standard solution containing 1000 ng/mL cytosine and 
40 ng/mL 5-methylcytosine and measured by UHPLC-ESI-MS 
There are several reasons that could explain the divergences in the ratio of absolute 
peak integrals shown in Table 2, including e.g. different ionization efficiencies, 
discrimination in transmission of ions below m/z 140 (particularly concerning the 
QTOF), and irregular matrix effects. The determination of absolute concentrations 
using appropriate labeled internal standards should therefore annihilate such 
discrepancies and clearly increase precision and accuracy. 
b) Reproducibility of concentration ratios after ISTD correction 
As next, signal responses of the mass analyzer have been transformed into absolute 
analyte concentrations. Differences between integrals in terms of ion response and 
matrix effects are compensated with signal intensities of the ISTDs that are 
themselves correlated to fix concentrations. The mol% ratio between two analytes 
was then obtained after conversion of the absolute amount (ng/mL) of cytosine and 
5-methylcytosine in concentrations (nmol/mL). 
In quantitative determination with MS, the use of labeled internal standards is the 
most appropriate way because analyte and ISTD have quasi identical ion responses 
(in full scan and MS/MS mode), same retention time, and undergo therefore same 
matrix effects (see chap. 1.2.3 c) for more details). For these reasons, known 
amounts of labeled internal standards, 2,4-[13C2,15N3]-cytosine and 5’,5’,5’,6-[2H4]-5-
methylcytosine (1000 and 50 ng/mL, respectively) were added to the sample used 
previously. 
The QTOF, ion trap and Qtrap mass analyzers were tested 10 times again under the 
same chromatographic and MS conditions with this unique solution of standards and 
ISTDs. The peak integrals of cytosine and 5-methylcytosine were then converted to 
absolute concentrations using the signal of their corresponding labeled ISTD. The 
ratios were finally expressed in mol% (see Figure 7).  
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Figure 7: Reproducibility and precision of 10 injections of a single solution containing 
standards of cytosine and 5-methylcytosine prepared in a 3.6 mol% ratio (black 
dashed line) and their corresponding labeled ISTD. Analyses were performed 
using the maXis QTOF, HCT ion trap and 3200 Qtrap mass analyzers. Mean 
ratios are given in brackets, intra-assay CV in red, and std dev in grey. 
ISTDs were added in the sample because they increase the precision of the results 
and allow an estimation of the absolute amounts of the analytes. One-point 
calibration methods make only sense since concentrations of analytes and ISTD are 
identical (cytosine and 2,4-[13C2,15N3]-cytosine, 1000 ng/mL) or comparable 
(40 ng/mL 5-methylcytosine and 50 ng/mL 5’,5’,5’,6-[2H4]-5-methylcytosine). They 
cannot be used for real samples where the unknown amount is varying. In this case, 
standard procedure with a calibration has to be used. 
The results obtained surprisingly diverge. On one hand, the Qtrap data is still 
excellent in terms of precision (CV of 1.7%), but the average ratio has been shifted 
from the effective 3.6 mol% to 5.9 mol%. On the other hand, the ion trap leads to an 
excellent ratio of 3.5 mol%, however with inacceptable precision (CV of 16 %), value 
that is even worse than without ISTD (12.1 %). Data qualities obtained from the 
QTOF were average, with 4.3 mol% instead of 11.2 % integral ratio. The CV of 8.5 % 
(6.4 %) was worse with an evident drift from the first to the 10th injection (see 
Figure 7).  
Addition of ISTD leads to better values of methylation grade (ion trap and QTOF) but 
not for CV’s. Qtrap shows still a very good CV but a poor accuracy. This is probably 
due to the one-point calibration procedure. 
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c) Selection of the mass analyzer 
Criteria of accuracy and precision have to be considered for the selection of the most 
appropriate mass analyzer. 
With a QTOF and an ion trap instrument, determination of the ratio of two integrated 
chromatographic peaks lead to imprecision beyond the tolerance whether a ISTD 
was used or not. This problem was revealed with the repeated analysis of a unique 
sample under identical chromatographic conditions. The use of an ISTD allowed 
correlation of the ion response to an absolute concentration and therefore improved 
the accuracy but, surprisingly, not the precision of the method (e.g. with the QTOF, 
CV of 6.4 and 8.5 % were obtained without and with ISTD, respectively, see Table 3). 
The poor reproducibility of integral ratios was confirmed by the analysis of the same 
sample on a second maXis QTOF instrument in the Bruker application’s laboratory. 
Furthermore, on-flow ESI-MS analyses of two further analytes, caffeine and 
theobromine, detected in a higher masse range (m/z of 191 and 185, respectively) 
lead also to such unexpected and inexplicable mismatches. 
A) 5-Methylcytosine/Cytosine integral ratio in mol%  (1 vial, 10 injections) 
         
  Effective ratio 
Qtrap 3200 
(MRM) 
maXis QTOF  
(FS) 
HCT ion trap  
(FS) 
5-Methylcytosine [mol%] 3.6 3.6 11.2 7.1 
CV [%]   1.8 6.4  12.1 
          
B) 5-Methylcytosine/Cytosine corrected in mol%  (1 vial, 10 injections) 
         
  Effective ratio 
Qtrap 3200 
(MRM) 
maXis QTOF  
(FS) 
HCT ion trap  
(FS) 
5-Methylcytosine [mol%] 3.6 5.9 4.3  3.5 
CV [%]   1.7 8.5  16.0 
     Table 3:  Accuracy and precision of the ratio between cytosine and 5-methylcytosine 
expressed in A) integral ratio and B) in mol% after ISTD correction 
The Qtrap mass analyzer provided clearly the most precise data (CV of 1.8 without 
and 1.7 % with ISTD). The main distinction with the QTOF and ion trap method was 
the use of MRM instead of FS acquisition mode. This could explain the variability of 
the measurements. This hypothesis was refuted with the determination of integral 
ratios of two components measured with a TSQ mass. The results obtained on the 
Waters TQD were however even worse with a CV of 12.8 % after ISTD correction  
(1 sample at 7.1 mol% ratio of cytosine/5-methylcytosine, 10 injections). 
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From the results shown in Table 3, it is possible to conclude that variance is neither 
specific to the type of instruments (triple quadrupole, ion trap or QTOF), nor 
depending on the type of MS acquisition method (MRM or full scan).There was no 
way to tune the QTOF or the ion trap in order to obtain satisfying data, which was 
confirmed by the Bruker application laboratory. A possible explanation could be 
related to the detectors or to the analog to digital conversion that is different in AB 
Sciex compared to Bruker and Waters instruments. 
Because the highest precision was achieved on an AB Sciex Qtrap 3200, the 
determination of the methylation grade of DNA was further validated on this 
instrument. 
4.2.3 Validation 
The method for determining the methylation grade of DNA based on UHPLC coupled 
to a Qtrap mass analyzer in the MRM mode was validated with samples containing 
1 µg of CT DNA (prepared from a stock solution) and labeled cytosine and  
5-methylcytosine ISTDs that were hydrolyzed with concentrated formic acid. The 
internal standardization is certainly the most appropriate procedure since loss of 
sample, decomposition, matrix effects, and ion suppression effects are compensated.  
The analysis of a series of 10 samples was repeated nine times in order to calculate 
intra- and inter-assay coefficients of variation. For quantitative determinations, two 
calibration curves with 6 points were prepared in a range of 100 to 3000 ng/mL and 
10 to 160 ng/mL for cytosine and 5-methylcytosine, respectively. Three series of 
samples were prepared simultaneously and analyzed in a joint sequence. The data 
recorded lead to excellent calibration curves with quadratic coefficients of correlation 
often close to 1 as presented in Figure 8. Quadratic calibrations curves are often 
used with MS detectors due to their non-linear ion responses over the concentration 
range. 
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Figure 8:  Quadratic internal calibration curves for the quantification of cytosine and  
5-methylcytosine in CT DNA with the Qtrap mass analyzer 
After calculating the absolute amount of cytosine and 5-methylcytosine in each 
sample, the masses were converted in mol and the degrees of methylation 
expressed in mol%. All nine series of quantitative determinations of the methylation 
grade of CT DNA are presented in Table 4.  
 
serie1 serie2 serie3 serie4 serie5 serie6 serie7 serie8 serie9 
 
6.573 6.658 7.042 6.804 6.767 6.421 6.929 7.018 6.883 
 
6.570 6.817 6.938 7.001 6.564 6.359 6.964 6.979 6.575 
 
6.585 6.928 7.284 6.792 6.652 6.649 7.139 6.701 6.788 
 
6.717 7.079 7.044 6.910 6.430 6.510 6.975 6.765 6.885 
 
6.498 6.684 6.821 6.738 6.858 6.706 6.919 6.799 7.036 
 
6.784 6.684 6.932 6.724 6.425 6.762 7.053 6.608 6.948 
 
6.749 6.762 7.220 7.146 6.549 6.639 7.087 7.016 6.880 
 
6.802 6.649 7.043 6.969 6.547 6.505 7.100 7.045 6.960 
 
6.681 6.873 6.649 6.702 6.568 6.647 6.929 6.923 7.045 
 
6.910 6.774 6.723 7.010 6.464 6.511 7.039 6.843 6.845 
          mean 6.687 6.791 6.970 6.880 6.582 6.571 7.013 6.870 6.885 
std dev 0.129 0.138 0.202 0.149 0.141 0.129 0.080 0.150 0.135 
CV [%] 1.930 2.032 2.892 2.171 2.144 1.966 1.143 2.182 1.967 
          
Table 4:  Determination of the methylation grade in nine series of ten CT DNA samples 
used for the calculation of intra- and inter-assay coefficients of variation 
To assign the overall intra-assay precision of the method, the CV’s of all nine series 
were plotted and the mean CV calculated. The average of 2.0 % obtained (see 
Figure 9) is close to the literature value of 1.7 % [23]. 
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Figure 9:  Intra-assay validation of the method for determination of the methylation grade of 
CT DNA (9 series of 10 samples) 
Regarding the inter-assay stability, the average methylation values were plotted for 
all nine series including relative errors (see Figure 10). A mean methylation grade of 
6.8 mol% (CV of 2.4 %) was obtained for the CT DNA reference. These values are 
close to the published values of 6.5 mol% (3.5 %) and 7.1 mol% (1.5 %) obtained 
from the same samples measured in Kok’s group.  
 
Figure 10:  Inter-assay validation of the methylation grade of CT DNA with 9 series of 10 
samples 
The good results of the validation reflect the quality of the developed quantification 
method, in particular sample preparation procedure and instrument precision and 
stability. This method is therefore suitable for the determination of the DNA 
methylation grade of patients, and to trace the possible relation between methylation 
and infections or diseases. 
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4.3 Conclusion  
During the method development, it has been demonstrated that the choice of the MS 
instrument is crucial in order to get accurate and reproducible data. Inexplicable 
results obtained from the first developed method on a QTOF mass analyzer revealed 
to be inaccurate. It has been shown that unstable ratios of peak integrals were 
obtained for repeated analyses of a unique sample containing two analytes. Neither 
precision, nor accuracy were enhanced by addition of an internal standard. Similar 
problems were also observed with ion trap or triple quadrupole mass analyzers from 
the same (Bruker) or from other manufacturer (Waters, ABSciex) operating in 
different acquisition modes (full scan or MS/MS). Therefore, it seems that the 
problems could arise from the detector and/or the analog to digital conversion. 
A reliable method based on UHPLC-Qtrap-MS/MS has been developed to determine 
the methylation grade of DNA. This new method requires 1 µg of material and has a 
time analysis of 8 min per sample. This is at least 33% faster than the best published 
method developed by Kok and coworkers [23]. The accuracy of 6.8 mol% of 
methylation found in CT DNA is really close the published value of 6.5 mol% [23], 
with a better inter-assay precision of 2.4 % obtained for the analysis of 9 series of 10 
CT DNA, compared to the published one (3.5 %). The 2 % intra-assay is also 
comparable to the literature value (1.7 %). This proves that our method can be 
chosen to check if infections or diseases like e.g. sepsis, cancer, and alcoholism 
influence the methylation grade of human DNA (see Chapt. 5 for application). 
This method could also be further used for the quantification of other damages to 
DNA as oxidative or UV induced mutations. A major drawback could be the selection 
of an appropriate internal standard or related substance.  
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4.4 Experimental part 
4.4.1 Chemical, standards and reagents 
Chromasolv® LC-MS grade acetonitrile (MeCN) and methanol (MeOH), formic acid 
(HCOOH, MS grade) and ammonium formate (NH4HCO2, MS grade), cytosine (99%, 
puriss), 5-methylcytosine hydrochlorid (99%, puriss), 2,4-[13C2,15N3]-cytosine (99 
at.% 13C; 98 at.% 15N), and calf thymus DNA (Type I, “Highly Polymerized”; 42 % GC 
content, sodium salt) were obtained from Sigma-Aldrich (Buchs, Switzerland). 
5’,5’,5’,6-[2H4]-5-methylcytosine (99.1 at.% 2H) was purchased from Dr. Ehrenstorfer 
(Augsburg, Germany). LC-MS grade H2O (< 3 ppb) was obtained by purification of 
deionized H2O with a MilliQ gradient apparatus equipped with a BioPack® 
ultrafiltration module (Millipore, Milford, MA, USA). 
4.4.2 Preparation of standard solutions 
All standard (STD) and internal standard (ISTD) solutions were prepared from a 
stock solution (SS) at a concentration of 100’000 ng/mL (1 mg of substance weighted 
accurately in 10 mL MeCN/MeOH 75:25). Summarized in Table 5, the procedure and 
dilution steps for making the solutions used for evaluation and calibration. 
Standard cytosine 
  
 
Solution Calc. conc. [ng/mL] Eff. conc. [ng/mL] Volume added Final volume [mL] 
SS(STD)  100'000   101'500      
WS1(STD)  10'000   10'150   1000 µl SS 10 
WS2(STD)  1'000   1'015   1000 µl WS1 10 
STD1  100.0   101.50   1000 µl WS2 10 
STD2  500.0   507.50   500 µl WS1 10 
STD3  1'000.0   1'015.00   1000 µl WS1 10 
STD4  1'500.0   1'522.50   150 µl SS 10 
STD5  2'000.0   2'030.00   200 µl SS 10 
STD6  3'000.0   3'045.00   300 µl SS 10 
   
 
 Standard 5-methylcytosine 
  
 
Solution Calc. conc. [ng/mL] Eff. conc. [ng/mL] Volume added Final volume [mL] 
SS(STD)  100'000   100'200      
WS1(STD)  10'000   10'020   1000 µl SS 10 
WS2(STD)  1'000   1'002   1000 µl WS1 10 
WS3(STD)  100   100   1000 µl WS2 10 
STD1  10.0   10.02   1000 µl WS3 10 
STD2  20.0   20.04   2000 µl WS3 10 
STD3  40.0   40.08   400 µl WS2 10 
STD4  80.0   80.16   800 µl WS2 10 
STD5  120.0   120.24   120 µl WS1 10 
STD6  160.0   160.32   160 µl WS1 10 
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Internal standard 2,4-[13C2,15N3]-cytosine 
 
 
Solution Calc. conc. [ng/mL] Eff. conc. [ng/mL] Volume added Final volume [mL] 
SS(ISTD)  100'000   100'600      
ISTD  1'000   1'006  500 µl SS(ISTD) 50 
   
 
 Internal standard 5’,5’,5’,6-[2H4]-5-methylcytosine 
  Solution Calc. conc. [ng/mL] Eff. conc. [ng/mL] Volume added Final volume [mL] 
SS(ISTD)  100'000   100'000      
WS1(ISTD)  10'000   10'000  1000 µl SS(ISTD) 10 
ISTD  50.0   50.00 250 µl WS1(ISTD) 50 
     
Table 5:  Solution preparation tables for both standards and internal standards including 
dilution steps 
The ISTD solution was prepared by mixing 500 µL of SS(ISTD) cytosine and 250 µL 
of WS1(ISTD) 5-methylcytosine in a 50 mL volumetric flask and diluted with 
MeCN/MeOH 75:25, to obtain a final concentration of 1006 ng/mL and 50 ng/mL of 
2,4-[13C2,15N3]-cytosine and 5’,5’,5’,6-[2H4]-5-methylcytosine, respectively. 
The standard solutions used for the calibration curves were built with one blank and 
six concentrations between 100 and 3’000 ng/mL for cytosine and 10 and 160 ng/mL 
for 5-methylcytosine. The first calibration point was prepared mixing 100 µL of STD1 
cytosine, 100 µL of STD1 5-methylcytosine in a micro-vial. The next five calibration 
points (STD2-6) are prepared exactly in the same way. Then, 100 µL of ISTD 
solution is added before sample preparation to all calibration points and quality 
control samples (see Chapt. 4.4.5). After evaporation of the solvent with continuous 
N2 gas flow in a heat block (Techne Dri-block DB-3D, Staffordshire, UK) at room 
temperature (RT), the samples were reconstituted in 100 µL of MeCN/MeOH 75:25. 
The standard solution containing 3.6 mol% 5-methylcytosine without ISTD used for 
evaluation of the mass analyzers was prepared by mixing 900 µL of STD3 cytosine 
with 900 µL of STD3 5-methylcytosine. After solvent evaporation under N2 at RT in a 
heat block, the samples were reconstituted in 900 µL MeCN/MeOH 75:25. 
The standard solution with 3.6 mol% 5-methylcytosine containing both ISTDs was 
prepared by mixing 700 µL of STD3 cytosine with 700 µL of STD3 5-methylcytosine 
and 700 µL of ISTD solution. Finally, the solvent was evaporated with N2 at RT in a 
heat block and the samples were reconstituted in 700 µL MeCN/MeOH 75:25. 
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4.4.3 Chromatography 
The QTOF and the ion trap mass analyzers were coupled to an Acquity system 
(Waters, Milford, MA, USA) equipped with sample manager, solvent manager, 
column manager and PDA eλ detector. 
The Qtrap instrument was connected to an Ultimate 3000 Binary Rapid Separation 
LC system (Dionex, Sunnyvale, CA, USA) equipped with an Ultimate 3000 
autosampler, a binary pump, and a DAD-3000RS diode array detector.  
Following conditions were used for the reversed phase conditions: Acquity UPLC 
BEH column (1.7 µm, 2.1 x 50 mm, Waters, Milford, MA, USA) and a mobile phase 
consisting of solvent A H2O and B MeCN both buffered with 5 mM nonafluoro-
pentanoic acid (NFPA). The compounds were eluted at 0.5 mL/min flow rate, first 
isocratically from 0 to 2 min at 5 % of B, followed with a first linear gradient from 5 % 
to 35 % of B within 3 min and a second linear gradient from 35 % to 70 % within 
3 min. The column was then equilibrated with 5 % of B during 3 min until next 
injection. The autosampler needle of the Acquity system was washed with a strong 
needle wash solution of MeOH/H2O 2:1 + 0.1% formic acid and a week needle wash 
solution of MeCN/H2O 10:90. A volume of 5 µL sample solution was respectively 
injected. 
For normal phase conditions, an Acquity UPLC BEH Amide column (1.7 µm, 2.1 x 
100 mm, Waters, Milford, MA, USA) and a mobile phase consisting of solvent A 
(MeCN/H2O 1:1) and B (MeCN/H2O 95:5) both buffered with 10 mM HCOONH4 and 
0.125% HCOOH were chosen. The compounds were eluted at 0.5 mL/min flow rate 
with a linear gradient from 95% to 85% of B within 4 min. The wash step consisted in 
a non-linear gradient (curve 2) from 85% to 50% of B in 2 min. The column was 
finally equilibrated during 2 min until the next injection. The autosampler needle of 
the Dionex system was washed with a solution of MeCN/H2O 9:1 and that of the 
Acquity with a strong needle wash solution of MeCN/MeOH 75:25 and a week needle 
wash solution of MeCN/H2O 95:5. A volume of 5 µL sample solution was respectively 
injected. 
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4.4.4 Mass spectrometry 
Mass spectrometer parameters were optimized with a continuous flow injection of a 
solution containing cytosine (concentration of 100 ng/mL), 5-methylcytosine 
(40ng/mL), 2,4-[13C2,15N3]-cytosine (100 ng/mL), and 5’,5’,5’,6-[2H4]-5-methylcytosine 
(50 ng/mL) at a flow rate of 7 µL/min. 
The maXis UHR-QTOF (Bruker Daltonics GmbH, Bremen, Germany) connected to 
the Acquity UPLC system (Waters) was equipped with an electrospray ion source. 
Condition for ESI: end plate offset (-500 V), Capillary (4000 V), nebulizer gas (N2, 
1.6 bar), dry gas (N2, 10 L/min), and dry temperature (200 °C). MS-parameters: 
funnel RF (200 Vpp), ISCID energy (0 eV), multipole RF (200 Vpp), ion energy (2 eV), 
low mass (50 m/z), collision energy (10 eV, He gas), collision RF (400 Vpp), ion 
cooler (45 Vpp), transfer time (32 µs), and pre-puls storage (9 µs). MS acquisitions 
were performed in the positive ionization mode at 20’000 full width half maximum 
(FWHM) resolution. Spectra were acquired between m/z 50 and 500, in the full scan 
mode, and at 5 Hz scan rate. An external mass calibration below 2 ppm accuracy 
was performed between m/z 91 and 1450 just before starting a sequence with a 2 
mM solution of sodium formate in H2O/propan-2-ol 1:1. Signals corresponding to 
cytosine (m/z 112.050), 5-methylcytosine (126.066), 2,4-[13C2,15N3]-cytosine 
(117.048), and 5’,5’,5’,6-[2H4]-5-methylcytosine (130.091) were integrated from high-
resolution extracted ion chromatograms with a mass width of ± 0.05 m/z and using 
the Bruker QuantAnalysis® software.  
The HCT ion trap mass spectrometer (Bruker Daltonics GmbH, Bremen, Germany) 
was connected to a Waters Acquity UPLC system from (Waters) and equipped with 
an electrospray ion source. Condition for ESI: nebulizer gas (N2, 35 psi), dry gas (N2, 
8 L/min), and dry temperature (320 °C). MS-parameters: target mass (m/z 120), 
compound stability (100 %), trap drive level (90 %). MS acquisitions were performed 
in the positive ion mode at a normal resolution (0.6 u peak width) and under ion 
charge control conditions (ICC, target: 10’000). Full scan MS were averaged over 
8 single spectra and acquired with a mass window between m/z 20 and 200. Data 
were processed with the Bruker DataAnalysis® software. 
The Dionex UHPLC system was coupled to a 3200 QTRAP LC/MS/MS hybrid triple 
quadrupole/linear ion trap mass spectrometer (AB Sciex, Foster City, CA, USA) 
equipped with a TurboIonSpray source. Ionization was performed using positive 
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electrospray ionization. Collision-induced dissociation was done in the second 
quadrupole with N2 as collision gas. Following optimized parameters were used: 
Curtain gas (CUR, 20 psi), collision gas (CAD, Medium), ion spray voltage  
(IS, 5000 V), temperature (TEM, 450 °C), ion source gas 1 (GS1, 50 psi), ion source 
gas 2 (GS2, 60 psi), interface heater (ihe, on), collision energy (CE, 21 V), and 
collision cell exit potential (CXP, 4 V). Compound specific parameters are 
summarized in Table 6.  
 
Declustering 
potential (DP) 
Entrance 
potential (EP) 
Collision cell entrance 
potential (CEP) 
cytosine 46 V 12 V 14 V 
2,4-[13C2,15N3]-cytosine 46 V 9.5 V 18 V 
5-methylcytosine 46 V 12 V 16 V 
5’,5’,5’,6-[2H4]-5-methylcytosine  51 V 11.5 V 16 V 
    
Table 6:  Qtrap MS/MS specific parameters for cytosine, 2,4-[13C2,15N3]-cytosine, 5-methyl-
cytosine, and 5’,5’,5’,6-[2H4]-5-methylcytosine 
For the detection of cytosine, 2,4-[13C2,15N3]-cytosine, 5-methylcytosine, and 
5’,5’,5’,6-[2H4]-5-methylcytosine, MS/MS transitions from m/z 112.0 to 95.0, 117.0 to 
99.0, 126.0 to 108.9, and 130.1 to 113.0, respectively, were selected with 150 ms 
dwell time. Data were acquired at normal resolution (0.6 u peak width) and 
processed using the Analyst software (AB Sciex). 
After integration of the corresponding HR-EIC (maXis) and EIC (ion trap, Qtrap) 
signals, a quadratic regression was finally used to calculate the absolute amount of 
cytosine and 5-methylcytosine in the hydrolyzed CT and human DNA samples. The 
percentage of methylated cytosine was calculated after conversion of ng/mL in 
nmol/mL and using following equation:  
5 methylcytosine mol% =
5 methylcytosine nmol
5 methylcytosine nmol + cytosine nmol
100  
4.4.5 DNA hydrolysis 
Aqueous solutions containing 1 g of CT DNA in 100 L or approximately 2 +g of 
human DNA (volumes varying between 10 and 500 +L) were transferred into 250 +L 
micro-vials (Infochroma, Zug, Switzerland). 100 L of the internal standard solution 
containing 1’006 and 50 ng/mL of 2,4-[13C2,15N3]-cytosine and 5’,5’,5’,6-[2H4]-5-
methylcytosine, respectively, dissolved in MeCN/MeOH 75:25 were added. After 
evaporation of the solvent with a continuous N2 gas flow at 23°C in a sample 
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concentrator (Techne Dri-block DB-3D), the residue was dissolved in 50 µl formic 
acid (98%). The micro-vials were then sealed with alumina crimp caps and 
PTFE/silicone/PTFE septa (Infochroma), and DNA was hydrolyzed at 150 °C for 3 h. 
After been cooled down, the solution was completely dried under a continuous N2 
flow at room temperature and the residue reconstituted in 100 µL MeCN/MeOH 75:25. 
Samples were stored at -20°C for maximum one day prior UHPLC-MS analysis. 
As quality control 100 µL of an aqueous CT DNA solution (10’000 ng/mL) was used 
sample during the determination of the methylation grade of human DNA. 
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CHAPTER 5 
METHYLATION METABOLISM IN SEPSIS AND SYSTEMIC 
INFLAMMATORY RESPONSE SYNDROME 1 
5.1 Introduction 
Despite an increase in knowledge on its pathogenesis, sepsis remains the most 
common non-cardiac cause of critical illness. The incidence of sepsis even increases, 
probably due to an increase in the number of immune-compromised patients, 
increase in anti- biotic resistance, and aging of the population [1]. 
The mortality of sepsis is around 30%, and many sepsis survivors suffer from 
sustained and severe long-term cognitive impairment and functional disability, which 
further intensifies the public health burden from this disease [2]. Almost all innovative 
treatment strategies have failed in the recent years, and clearly, there is a strong 
need for better insight in disease pathogenesis and subsequent emerging treatment 
strategies. 
In a rodent model it has been recently shown that sepsis leads to alterations of 
methylation metabolism, especially increased plasma S-adenosyl methionine (SAM) 
levels [3]. S-adenosyl methionine (SAM) has a central position in methylation 
metabolism as a universal and unique methyl-donor to maintain normal methylation 
of DNA, RNA, proteins, phospholipids and variety of other molecules. The 
degradation product of SAM is S-adenosyl homocysteine (SAH). As SAM and SAH 
are the substrate and product of methylation reactions and SAH is a potent inhibitor 
                                            
1Paper accepted: Methylation metabolism in sepsis and systemic inflammatory response syndrome, 
Scandinavian Journal of Clinical and Laboratory Investigation, 2013, Alexander Semmler, Jean-
Christophe Prost, Yvo Smulders, Desiree Smith, Henk Blom, Laurent Bigler, Michael Linnebank 
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of transmethylation reactions, the cellular SAM/SAH ratio is commonly regarded as 
reflecting methylation capacity. Alterations in methylation metabolism during sepsis 
may be clinically relevant because SAM has been demonstrated to have anti-
inflammatory function in sepsis [4] and endotoxemia [5] and because alterations of 
methylation capacity potentially impair a huge variety of essential biochemical 
reactions and thereby may contribute to disease mortality. In this study we address 
possible alterations in methylation metabolism in human sepsis. 
5.2 Method  
5.2.1 Patient selection 
Adult patients of Caucasian origin treated in one of the Intensive Care Units (ICU) at 
the University Hospital Bonn were included. Patients were classified as having sepsis 
or systemic inflammatory response syndrome (SIRS) diagnosed according to the 
diagnostic criteria defined by the American College of Chest Physicians/Society of 
Critical Care Medicine Consensus Conference [6] (n = 12). Patients who were 
treated due to traumatic brain injury, stroke (subarachnoid haemorrhage or 
ischaemic), and who did not met the diagnostic criteria for sepsis/SIS were included 
as comparison group (n = 22). Exclusion criteria included pre- existing metabolic 
diseases that might influence test results such as diabetes mellitus, alcohol abuse or 
patients with pre-existing renal or hepatic dysfunction. Patients with baseline vitamin 
B12 and folate plasma levels below the reference range were also excluded from the 
study. Patients who developed renal or hepatic dysfunction during the ICU treatment 
were not excluded from the study. Patients who developed renal impairment during 
ICU treatment received hemofiltration as considered necessary by the treating 
physician. The ICU treatment of all patients was carried out according to standard 
clinical procedures. Critically ill patients who could not eat received enteral nutrition 
sup- port if they did not have contraindications to enteral feeding (e.g. peritonitis, 
pancreatitis, ileus). Others received parenteral nutrition. Patients were included in the 
study within the first three days of ICU treatment. Blood samples were taken two 
times a week, until the ICU treatment was discontinued. Because sample collection 
was discontinued after discharge from ICU and sepsis patients stayed longer on the 
ICU than non-septic patients, there was a significant difference between groups in 
number of samples available after the 5th sample (third week of ICU treatment). 
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Therefore, all samples collected after the 5th one were excluded from statistical 
analyses. Medical data collected during ICU treatment included diagnosis, length of 
ICU stay, survival, age, and gender. 
5.2.2 Ethics statement 
All patients gave written informed consent. When patients were not able to consent, 
because they had analgosedation, ventilator support or a neurological deficit, their 
legal representatives were asked to consent. The study was approved by the local 
ethics committee of the University of Bonn. 
5.2.3 Analytical methods 
Blood samples were collected in EDTA-containing vials for the determination of 
plasma SAM and SAH, and DNA isolation. Vials containing heparinlithium as 
anticoagulant were used for later measurement of homocysteine levels. Vials were 
immediately placed on ice. To obtain plasma, the blood was first centrifuged for 15 
min at 4000 g and 4°C, immediately after collection. The supernatant was 
deproteinized by perchloric acid 10%. All aliquots were stored at –80°C for 1–2 
months before shipment on dry ice. Deproteinized plasma was used for simultaneous 
determination of SAM and SAH by using stable isotope dilution tandem mass 
spectrometry as previously published [7]. Inter-assay coefficients of variation were 
6.8% for SAM and 6.9% for SAH. 
Homocysteine was determined by fully automated particle-enhanced 
immunonephelometry with a BN II System (Dade Behring) by enzymatic conversion 
to S-adenosyl homocysteine (SAH). The intra-assay coefficient of variation of the 
homocysteine assay was 3.4 % (mean: 11 µmol/L, n = 20), while the inter-assay 
coefficient was 5.6 % (mean: 11 mg/dL, n = 20). Serum concentrations of vitamin 
B12 and folate were measured by means of a competitive chemiluminescent 
immunoassay with an Access™ Immunoassay System (Beckman Coulter, Krefeld, 
Germany) according to manufacturer’s instructions.  
5.2.3 Global DNA-methylation 
Global DNA-methylation was measured by liquid chromatography tandem mass 
spectrometry according the method developed and validated (see Chap. 4 and 
literature [8]). In short, 1 µg of DNA was hydrolyzed using formic acid. Cytosine and 
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5-methylcytosine were separated using gradient elution normal phase 
chromatography and electrospray ionization (ESI) tandem mass spectrometry, 
operating in the multiple reaction monitoring (MRM) mode and quantified using 
labeled internal standards. The level of DNA methylation is expressed as the  
5-methylcytosine/total-cytosine ratio. The intra- and inter-assay coefficient of 
variation (CV) for the 5-methylcytosine/total-cytosine was 2.0 % (n = 9) and 2.4 %  
(n = 9) for calf thymus DNA (mean 5-methylcytosine/total-cytosine ratio 6.8 %) 
respectively. For human control (n = 50) and patients (n = 60) samples the  
5-methylcytosine/total-cytosine ratio varied from 2.3 % to 5.8 % (median 4.3 %) and 
from 2.6 % to 6.3 % (median 4.4 %), respectively  
5.2.4 Statistics 
Biochemical parameters are presented as median (range) and analyzed using 
ANOVA for repeated measures for samples 1–5. IBM SPSS Statistics 20 (SPSS Inc., 
Chicago, IL, USA) was used. To address clustering of measurements within patients, 
linear regression with robust standard errors was used to compute differences 
between values of patients with and without sepsis. Stata 11 (StataCorp, College 
Station, TX, USA) was used. 
5.3. Results 
5.3.1 Clinical Characteristics 
The clinical characteristics of the patients included are summarized in Table I. Septic 
patients were older, stayed longer on the ICU, had higher APACHE 2 scores, more 
often renal failure, and received more often parenteral nutrition during ICU treatment. 
5.3.2 Biochemical Parameters 
The results of all measured biochemical parameters are shown are shown in Figures 
1–4. Plasma SAM levels were increased in septic patients by 127 nmol/L (95% CI 
81–172; p < 0.001). Plasma SAH levels were increased in septic patients by 48 
nmol/L (95% CI 24–71; p < 0.001). The ratio of SAM/SAH was decreased in septic 
patients by 1.67 (95% CI 2.70–0.64; p > 0.002). There was no difference in plasma 
homocysteine levels (reduction of 0.63 µmol/L in septic patients, 95% CI reduction of 
2.56 to an increase of 1.29; p = 0.32) and no difference in global DNA methylation 
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between septic and non-septic patients (reduction of 0.064 in septic patients, 95% CI 
reduction of 0.039 to an increase of 0.17; p = 0.21). Folate and vitamin B12 levels 
were within the reference range for all patients and not different between septic and 
non-septic patients at all measured time points (data not shown). 
 Sepsis/SIRS Non-septic patients 
Age (years) 65.5 (24–76) 49 (33–80) 
Gender (female/male), n 5/7 8/14 
Apache 2 score 21.5 (17–28) 12 (3–26) 
ICU length of stay (days) 22.5 (15–81) 10 (5–32) 
Survival (%) 75% 95% 
Multiple trauma (%) 33% 5% 
Head trauma (%) 8% 18% 
Stroke (%) 0% 82% 
Surgery (%) 91% 59% 
Peritonitis/pancreatitis (%) 33% 0% 
Sepsis/SIRS (%) 50%/50% - 
Parenteral nutrition (%) 50% 27% 
Hemofiltration (%) 58% 9% 
Vitamin B12 baseline pmol/L (n 130–680) 559 (203–739) 498 (128–1107) 
Folic acid baseline nmol/L (n 6.8–39) 19.0 (10.9–29.2) 12.9 (7.0–35.6) 
   
Table 1:  Clinical characteristics of sepsis and non-septic ICU patients. Continuous 
variables are presented as median (range). SIRS, systemic inflammatory 
response syndrome. 
The results of all measured biochemical parameters are shown are shown in Figures 
1–4. Plasma SAM and SAH levels were higher in septic patients. The ratio of 
SAM/SAH was lower in septic patients. There was no difference in plasma 
homocysteine levels and no difference in global DNA methylation between septic and 
non-septic patients. Folate and vitamin B12 levels were within the reference range for 
all patients and not different between septic and non-septic patients at all measured 
time points (data not shown). 
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Figure 1: Plasma SAM (A) and SAH (B) levels. X-axis depicts the week when the sample 
was taken. Filled circels represent sepsis patients, empty circles depict non-
septic ICU patients. Error bars represent SEM. p-values are significance levels of 
ANOVA for repeated measures. Bar plots are not exactly placed on the five 
different time points to avoid overlap of error bars. 
5.4. Discussion 
This study shows that human methylation metabolism may be altered during sepsis. 
Plasma SAM and SAH levels of sepsis and control patients did not approximate 
throughout the observation period. This demonstrates that the alterations of 
methylation metabolism during sepsis are sustained and do not normalize during ICU 
treatment. 
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In septic patients, plasma SAM and SAH levels are increased. As intracellular SAM 
and SAH levels re physiologically several times higher than their plasma levels [9], 
the increase of plasma SAM and SAH levels may be explained by sepsis-induced 
intravascular hemolysis and lysis of other cells, such as liver cells and therefore 
release of cell SAM and SAH into the plasma. However, the present data do only 
allow speculations on the underlying mechanisms of SAM and SAH level changes. 
Patients diagnosed with sepsis in general had a more severe disease than non-
septic patients documented by higher APACHE2 scores, more renal failure, longer 
ICU treatment, more use of parental nutrition. Therefore, it is possible that the 
changes seen in the methylation metabolism are, in part, not specific for sepsis/SIRS, 
but an expression of disease severity and its treatment. 
 
Figure 2:  Error bar plots of plasma SAM and SAH ratios. X-axis depicts the week when the 
sample was taken. Filled circels represent sepsis patients, empty circles depict 
non-septic ICU patients. Error bars represent SEM. p-values are significance 
levels of ANOVA for repeated measures. Bar plots are not exactly placed on the 
five different time points to avoid overlap of error bars. 
In a rodent model of sepsis, we observed increased plasma SAM levels 24 hours 
after sepsis-induction, but the plasma SAH levels remained unchanged [3]. However, 
the animal data are not readily comparable with the present study, as they only 
demonstrate a one-time measurement of plasma SAM and SAH levels 24 h after 
sepsis induction, and do not show the progression of SAM/SAH levels during more 
than two weeks of sepsis as the current study. In septic patients, SAH levels 
approximated to the levels observed in disease controls during the clinical course. 
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Thus, the normal SAH level observed in rodents might well have been a question of 
the time- point of measurement. 
 
Figure 3: Error bar plots of plasma homocysteine levels. X-axis depicts the week when the 
sample was taken. Filled circels represent sepsis patients, empty circles depict 
non-septic ICU patients. Error bars represent SEM. p-values are significance 
levels of ANOVA for repeated measures. Bar plots are not exactly placed on the 
five different time points to avoid overlap of error bars. 
Plasma homocysteine levels have been reported to correlate with plasma SAH levels 
and also with lymphocyte DNA methylation [10]. We did not observe an association 
of SAH and homocysteine plasma levels, as the plasma homocysteine levels 
remained unaltered during the whole observation period. The sepsis-induced 
changes of SAM and SAH levels result in a reduced SAM/SAH ratio and thus in a 
significantly reduced methylation capacity during sepsis. However, this was not 
associated with changes of homocysteine plasma levels or global methylation of 
leukocyte DNA. The distribution of data differed between groups as in the group of 
non-septic ICU patients we included more patients but with less measurements per 
patient, because non-septic patients had on average a shorter ICU stay. We 
therefore additionally calculated linear regression with robust standard errors to 
address clustering of measurements within patients. These calculations show a wide 
95% confidence interval for homocysteine and for DNA-methylation indicating that 
small effect sizes may have been over- looked and possibly could be detected in a 
larger sample. It is also possible that the sepsis-induced changes of methylation 
capacity do affect other SAM methyl transfer reactions such as histone or RNA 
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methylation, methylation of proteins, neurotransmitters and phospholipids, but this 
has not been examined in the present study. Thus, further studies may explore the 
clinical relevance of those observed changes. 
 
Figure 4:  Error bar plots of percentage of methylated cytosine (%mCyt). X-axis depicts the 
week when the sample was taken. Filled circels represent sepsis patients, empty 
circles depict non- septic ICU patients. Error bars represent SEM. p-values are 
significance levels of ANOVA for repeated measures. Bar plots are not exactly 
placed on the five different time points to avoid overlap of error bars. 
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SUMMARY !  ZUSAMMENFASSUNG 
1. English version 
Epigenetic modifications, as e.g. methylation of histones and DNA, regulate gene 
expression. However, misregulation of this methylation can lead to very dangerous 
diseases as cancers, neurological disorders or autoimmune diseases. DNA also 
undergoes simply changes in the genomic sequence called mutations. They can be 
classified in advantageous, neutral and lethal processes. Advantageous mutations 
can contribute to evolutionary changes due to environmental influences. In contrast, 
lethal damages of the genomic sequence in cellular processes arising from DNA 
methylation, replication errors, ionizing radiation, or UV-irradiations, frequently result 
in cancers. 
These important concepts necessary for the macromolecular machinery of life are 
presented in the first part of Chapter 1. They include also the flow of genetic 
information in a cell, primary, secondary, and tertiary structures of DNA, as well as 
packaging of DNA in a cell by proteins called histones. 
As the rate of DNA mutation and relative binding affinities of small molecules to DNA 
will be considered in this thesis, the second part of Chapter 1 deals with quantitative 
determinations. Aspects of calibration, systematic and random errors, limit of 
detection, limit of quantification, dynamic range, and linearity are discussed. 
Combination of chromatography with mass spectrometry is often the method of 
choice used in quantification. Regarding the sample properties, criteria for selecting 
the most appropriate analytical method are developed, including chromatography, 
ionization modes, and mass analyzers. 
In Chapter 2, a method has been optimized in order to detect double stranded DNA 
with maximal intensity and minimal adducts formation using an ESI-HR-QTOF mass 
spectrometer. With this method, non-covalent interactions between short 14-mers 
ds DNA and small organic molecules were investigated, including polyamine 
derivatives, flavonoids (Figure 1), or DNA stains (DAPI and EthBr).  
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Figure 1:  ESI-MS spectra of ds1 d(AACTCCCGGCACAC/GTGTGCCGGGAGTT) mixed 
with (A) spermine, (B) 5,10-bis(E-cinnamoyl) spermine and (C) vitexin in a 1:4 
ratio. Calculated fraction of bound DNA (in mol%) is framed. 
The new ESI-HR-QTOF method was validated with the measure of relative binding 
affinities between flavonoids and synthetic ds DNA strands. The results obtained 
were comparable to published data, although the absolute values were lower. 
Experiments with the ligands DAPI and EthBr demonstrated that the method could 
also be used to investigate the selectivity of the non-covalent interactions with regard 
to the GC- and AT-content of the DNA sequences. Finally, polyamines derivatives 
were found to interact with DNA under MS conditions, whereby acyl-polyamines 
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presented twice so high binding affinities than free polyamines (ca 4 compared to 
2 %, respectively). However, these values are much lower as those observed for the 
flavonoids derivatives (6 – 28 %). 
In Chapter 3, a method was developed for quantifying the photoprotection effect of 
secondary metabolites in relation to UV irradiation of ds DNA. Therefore, a procedure 
was developed consisting of a self-made UV-irradiation box, photolysis of TpT 
solutions in presence of UV filters dissolved in separated or in the same cuvette, and 
UHPLC-ESI-MS quantification. Best chromatographic properties were obtained with 
normal phase conditions. Best selectivity of the MS-detection was obtained with a 
method based on MS/MS and best sensitivity with acquisition in the high-resolution 
full-scan mode. It appears that signals corresponding to photoproducts were of low 
intensities, probably because of the very low quantum yields of only 2% for the major 
product. 
 
Figure 2:  Sum of the formation of all four photoproducts after irradiating an aqueous 
solution of 10 µM TpT at 312 nm during 56 min without and in the presence of 50 
µM UV filter solutions of apigenin, vitexin, kuromanin, p-coumaric acid, spermine, 
and 5,10-bis(E-cinnamoyl) spermine prepared in separated cuvettes 
The inhibition rate of TpT photoproduct formation was measured in presence of 
specific natural products (polyamines and their derivatives, flavonoids, anthocyan 
and hydroxycinnamic acid) in two quartz micro-cuvettes (see Figure 2). A decrease 
of photoproduct formation is observed after irradiation of TpT at 312 nm in presence 
of these UV-filters. Only spermine did not inhibit photoproduct formation. This is due 
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to the lack of chromophore absorbing in the irradiation wavelength. Similar effects 
have been observed at 254 nm, but to a lesser extent. Preliminary experiences of 
photoprotection were also performed with oligomers (TpT and ds DNA) using single 
cuvette. Unfortunately the signals obtained were just above the limit of detection. 
Chapter 4 discusses the development of an analytical method for the quantitative 
determination of the methylation grade of DNA. High-resolution and tandem mass 
spectrometric techniques were used in combination with the addition of isotopically 
labeled internal standards to the samples. UHPLC-ESI-MS/MS showed the best 
reproducibility and was also more precise than other tested mass analyzers as QTOF 
or ion trap operated in full scan acquisition mode (Figure 3). The method was finally 
validated using calf thymus DNA samples. 
 
Figure 3: Reproducibility and precision of 10 injections of a single solution containing 
standards of cytosine and 5-methylcytosine prepared in a 3.6 mol% ratio (black 
dashed line) and their corresponding labeled ISTD. Analyses were performed 
using the maXis QTOF, HCT ion trap and 3200 Qtrap mass analyzers. Mean 
ratios are given in brackets, intra-assay CV in red, and standard deviation in grey. 
Compared to the best-published method, an analysis time reduction of 33 % could be 
achieved with the method developed here. A mean methylation grade of 6.8% was 
obtained with intra- and inter-assay CVs of 2.0 and 2.4%, respectively. These values 
indicate that the new method is precise and reproducible enough to be used for the 
quantification of 5-methylcytosine in patient samples.  
Chapter 5 involves an application of the method for determination of the DNA 
methylation grade developed in Chapter 4. A biological study was completed to verify 
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if methylation metabolism and DNA methylation are correlated in human sepsis 
systemic inflammatory response syndrome. The global DNA-methylation was 
measured by means of extracting DNA from blood samples and quantifying cytosine 
and 5-methylcytosine with the new UHPLC-ESI-MS/MS method. It appears that 
sepsis and systemic inflammatory response syndrome induce considerable changes 
of methylation metabolism without apparent functional consequences on 
homocysteine plasma levels or DNA methylation. 
Summary ! Zusammenfassung 
 142 
1. Deutsche Version 
Epigenetische Änderungen wie zB die Methylierung von Histonen und und der DNA 
regeln den Ausdruck der Gene. Gleichwohl können Fehlregelungen dieser 
Methylierung jedoch zu sehr gefährlichen Krankheiten wie Krebs, neurologischen 
Störungen oder autoimmunen Krankheiten führen. Die DNA unterliegt auch 
einfachen Änderungen in der genomischen Sequenz, den sogenannten Mutationen.  
Sie können eingeteilt werden in vorteilhafte, neutrale und tödliche Prozesse. Die 
vorteilhaften Mutationen können zu evolutionären Änderungen bedingt durch 
Umwelteinflüsse beitragen. Im Gegensatz haben tödlichen Beschädigungen der 
genomischen Sequenz in Zellprozessen herrührend von einer DNA Methylierung, 
Replikationsfehlern, ionisierenden Strahlen oder UV-Bestrahlung oft Krebs zur Folge. 
Diese für die makromolekularen Mechanismen des Lebens wichtigen Begriffe 
werden im ersten Teil von Kapitel 1 vorgestellt. Sie enthalten auch den Fluss der 
genetischen Information in der Zelle, die primären, sekundären und tertiären 
Strukturen der DNA sowie das Einbetten der DNA in einer Zelle durch Proteine, den 
sogenannten Histonen. 
Da die Geschwindigkeit der DNA Mutation und die relative Bindungsaffinität von 
kleinen Molekülen zur DNA in dieser Arbeit betrachtet werden, behandelt der zweite 
Teil von Kapitel 1 die quantitative Bestimmung. Gesichtspunkte zur Kalibrierung, der 
systematischen und zufälligen Fehler, der Detektionsgrenzen, der 
Quantifizierungsgrenzen, des dynamischen Bereiches und der Linearität werden 
diskutiert. Chromatographie kombiniert mit Massenspektrometrie ist eine oft benützte 
Methodenwahl für die Quantifizierung. Bezüglich der Probeneigenschaften werden   
Auswahlkriterien für die geeignetste Methode entwickelt, einschliesslich 
Chromatographie, Ionisierungsmodus und Massenanalysator. 
In Kapitel 2 wird eine Methode optimiert um eine doppel-strängige DNA mit 
maximaler Intensität und einer minimalen Bildung von Nebenprodukten zu 
detektieren mittels eines ESI-HR-QTOF Massenspektrometers. Mit dieser Methode 
wurden nicht-kovalente Wechselwirkungen zwischen kurzen 14-mers ds DNA und 
kleinen organischen Molekülen untersucht, einschliesslich Polyamin-Derivate, 
Flavonoide (Figur 1) oder DNA Flecken (DAPI und EthBr). 
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Figur 1:  ESI-MS Spektra von ds1 d(AACTCCCGCACAC/GTGTGCCGGGAGTT) 
gemischt mit (A) Spermin, (B) 5, 10-bis(E-cinnamoyl) Spermin und (C) Vitexin in 
einem 1:4 Verhältnis. Der berechnete Anteil von gebundener DNA (in mol%) ist 
eingerahmt.  
Die neue ESI-HR-QTOF Methode wurde validiert durch die Messung der relativen 
Bindungsaffinität zwischen Flavonoiden und synthetischen ds DNA Strängen. Die 
erhaltenen Resultate waren vergleichbar mit publizierten Daten, auch wenn die 
absoluten Werte tiefer lagen. Versuche mit den Liganden DAPI und EthBr bewiesen, 
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dass die Methode auch benützt werden kann um die Selektivität von nicht-kovalenten 
Wechselwirkungen bezüglich des GC- und AT-Gehaltes der DNA-Sequenzen zu 
untersuchen. Schliesslich wurde bemerkt, dass Polyaminderivate mit der DNA unter 
MS-Bedingungen in Wechselwirkung treten, wobei Acyl-Polyamine eine zweifach 
höhere Bindungsaffinität aufwiesen als freie Polyamine (ca 4 verglichen mit 2% 
respective). Hingegen sind diese Werte viel tiefer als jene die für Flavonoid-Derivate 
beobachtet wurden (6 – 28 %). 
In Kapitel 3 wurde eine Methode entwickelt um den Photoschutzeffekt von 
Sekundärmetaboliten im Zusammenhang mit der UV-Bestrahlung von ds DNA zu 
quantifizieren. Hierzu wurde ein Verfahren entwickelt bestehend aus einem hier 
gefertigten UV-Bestrahlungskasten, Photolyse von TpT-Lösungen im Beisein von 
UV-Filter gelöst in einer separaten oder der gleichen Küvette, und einer UHPL-ESI-
MS Quantifizierung. Die besten chromatographischen Eigenschaften wurden unter 
normalen Phasenbedingungen erreicht. Die beste Selektivität der MS-Detektierung 
wurde erreicht mit einer Methode basierend auf MS/MS und beste Empfindlichkeit 
mit der Aufnahme im hoch-auflösenden Full-Scan Modus 
 
 
Figure 2:  Summe der Bildung aller vier  Photoprodukte nach nach Bestrahlung einer 
wässerigen Lösung von µM TpT bei 312 nm während 56 min ohne und im 
Beisein einer 50 µM UV Filter Lösung von Apigenin, Vitexin, Kuromanin, p-
coumarichen Säure, Spermin, and 5,10-bis(E-cinnamoyl) Spermin hergestellt in 
separaten Küvetten 
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Man sieht, dass Signale welche Photoprodukten entsprechen von tiefer Intensität 
sind, dies wahrscheinlich wegen einer tiefen Quantenausbeute von nur 2% für das 
Hauptprodukt.  
Die Inhibitonsrate der Bildung von TpT Photoprodukten wurde gemessen im Beisein 
von spezifischen natürlichen Produkten (Polyamine und ihre Derivate, Flavonoide, 
Anthocyan und hydroxycinnamicher Säure) in zwei Quarz-Mikroküvetten (siehe 
Figur 2) Eine Abnahme der Bildung von Photoprodukten wurde nach der Bestrahlung 
von TpT bei 312 nm im Beisein von diesen UV-Filter beobachtet.  Nur Spermin 
inhibierte die Bildung von Photoprodukten nicht. Dies ist bedingt durch die 
Abwesenheit von Chromophoren die in diesem Strahlungswellenbereich absobieren. 
Aehnliche Effekte wurden bei 254 nm beobachtet, wenn auch weniger stark. 
Vorläufige Versuche von Photoschutz wurden auch ausgeführt mit Oligomeren (TpT 
und ds DNA) unter Benützung einer einzelnen Küvette. Leider waren die erhaltenen 
Resultate unterhalb der Detektionsgrenze.  
Kapitel 4 diskutiert die Entwicklung einer analytischen Methode für die quantitative 
Bestimmung des Methylierungsgrades der DNA. Hoch auflösende und tandem 
massenspektrometrische Techniken wurden benützt in Verbindung mit der Zugabe 
von isotopisch markierten internen Normalen zu den Proben. UHPLC-ESI-MS/MS 
zeigte die beste Reproduzierbarkeit und war auch genauer als andere getesteten 
Massanalysatoren wie QTOF oder eine Ionen-Falle im „Full Scan Acquisition“ Modus 
(Figur 3). Die Methode wurde schliesslich validiert unter Benützung von Kalbsthymus 
DNA Proben.  
 
Summary ! Zusammenfassung 
 146 
 
 Figur 3: Reproduzierbarkeit und Genauigkeit von 10 Injektionen in einer einzelnen 
Lösung enthaltend Standards von Cytosine und 5-Methylcytosine zubereitet in 
einem 3.6 mol% Verhältnis (schwarz gestrichelte Linie) und ihre entsprechend 
markierte ISTD. Es wurden Analysen ausgeführt unter Benützung von maXis 
QTOF, einer HCT Ionenfalle und einem 3200 Qtrap Massenanalysator. Mittlere 
Verhältnisse sind in Klammern angegeben und die Intraproben CV in rot, und die 
Standardabweichung in grau. 
Verglichen mit der besten publizierten Methode wurde mit der hier entwickelten 
Methode eine Reduzierung der Analysenzeit von 33% erreicht. Ein mittlerer 
Methylierungsgrad von 6.8 % wurde erreicht mit intra- und inter-Proben CVs von 2 % 
respektive von 2.4 %. Diese Werte zeigen auf, dass die neue  Methode genügend 
genau und reproduzierbar um für die Quantifizierung von 5-methylcytosine in 
Patientenproben benützt zu werden.  
Kapitel 5 beinhaltet die Anwendung der in Kapitel 4 entwickelten Methode für die 
Bestimmung des Methylierungsgrades der DNA. Eine biologische Studie wurde 
ausgeführt um nach zu prüfen ob der Methylierungsstoffwechsel und die DNA 
Methylierung korreliert sind bei einem menschlichen septisch systemischen 
entzündlichem Reaktionssyndrom. Die globale DNA-Methylierung wurde gemessen 
mit Hilfe der Extrahierung von DNA aus Blutproben und der Quantifizierung von 
Cytosin und 5-Methylcytosin mit der neuen UHPLC-ESI-MS/MS Methode. Es scheint, 
dass septische und systemische entzündliche Reaktionssyndrome beachtliche 
Aenderungen des Methylierungsstoffwechsels herbeiführen ohne sichtbare 
funktionale Konsequenzen auf die Homocystein-Plasmaniveaus oder die DNA-
Methylierung. 
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LIST OF ABBREVIATION 
ap apigenin 
APCI atmospheric pressure chemical ionization 
BEH Bridged Ethylene Hybrid 
CE capillary electrophoresis 
CI chemical ionization 
CID collision-induced dissociation 
cou p-coumaric acid 
c-s T<>T cis-syn I cyclobutane thymine 
CT calf thymus  
CV coeffiecient of variation 
Da dalton 
DAPI 4',6-diamidino-2-phenylindole 
ds double stranded 
DMSO dimethyl sulfoxide 
EI electron ionization 
EIC extracted ion chromatogram 
ESI electrospray ionization 
EthBr ethidium bromide 
Eth ethidium 
fb(DNA) fraction of bound DNA 
FT-ICR Fourier-transform ion cyclotron resonance 
FS full scan 
glu glucose 
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GC gaz chromatography 
HPLC high performance liquid chromatography 
HR high-resolution 
ICU Intensive Care Units 
ISTD internal standard 
ku kuromanin 
LOD limit of detection 
LOQ limit of quantification 
MALDI matrix-assisted laser desorption ionization 
min minutes 
mol% mole percent 
MR molecular mass 
MRM multiple reaction-monitoring 
MS mass spectrometry 
MS/MS tandem mass spectrometry 
m/z mass to charge 
NEC non-endcapped 
NH4OAc ammonium acetate 
NH4HCO2 ammonium formate 
RP  reversed-phase 
SAH S-adenosyl homocysteine 
SAM S-adenosyl methionine 
SAR structure-activity relationship 
SIL stable-isotope-labeled 
SIM single ion monitoring 
SIRS systemic inflammatory response syndrome 
spd spermidine 
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spm spermine 
S/N signal to noise ratio 
SRM selectecte reaction-monitoring 
STD standard 
Q quadrupole 
QIT quadrupole ion trap 
QC quality control 
QqQ triple quadrupole 
Tm melting temperature 
TOF time-of-flight 
TpT thymidylyl(3’-5’)thymidine 
t-s T<>T trans-syn I cyclobutane thymine 
UHPLC ultra high perfomance liquid chromatography 
vi vitexin 
1,14-cin spm 1,14-bis(E-cinnamoyl) spermine 
5,10-cin spm 5,10-bis(E-cinnamoyl) spermine 
6-4 TT pyrimidine (6-4) pyrimidone 
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